<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Ready‐to‐use therapeutic food (RUTF) for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age - Schoonees, A - 2019 | Cochrane Library</title> <meta content="Ready‐to‐use therapeutic food (RUTF) for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age - Schoonees, A - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009000.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Ready‐to‐use therapeutic food (RUTF) for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age - Schoonees, A - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009000.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009000.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Ready‐to‐use therapeutic food (RUTF) for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age" name="citation_title"/> <meta content="Anel Schoonees" name="citation_author"/> <meta content="Stellenbosch University" name="citation_author_institution"/> <meta content="anelschoonees@sun.ac.za" name="citation_author_email"/> <meta content="Martani J Lombard" name="citation_author"/> <meta content="North‐West University" name="citation_author_institution"/> <meta content="Alfred Musekiwa" name="citation_author"/> <meta content="Stellenbosch University" name="citation_author_institution"/> <meta content="Etienne Nel" name="citation_author"/> <meta content="Stellenbosch University" name="citation_author_institution"/> <meta content="Jimmy Volmink" name="citation_author"/> <meta content="Stellenbosch University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD009000.pub3" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/05/15" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009000.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009000.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009000.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Food, Formulated; *Weight Gain; Fast Foods; Randomized Controlled Trials as Topic; Recurrence; Severe Acute Malnutrition [*diet therapy, mortality]; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009000.pub3&amp;doi=10.1002/14651858.CD009000.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="sogqpCtr";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009000\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009000\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","pt","ms","fr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009000.pub3",title:"Ready\\u2010to\\u2010use therapeutic food (RUTF) for home\\u2010based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age",firstPublishedDate:"May 15, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Developmental, Psychosocial and Learning Problems Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009000.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009000.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009000.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009000.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009000.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009000.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009000.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009000.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009000.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009000.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>16178 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009000.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-sec-0174"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-sec-0043"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-sec-0044"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-sec-0073"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-sec-0167"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/appendices#CD009000-sec-0179"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/table_n/CD009000StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/table_n/CD009000StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Ready‐to‐use therapeutic food (RUTF) for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/information#CD009000-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Anel Schoonees</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/information#CD009000-cr-0003">Martani J Lombard</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/information#CD009000-cr-0004">Alfred Musekiwa</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/information#CD009000-cr-0005">Etienne Nel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009000.pub3/information#CD009000-cr-0006">Jimmy Volmink</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/information/en#CD009000-sec-0233">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 15 May 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009000.pub3">https://doi.org/10.1002/14651858.CD009000.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009000-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009000-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009000-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009000-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009000-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD009000-abs-0002">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009000-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009000-abs-0001" lang="en"> <section id="CD009000-sec-0001"> <h3 class="title" id="CD009000-sec-0001">Background</h3> <p>Management of severe acute malnutrition (SAM) in children comprises two potential phases: stabilisation and rehabilitation. During the initial stabilisation phase, children receive treatment for dehydration, electrolyte imbalances, intercurrent infections and other complications. In the rehabilitation phase (applicable to children presenting with uncomplicated SAM or those with complicated SAM after complications have been resolved), catch‐up growth is the main focus and the recommended energy and protein requirements are much higher. In‐hospital rehabilitation of children with SAM is not always desirable or practical ‐ especially in rural settings ‐ and home‐based care can offer a better solution. Ready‐to‐use therapeutic food (RUTF) is a widely used option for home‐based rehabilitation, but the findings of our previous review were inconclusive. </p> </section> <section id="CD009000-sec-0002"> <h3 class="title" id="CD009000-sec-0002">Objectives</h3> <p>To assess the effects of home‐based RUTF used during the rehabilitation phase of SAM in children aged between six months and five years on recovery, relapse, mortality and rate of weight gain. </p> </section> <section id="CD009000-sec-0003"> <h3 class="title" id="CD009000-sec-0003">Search methods</h3> <p>We searched the following databases in October 2018: CENTRAL, MEDLINE, Embase, six other databases and three trials registers. We ran separate searches for cost‐effectiveness studies, contacted researchers and healthcare professionals in the field, and checked bibliographies of included studies and relevant reviews. </p> </section> <section id="CD009000-sec-0004"> <h3 class="title" id="CD009000-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) and quasi‐RCTs, where children aged between six months and five years with SAM were, during the rehabilitation phase, treated at home with RUTF compared to an alternative dietary approach, or with different regimens and formulations of RUTF compared to each other. We assessed recovery, deterioration or relapse and mortality as primary outcomes; and rate of weight gain, time to recovery, anthropometrical changes, cognitive development and function, adverse outcomes and acceptability as secondary outcomes. </p> </section> <section id="CD009000-sec-0005"> <h3 class="title" id="CD009000-sec-0005">Data collection and analysis</h3> <p>We screened for eligible studies, extracted data and assessed risk of bias of those included, independently and in duplicate. Where data allowed, we performed a random‐effects meta‐analysis using Review Manager 5, and investigated substantial heterogeneity through subgroup and sensitivity analyses. For the main outcomes, we evaluated the quality of the evidence using GRADE, and presented results in a 'Summary of findings' table per comparison. </p> </section> <section id="CD009000-sec-0006"> <h3 class="title" id="CD009000-sec-0006">Main results</h3> <p>We included 15 eligible studies (n = 7976; effective sample size = 6630), four of which were cluster trials. Eight studies were conducted in Malawi, four in India, and one apiece in Kenya, Zambia, and Cambodia. Six studies received funding or donations from industry whereas eight did not, and one study did not report the funding source. </p> <p>The overall risk of bias was high for six studies, unclear for three studies, and low for six studies. Among the 14 studies that contributed to meta‐analyses, none (n = 5), some (n = 5) or all (n = 4) children were stabilised in hospital prior to commencement of the study. One small study included only children known to be HIV‐infected, another study stratified the analysis for 'recovery' according to HIV status, while the remaining studies included HIV‐uninfected or untested children. Across all studies, the intervention lasted between 8 and 16 weeks. Only five studies followed up children postintervention (maximum of six months), and generally reported on a limited number of outcomes. </p> <p>We found seven studies with 2261 children comparing home‐based RUTF meeting the World Health Organization (WHO) recommendations for nutritional composition (referred to in this review as standard RUTF) with an alternative dietary approach (effective sample size = 1964). RUTF probably improves recovery (risk ratio (RR) 1.33; 95% confidence interval (CI) 1.16 to 1.54; 6 studies, 1852 children; moderate‐quality evidence), and may increase the rate of weight gain slightly (mean difference (MD) 1.12 g/kg/day, 95% CI 0.27 to 1.96; 4 studies, 1450 children; low‐quality evidence), but we do not know the effects on relapse (RR 0.55, 95% CI 0.30 to 1.01; 4 studies, 1505 children; very low‐quality evidence) and mortality (RR 1.05, 95% CI 0.51 to 2.16; 4 studies, 1505 children; very low‐quality evidence). </p> <p>Two quasi‐randomised cluster trials compared standard, home‐based RUTF meeting total daily nutritional requirements with a similar RUTF but given as a supplement to the usual diet (213 children; effective sample size = 210). Meta‐analysis showed that standard RUTF meeting total daily nutritional requirements may improve recovery (RR 1.41, 95% CI 1.19 to 1.68; low‐quality evidence) and reduce relapse (RR 0.11, 95% CI 0.01 to 0.85; low‐quality evidence), but the effects are unknown for mortality (RR 1.36, 95% CI 0.46 to 4.04; very low‐quality evidence) and rate of weight gain (MD 1.21 g/kg/day, 95% CI ‐ 0.74 to 3.16; very low‐quality evidence). </p> <p>Eight studies randomised 5502 children (effective sample size = 4456) and compared standard home‐based RUTF with RUTFs of alternative formulations (e.g. using locally available ingredients, containing less or no milk powder, containing specific fatty acids, or with added pre‐ and probiotics). For recovery, it made little or no difference whether standard or alternative formulation RUTF was used (RR 1.03, 95% CI 0.99 to 1.08; 6 studies, 4188 children; high‐quality evidence). Standard RUTF decreases relapse (RR 0.84, 95% CI 0.72 to 0.98; 6 studies, 4188 children; high‐quality evidence). However, it probably makes little or no difference to mortality (RR 1.00, 95% CI 0.80 to 1.24; 7 studies, 4309 children; moderate‐quality evidence) and may make little or no difference to the rate of weight gain (MD 0.11 g/kg/day, 95% CI −0.32 to 0.54; 6 studies, 3807 children; low‐quality evidence) whether standard or alternative formulation RUTF is used. </p> </section> <section id="CD009000-sec-0007"> <h3 class="title" id="CD009000-sec-0007">Authors' conclusions</h3> <p>Compared to alternative dietary approaches, standard RUTF probably improves recovery and may increase rate of weight gain slightly, but the effects on relapse and mortality are unknown. Standard RUTF meeting total daily nutritional requirements may improve recovery and relapse compared to a similar RUTF given as a supplement to the usual diet, but the effects on mortality and rate of weight gain are not clear. When comparing RUTFs with different formulations, the current evidence does not favour a particular formulation, except for relapse, which is reduced with standard RUTF. Well‐designed, adequately powered, pragmatic RCTs with standardised outcome measures, stratified by HIV status, and that include diarrhoea as an outcome, are needed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009000-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009000-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009000-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009000-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009000-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009000-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD009000-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009000-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009000-abs-0005" lang="en"> <h3>Ready‐to‐use therapeutic food (RUTF) as home‐based treatment for severely malnourished children between six months and five years </h3> <p><b>Background</b> </p> <p>Malnourished children usually look very thin or wasted and they have a high risk of death and illness. Treating severely malnourished children in hospitals is not always desirable or practical in rural settings, and home‐based treatment may be better. Home‐based treatment can be food prepared by a caregiver (such as flour porridge or energy‐ and nutrient‐dense locally available foods), or ready‐to‐use therapeutic food (RUTF) provided by a clinic. RUTF is usually made according to a standard, energy‐rich composition defined by the World Health Organization (WHO). Typically, the ingredients for standard RUTF include milk powder, sugar, peanut butter, vegetable oil, vitamins and minerals; but ingredients vary depending on local availability, cost and acceptability. Benefits of RUTF include a long shelf life without refrigeration and they require no preparation. This is an update of our previous review, where definite conclusions about the effects of RUTF could not be drawn from the four studies that were available at that time. </p> <p><b>Review question</b> </p> <p>We assessed standard RUTF compared to an alternative dietary approach (e.g. flour porridge or locally available foods) and examined whether smaller amounts and different formulations of RUTF can achieve similar health outcomes in severely malnourished children aged between six months and five years. The main health outcomes that we investigated were recovery from severe malnutrition, deterioration or relapse, death and the rate of weight gain. </p> <p><b>Included study characteristics</b> </p> <p>We searched databases for studies up to the October 2018, and found 15 studies with 7976 children. Eight studies were conducted in Malawi, four in India, and one apiece in Kenya, Zambia, and Cambodia. One small study included only children infected with HIV, another study analysed children with and without HIV separately for the main outcome (recovery), while the other studies included children who were not infected with HIV or who were untested. Overall, we judged six studies to be at high risk of bias, three studies to be at unclear risk of bias, and six studies to be at low risk of bias. (With 'risk of bias', we mean the extent to which the methods used in a study enable it to determine the truth.) All the studies lasted between 8 and 16 weeks. Only five studies followed up children after the study (for a maximum of six months), and generally reported on a limited number of outcomes. </p> <p>Of our 15 included studies, six were linked to funding or donations from industry, one did not report the source of funding, and eight studies reported funding where sponsors did not include industry. </p> <p><b>Key findings</b> </p> <p>Compared to alternative dietary approaches, standard RUTF probably improves recovery (moderate‐quality evidence) and may increase the rate of weight gain slightly (low‐quality evidence), but the effects on relapse and death are unknown (very low‐quality evidence). With 'quality of evidence' we mean how confident we are that the particular finding represents the true effect. For example, 'very low‐quality' means we are very uncertain about the finding, 'low‐quality evidence' means the future research is <i>very likely</i> to change the finding, 'moderate‐quality evidence' means that future studies <i>may</i> change this finding, and 'high‐quality evidence' means that it is <i>unlikely</i> that future studies will change the finding. </p> <p>Standard RUTF meeting total daily nutritional requirements may improve recovery and relapse compared to a similar RUTF given supplementary to the usual diet (low‐quality evidence), but for death and the rate of weight gain, the effects are not known (very low‐quality evidence). </p> <p>When comparing RUTFs of different formulations, it makes little or no difference for recovery whether a standard or alternative formulation RUTF is used (high‐quality evidence). For relapse, using standard RUTF decreases relapse (high‐quality evidence). It probably makes little or no difference to death (moderate‐quality evidence) and to the rate of weight gain (low‐quality evidence) whether standard or alternative formulation RUTF is used. </p> <p>Well‐designed, randomised controlled trials (experimental studies where participants meeting the inclusion criteria have an equal chance of being allocated to any of the intervention or control groups) in which analyses have been performed separately for children with and without HIV, and that also measure and report on diarrhoea occurrence, are needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009000-sec-0174" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009000-sec-0174"></div> <h3 class="title" id="CD009000-sec-0175">Implications for practice</h3> <section id="CD009000-sec-0175"> <p>Standard ready‐to‐use therapeutic food (RUTF) probably improves recovery and may increase the rate of weight gain compared to alternative dietary approaches, but its effects on relapse and mortality are unknown. Standard RUTF meeting total daily nutritional requirements may improve recovery and relapse compared to a similar RUTF given as a supplement to the usual diet. However, its effects on mortality and the rate of weight gain are not clear. When comparing RUTFs with different formulations, the current evidence does not favour a particular formulation, except for relapse, which is reduced with standard RUTF. The current limitations in the evidence base do not allow us to draw definitive conclusions regarding the applicability of these findings to children with severe acute malnutrition (SAM) with or without comorbidity and at different ages and levels of severity. </p> </section> <h3 class="title" id="CD009000-sec-0176">Implications for research</h3> <section id="CD009000-sec-0176"> <p>Well‐designed, adequately‐powered, pragmatic randomised controlled trials (RCTs) of RUTF are needed, reported according to the <a href="http://www.consort-statement.org/consort-2010" target="_blank">CONSORT guidelines</a>, as is more detailed reporting regarding the interventions and their implementation (according to the guidelines given in <a href="./references#CD009000-bbs2-0100" title="HoffmannTC , OxmanAD , IoannidisJP , MoherD , LassersonTJ , ToveyDI , et al. Enhancing the usability of systematic reviews by improving the consideration and description of interventions. BMJ2017;357:j2998. [DOI: 10.1136/bmj.j2998; PUBMED: 28729459] ">Hoffmann 2017</a>). Studies where children are tested and treated for HIV, and where randomisation and analyses are stratified by confirmed HIV status, are needed to explore the influence of HIV on recovery from SAM. A serious limitation of the existing studies is the use of different definitions of outcomes, such as recovery (different reference or child growth standards and cut‐off points), and anthropometrical measurements (assessed at different time points). More attention should be given to the type and standardisation of SAM outcomes in future RUTF research. The focus needs to be on recovery, relapse, mortality and the rate of weight gain, but also on adverse effects, such as diarrhoea and allergic reactions, as these outcomes are important to patients. In addition, cost implications (for example, cost per death averted and cost per disability‐adjusted‐life year (DALY) averted) should be reported in future studies to enable a cost‐effectiveness analysis. </p> <p>Adherence to RUTF as intervention is unclear; only three included studies reported on compliance, and the selling of dispensed RUTF or sharing it with siblings or other family members is likely. Therefore, future studies could investigate whether a greater effort to promote adherence ‐ and thus higher rate of consumption by the target child ‐ could improve the cost‐effectiveness of RUTF treatment. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009000-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009000-sec-0036"></div> <div class="table" id="CD009000-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children aged 6 months‐5 years with SAM (and mixed HIV comorbidity), some of whom had been stabilised as inpatients pre‐trial<br/> <b>Setting:</b> 3 studies conducted in India and 3 in Malawi; in 2 studies rehabilitation started in hospital, but in most cases, across all studies, the rehabilitation phase occurred at home<br/> <b>Experimental intervention:</b> standard RUTF formulations, produced either in a factory or local site kitchens, and meeting total daily nutritional requirements<br/> <b>Control intervention:</b> alternative dietary approaches: caregiver‐prepared locally available foods, some of which were fortified and energy dense </p> <p><b>Intervention duration:</b> 8‐16 weeks across studies </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with alternative dietary approaches</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard RUTF meeting total daily requirements</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recovery during intervention</b> </p> <p>defined as achieving WHZ ≥ −2 and absence of oedema in 1 study; reaching a WHZ score &gt; −2 and without oedema in 1 study; WHZ &gt; −2 in 1 study; having a WHZ score ≥ 0 in 1 study; reaching 100% weight for height in 1 study; and reaching 115% of baseline weight in 1 study </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.33<br/> (1.16 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1852<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children are probably more likely to recover on standard RUTF</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>391 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>521 per 1000</b><br/> (454 to 603) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Relapse during intervention</b> </p> <p>defined as admission to inpatient therapeutic care or recurrence of oedema or systematic infections during the study period, and dropouts during intervention period </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.55<br/> (0.30 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1505<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>b,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are uncertain whether standard RUTF decreases relapse</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>195 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>107 per 1000</b><br/> (59 to 197) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality during intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/> (0.51 to 2.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1505<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are uncertain whether standard RUTF decreases mortality</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>23 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 1000</b><br/> (12 to 50) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate of weight gain (g/kg/day) during intervention</b> </p> <p>3 studies measured weight gain during the first 4 weeks of the intervention period and 1 study until recovery or 16 weeks after enrolment, whichever was earlier </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the control groups was <b>2.76 g/kg/day</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the intervention groups was, on average,<b>1.12g/kg/day higher</b> (0.27 higher to 1.96 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1450<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard RUTF may increase the rate of weight gain slightly</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>RUTF:</b> ready‐to‐use therapeutic food; <b>SAM: s</b> evere acute malnutrition; <b>WHZ:</b> weight‐for‐age z score </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for risk of bias: three studies judged to have a high risk of selection bias, and one study judged to have a high risk of attrition and other bias.<br/> <sup>b</sup>Downgraded by one level for indirectness: significant difference between subgroups based on whether all or some children were stabilised in hospital before the trial.<br/> <sup>c</sup>Downgraded by one level for risk of bias: three studies judged to have a high risk of selection bias.<br/> <sup>d</sup>Downgraded by one level for inconsistency: I<sup>2</sup> statistic is more than 50%.<br/> <sup>e</sup>Downgraded by one level for imprecision: 95% CI includes both an important benefit and harm. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009000-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children aged 6 months‐5 years with SAM (1 study included HIV‐uninfected children; 1 study included HIV‐infected children), all of whom had been stabilised as inpatients pre‐trial.<br/> <b>Setting:</b> both studies conducted in Malawi, with rehabilitation at home<br/> <b>Experimental intervention:</b> standard RUTF formulation, produced in a factory, and meeting total daily nutritional requirements<br/> <b>Control intervention:</b> a similar RUTF to that used as the experimental intervention, but given as a supplement to the usual diet </p> <p><b>Intervention duration:</b> 16 weeks in 1 study; undefined duration in 1 study </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RUTF supplement</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard RUTF formulation meeting total daily requirements</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recovery during intervention</b> </p> <p>defined as WHZ &gt; 0 in 1 study; 100% weight for height in 1 study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.41<br/> (1.19 to 1.68) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>210<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a,b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children may be more likely to recover on standard RUTF in amounts meeting total daily nutritional requirements </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>582 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>821 per 1000</b><br/> (693 to 978) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Relapse during intervention</b> </p> <p>defined as admission to inpatient therapeutic care or recurrence of oedema or systematic infections during the study period, and dropouts during intervention period </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.11<br/> (0.01 to 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>210<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a,b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Standard RUTF meeting total daily nutritional requirements may decrease relapse</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>107 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b><br/> (1 to 91) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality during intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.36<br/> (0.46 to 4.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>210<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low<sup>a,b,c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are uncertain whether standard RUTF meeting total daily nutritional requirements decreases mortality </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b><br/> (23 to 199) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate of weight gain (g/kg/day) during intervention</b> </p> <p>defined as change between baseline and week 4 of the intervention period</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the control groups was <b>3.05 g/kg/day</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the intervention groups was, on average, <b>1.21 g/kg/day higher</b> (0.74 lower to 3.16 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low<sup>a,c,d,e</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether standard RUTF meeting total daily nutritional requirements increases the rate of weight gain </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>RUTF:</b> ready‐to‐use therapeutic food; <b>SAM: s</b> evere acute malnutrition; <b>WHZ:</b> weight‐for‐age z score </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for risk of bias: high risk of selection and attrition bias.<br/> <sup>b</sup>Downgraded by one level for indirectness: the two studies were conducted in the same country.<br/> <sup>c</sup>Downgraded by one level for imprecision: 95% CI includes both an important benefit and harm.<br/> <sup>d</sup>Downgraded by one level for imprecision: 95% CI includes both an important benefit and harm, and the total sample size is smaller than the optimal information size.<br/> <sup>e</sup>Downgraded by one level for inconsistency: I<sup>2</sup> statistic more than 50%; subgrouped for HIV‐status as one study included only HIV‐uninfected children (RR 2.1, 95% CI 1.12 to 3.08) and the other study included only HIV‐infected children (RR 0.1, 95% CI −1.53 to 3.16). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009000-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Standard ready‐to‐use therapeutic food (RUTF) versus RUTF using an alternative formulation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Standard ready‐to‐use therapeutic food (RUTF) versus RUTF using an alternative formulation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children aged 6 months‐5 years with SAM (and mixed HIV comorbidity), some of whom had been stabilised as inpatients pre‐trial<br/> <b>Setting:</b> 4 studies conducted in Malawi, 1 in Zambia, 1 in Kenya and 1 in Cambodia; although in 2 studies, some or all children started rehabilitation in hospital and much of the rehabilitation phase across all studies occurred at home<br/> <b>Experimental intervention:</b> standard RUTF formulations, produced either in a factory or local site kitchens, and meeting total daily nutritional requirements<br/> <b>Control intervention:</b> RUTF with alternative ingredients, produced in a factory </p> <p><b>Intervention duration:</b> 8‐16 weeks across studies </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RUTF with alternative ingredients</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RUTF with standard ingredients (peanut‐ and milk‐based)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recovery during intervention</b> </p> <p>defined as weight gain ≥ 15% in relation to baseline weight, absence of complications and oedema, and MUAC &gt; 110 mm in 2 studies; MUAC &gt; 12.4 cm without oedema in 1 study; WHZ ≥ 80% for two consecutive visits in 1 study; WHZ &gt; −2 and no oedema in 1 study; and not defined in 1 study </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.99 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4188<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Makes little or no difference whether standard or alternative recipe formulation RUTF is used for recovery </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>717 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>738 per 1000</b><br/> (710 to 774) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Relapse during intervention</b> </p> <p>defined as admission to inpatient therapeutic care, remain wasted, and dropouts during intervention period </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.84<br/> (0.72 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4188<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Standard, factory‐produced RUTF meeting total daily nutritional requirements decreases relapse slightly </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>137 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>115 per 1000</b><br/> (99 to 135) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality during intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.80 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4309<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>It probably makes little or no difference to mortality whether standard or alternative recipe formulation RUTF is used </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b><br/> (68 to 106) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate of weight gain (g/kg/day) during intervention</b> </p> <p>defined as change over first 4, 8, 10, 16 weeks of the intervention period in 4 studies; change until end of intervention period (no maximum number of weeks applied) in 1 study; and regression analysis with adjustment over the entire study in 1 study </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the control groups was <b>2.6 g/kg/day</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the intervention groups was, on average, <b>0.11 g/kg/day higher</b><br/> (0.32 lower to 0.54 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3807<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a,b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It may make little or no difference in the rate of weight gain whether standard or alternative recipe formulation RUTF is used </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MUAC:</b> mid‐upper arm circumference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>RUTF:</b> ready‐to‐use therapeutic food; <b>SAM: s</b> evere acute malnutrition; <b>WHZ:</b> weight‐for‐age z score </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for imprecision: the 95% CI includes both an important benefit and harm.<br/> <sup>b</sup>Downgraded by one level for inconsistency: I<sup>2</sup> statistic more than 50%. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009000-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009000-sec-0037">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009000-sec-0244">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD009000-sec-0037"></div> <section id="CD009000-sec-0038"> <h3 class="title" id="CD009000-sec-0038">Description of the condition</h3> <p>Malnutrition occurs when the quantity of one or more macronutrients available to the body is inadequate to sustain optimal bodily functions (undernutrition) or when an excessive amount of energy is consumed (overnutrition); this is often accompanied by micronutrient deficiencies (<a href="./references#CD009000-bbs2-0118" title="ManaryMJ , SandigeHL . Management of acute moderate and severe childhood malnutrition. BMJ2008;337:a2180. [DOI: 10.1136/bmj.a2180; PUBMED: 19008271] ">Manary 2008</a>). Malnutrition in infants and young children may present as stunting, wasting, overweight or obesity (<a href="./references#CD009000-bbs2-0142" title="United Nations Children’sFund , World Health Organization, World Bank Group. Levels and trends in child malnutrition. www.who.int/nutgrowthdb/jme_brochoure2017.pdf?ua=1 (accessed 4 August 2017). ">UNICEF/WHO/WBG 2017</a>). Stunting and wasting refer to undernutrition, while overweight and obesity are manifestations of overnutrition. </p> <p>Stunting is a chronic form of malnutrition resulting in linear growth deficits relative to well‐nourished children of the same age (<a href="./references#CD009000-bbs2-0142" title="United Nations Children’sFund , World Health Organization, World Bank Group. Levels and trends in child malnutrition. www.who.int/nutgrowthdb/jme_brochoure2017.pdf?ua=1 (accessed 4 August 2017). ">UNICEF/WHO/WBG 2017</a>). A child is defined as stunted if his or her length or height is more than two standard deviations (SD) below the median value for his or her age and sex, based on the World Health Organization (WHO) Child Growth Standards (<a href="./references#CD009000-bbs2-0145" title="World Health Organization (WHO). Training course on child growth assessment: WHO child growth standards. www.who.int/childgrowth/training/module_c_interpreting_indicators.pdf (accessed 8 November 2017). ">WHO 2008</a>). Children whose length or height for age falls below this cut‐off point may never achieve their full physical or cognitive potential (<a href="./references#CD009000-bbs2-0142" title="United Nations Children’sFund , World Health Organization, World Bank Group. Levels and trends in child malnutrition. www.who.int/nutgrowthdb/jme_brochoure2017.pdf?ua=1 (accessed 4 August 2017). ">UNICEF/WHO/WBG 2017</a>). </p> <p>By contrast, wasting ‐ the form of malnutrition that is the focus of this review ‐ is an acute condition in which a child is too thin for his or her length or height (i.e. low weight for length or height). Acute malnutrition is classified according to severity as either moderate acute malnutrition (MAM) or severe acute malnutrition (SAM). The conceptual framework by the United Nations Children's Fund (UNICEF) shows the immediate, underlying and basic causes of child undernutrition, with its short‐ and long‐term consequences (<a href="./references#CD009000-bbs2-0137" title="United Nations Children’s Fund(UNICEF) . Improving child nutrition: the achievable imperative for global progress. www.unicef.org/publications/files/Nutrition_Report_final_lo_res_8_April.pdf (accessed 1 August 2018). ">UNICEF 2013a</a>). Children diagnosed with MAM or SAM have an increased risk of infectious diseases, developmental delays, and death. SAM is a particularly life‐threatening condition, which requires early detection before the onset of complications, and prompt treatment (<a href="./references#CD009000-bbs2-0138" title="United Nations Children's Fund(UNICEF) . Ready‐to‐use therapeutic food for children with severe acute malnutrition. www.unicef.org/media/files/Current_Issues_Paper_‐_Ready_To_Use_Therapeutic_Food.pdf (accessed 4 August 2017). ">UNICEF 2013b</a>). The initial treatment of SAM varies depending on whether it is complicated by infection, metabolic disturbances, severe oedema or poor appetite; or uncomplicated, where children are clinically well, alert and have an appetite (<a href="#CD009000-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD009000-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Diagram depicting our review question and main subgroup analysis" data-id="CD009000-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Diagram depicting our review question and main subgroup analysis</p> </div> </div> </div> <p>In children under five years of age, MAM is defined as a weight‐for‐height z score (WHZ) between three and two SD below the median or between 70% and 80% of the median, or mid‐upper arm circumference (MUAC) between 115 mm and 125 mm, and no oedema (<a href="./references#CD009000-bbs2-0073" title="BlackRE , AllenLH , BhuttaZA , CaulfieldLE , deOnisM , EzzatiM , et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet2008;371(9608):243‐60. [DOI: 10.1016/S0140‐6736(07)61690‐0] ">Black 2008</a>; <a href="./references#CD009000-bbs2-0114" title="LazzeriniM , RubertL , PaniP . Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009584.pub2; PUBMED: 23794237] ">Lazzerini 2013</a>; <a href="./references#CD009000-bbs2-0146" title="World Health Organization (WHO). Technical note: supplementary foods for the management of moderate acute malnutrition in infants and children 6–59 months of age. apps.who.int/iris/bitstream/10665/75836/1/9789241504423_eng.pdf?ua=1&amp;ua=1 (accessed 4 August 2017). ">WHO 2012</a>). SAM is diagnosed when children have a combination of a WHZ of more than three SDs below the median, a MUAC of less than 115 mm, and the presence of nutritional oedema (<a href="./references#CD009000-bbs2-0077" title="CollinsS , YatesR . The need to update the classification of acute malnutrition. Lancet2003;362(9379):249. [DOI: 10.1016/S0140‐6736(03)13926‐8; PUBMED: 12885498] ">Collins 2003</a>; <a href="./references#CD009000-bbs2-0118" title="ManaryMJ , SandigeHL . Management of acute moderate and severe childhood malnutrition. BMJ2008;337:a2180. [DOI: 10.1136/bmj.a2180; PUBMED: 19008271] ">Manary 2008</a>; <a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009</a>). MAM or SAM without bilateral pitting oedema is referred to as marasmus, while kwashiorkor is the term used when bilateral pitting oedema is present (<a href="./references#CD009000-bbs2-0118" title="ManaryMJ , SandigeHL . Management of acute moderate and severe childhood malnutrition. BMJ2008;337:a2180. [DOI: 10.1136/bmj.a2180; PUBMED: 19008271] ">Manary 2008</a>). See <a href="#CD009000-tbl-0004">Table 1</a> for a more detailed classification system for MAM and SAM. </p> <div class="table" id="CD009000-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Classification of severe acute malnutrition in children under 60 months old by Collins and colleagues in 2006*</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severe acute malnutrition with complications</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severe acute malnutrition without complications</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral pitting oedema grade 3<sup>a</sup> (severe oedema) </p> <p>OR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MUAC &lt; 115<sup>b</sup> mm </p> <p>OR</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MUAC &lt; 115<sup>b</sup> mm and bilateral pitting oedema grades 1<sup>a</sup> or 2<sup>a</sup> (marasmic kwashiorkor) </p> <p>OR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral pitting oedema grades 1<sup>a</sup> or 2<sup>a</sup> with MUAC ≥ 115<sup>b</sup> mm </p> <p>AND</p> <p> <ol id="CD009000-list-0001"> <li> <p>Appetite</p> </li> <li> <p>Clinically well</p> </li> <li> <p>Alert</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MUAC &lt; 110<sup>b</sup> mm or bilateral pitting oedema grades 1<sup>a</sup> or 2<sup>a</sup> </p> <p>AND 1 of the following</p> <p> <ol id="CD009000-list-0002"> <li> <p>Anorexia</p> </li> <li> <p>Lower‐respiratory tract infection<sup>c</sup> </p> </li> <li> <p>Severe palmar pallor</p> </li> <li> <p>High fever</p> </li> <li> <p>Severe dehydration</p> </li> <li> <p>Not alert</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>↓</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>↓</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient care IMCI/WHO protocol</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient therapeutic care protocols</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>IMCI:</b> Integrated Management of Childhood Illness; <b>MUAC:</b> mid‐upper arm circumference; <b>UNICEF:</b> United Nations Children's Fund; <b>WHO:</b> World Health Organization </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>*</sup><a href="./references#CD009000-bbs2-0079" title="CollinsS , DentN , BinnsP , BahwereP , SadlerK , HallamA . Management of severe acute malnutrition in children. Lancet2006;368(9551):1992‐2000. [DOI: 10.1016/S0140‐6736(06)69443‐9; PUBMED: 17141707] ">Collins 2006a</a> </p> <p><sup>a</sup>Grade 1: mild oedema on both feet or both ankles; Grade 2: moderate oedema on both feet, and on lower legs, hands or lower arms; Grade 3: severe generalised oedema affecting feet, legs, hands, arms and face.<br/> <sup>b</sup>Both the WHO and UNICEF recommend that the cut‐off value for the MUAC for severe acute malnutrition is 115 mm (<a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009</a>). Previously it was 110 mm (<a href="./references#CD009000-bbs2-0079" title="CollinsS , DentN , BinnsP , BahwereP , SadlerK , HallamA . Management of severe acute malnutrition in children. Lancet2006;368(9551):1992‐2000. [DOI: 10.1016/S0140‐6736(06)69443‐9; PUBMED: 17141707] ">Collins 2006a</a>). The adoption of this higher cut‐off value will sharply increase the caseloads, which may influence the cost of nutrition programmes greatly (<a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009</a>). However, detecting more children as severely malnourished earlier will lead to a shorter treatment period, which may bring down the cost per child (<a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009</a>).<br/> <sup>c</sup>IMCI criteria: 60 respirations/min for children aged &lt; 2 months; 50 respirations/min for children aged 2 to 12 months; 40 respirations/min for children aged 1 to 5 years; 30 respirations/min for children aged &gt; 5 years. </p> </div> </div> <p>Although some conditions, such as HIV/AIDS, tuberculosis (TB) and kidney failure, may contribute to the onset of undernutrition, poverty and food insecurity are by far the major causes. Undernutrition and infection often co‐exist and are mutually reinforcing: undernutrition increases susceptibility to infection while infection contributes to malnutrition (<a href="./references#CD009000-bbs2-0112" title="KrugerHS , HendricksM , PuoaneT . Nutritional management of multiple nutrient deficiencies. In: SteynNP , TempleNJ editor(s). Community Nutrition Textbook for South Africa: A Rights‐Based Approach. Tygerberg (ZA): Chronic Diseases of Lifestyle Unit, Medical Research Council, 2008:674‐9. ">Kruger 2008</a>; <a href="./references#CD009000-bbs2-0123" title="NaudeCE , LabuschangeIL , LabadariosD . Nutritional management of HIV/AIDS and TB. In: SteynNP , TempleNJ editor(s). Community Nutrition Textbook for South Africa: A Rights‐Based Approach. Tygerberg (ZA): Chronic Diseases of Lifestyle Unit, Medical Research Council, 2008:751‐94. ">Naude 2008</a>). Infections are associated with anorexia (loss of appetite), electrolyte and metabolic imbalances (<a href="./references#CD009000-bbs2-0147" title="World Health Organization (WHO). Guideline: updates on the management of severe acute malnutrition in infants and children. apps.who.int/iris/bitstream/10665/95584/1/9789241506328_eng.pdf (accessed 18 September 2017). ">WHO 2013</a>); fever increases energy expenditure; and diarrhoea decreases nutrient absorption and can contribute to electrolyte imbalances (<a href="./references#CD009000-bbs2-0147" title="World Health Organization (WHO). Guideline: updates on the management of severe acute malnutrition in infants and children. apps.who.int/iris/bitstream/10665/95584/1/9789241506328_eng.pdf (accessed 18 September 2017). ">WHO 2013</a>). </p> <p>Despite sustained efforts to combat malnutrition (<a href="./references#CD009000-bbs2-0094" title="HawkesC , HaddadL , UdomkesmaleeE , Co‐Chairs of the Independent Expert Group of the Global Nutrition Report. The Global Nutrition Report 2015: what we need to do to advance progress in addressing malnutrition in all its forms. Public Health Nutrition2015;18(17):3067‐9. [DOI: 10.1017/S1368980015003158; PUBMED: 26551284] ">Hawkes 2015</a>), rates are still alarmingly high. Worldwide, 155 million children under five years of age are stunted, 52 million suffer from wasting (with an additional 17 million suffering from severe wasting) and 41 million are overweight (<a href="./references#CD009000-bbs2-0142" title="United Nations Children’sFund , World Health Organization, World Bank Group. Levels and trends in child malnutrition. www.who.int/nutgrowthdb/jme_brochoure2017.pdf?ua=1 (accessed 4 August 2017). ">UNICEF/WHO/WBG 2017</a>). Africa and Asia have the greatest share of all forms of malnutrition. Although less than half of all children under five years old live in lower‐middle income countries, a disproportionate two‐thirds of all stunted children and about three‐quarters of all wasted children live in these countries (<a href="./references#CD009000-bbs2-0142" title="United Nations Children’sFund , World Health Organization, World Bank Group. Levels and trends in child malnutrition. www.who.int/nutgrowthdb/jme_brochoure2017.pdf?ua=1 (accessed 4 August 2017). ">UNICEF/WHO/WBG 2017</a>). </p> </section> <section id="CD009000-sec-0039"> <h3 class="title" id="CD009000-sec-0039">Description of the intervention</h3> <p>Addressing the underlying causes of economic deprivation and inequity is, undoubtedly, the only way to eradicate undernutrition in the long term. However, specific nutritional interventions can help ameliorate the health consequences of nutritional deprivation in the interim (<a href="./references#CD009000-bbs2-0073" title="BlackRE , AllenLH , BhuttaZA , CaulfieldLE , deOnisM , EzzatiM , et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet2008;371(9608):243‐60. [DOI: 10.1016/S0140‐6736(07)61690‐0] ">Black 2008</a>), and this review focuses on one such intervention for children with SAM. </p> <p>Until about two decades ago, SAM was primarily managed in hospitals, which greatly limited treatment coverage and impact (<a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>). To reach more children, a community‐based approach, which involves timely detection and provision of treatment for those without medical complications, was developed (<a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>). </p> <p>The treatment of SAM can be divided into two potential phases, namely stabilisation and rehabilitation. Stabilisation involves a range of clinical interventions, such as treatments for dehydration, electrolyte imbalances and infections (<a href="./references#CD009000-bbs2-0069" title="AshworthA , KhanumS , JacksonA , SchofieldC . Guidelines for the inpatient treatment of severely malnourished children. www.who.int/nutrition/publications/guide_inpatient_text.pdf (accessed 2 November 2017). ">Ashworth 2003</a>). In terms of nutritional support, the WHO recommends continuing breastfeeding (where applicable) along with oral or nasogastric feeds that provide 100 kCal/kg/day (418 kJ/kg/day) and a low protein intake of 1.0 to 1.5 g/kg/day. F‐75, a starter, milk‐based therapeutic formula with a relatively low energy (75 kCal (314 kJ)) and protein content (0.9 g per 100 mL), is typically used during the stabilisation phase (<a href="./references#CD009000-bbs2-0067" title="Action againsthunger . Acute malnutrition: a preventable pandemic. www.actionagainsthunger.org/sites/default/files/publications/Acute_Malnutrition_A_Preventable_Pandemic_01.2009.pdf (accessed 20 May 2013). ">Action Against Hunger 2009</a>; <a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009</a>). F‐75 aids in initial metabolic recovery, helping to restore electrolyte imbalances (<a href="./references#CD009000-bbs2-0067" title="Action againsthunger . Acute malnutrition: a preventable pandemic. www.actionagainsthunger.org/sites/default/files/publications/Acute_Malnutrition_A_Preventable_Pandemic_01.2009.pdf (accessed 20 May 2013). ">Action Against Hunger 2009</a>). Oedema (if present) usually starts to disappear, leading to weight loss (fluid loss). </p> <p>Once the child's appetite has improved and s/he is in a stable medical condition, the rehabilitation phase starts, with catch‐up growth becoming the main focus. In this phase, the recommended energy requirement is 150 to 220 kCal/kg/day (628 to 921 kJ/kg/day) and 2.0 to 6.0 g/kg/day of protein (<a href="./references#CD009000-bbs2-0069" title="AshworthA , KhanumS , JacksonA , SchofieldC . Guidelines for the inpatient treatment of severely malnourished children. www.who.int/nutrition/publications/guide_inpatient_text.pdf (accessed 2 November 2017). ">Ashworth 2003</a>). Traditionally, F‐100 (a milk‐based therapeutic diet, higher in energy (100 kCal/418 kJ) and much higher in protein (2.9 g per 100 mL) than F‐75) is given as part of inpatient care to initiate weight gain (<a href="./references#CD009000-bbs2-0147" title="World Health Organization (WHO). Guideline: updates on the management of severe acute malnutrition in infants and children. apps.who.int/iris/bitstream/10665/95584/1/9789241506328_eng.pdf (accessed 18 September 2017). ">WHO 2013</a>). </p> <p>Children with complicated SAM require stabilisation as inpatients while those with uncomplicated SAM often do not need inpatient stabilisation (<a href="./references#CD009000-bbs2-0147" title="World Health Organization (WHO). Guideline: updates on the management of severe acute malnutrition in infants and children. apps.who.int/iris/bitstream/10665/95584/1/9789241506328_eng.pdf (accessed 18 September 2017). ">WHO 2013</a>; <a href="./references#CD009000-bbs2-0149" title="World Health Organization (WHO). Management of severe acute malnutrition in infants and children. www.who.int/elena/titles/full_recommendations/sam_management/en/ (accessed 8 November 2017). ">WHO 2017b</a>; <a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>). Although the approach used can differ between countries and settings, children who are stabilised in hospital usually start rehabilitation as inpatients but complete most of the rehabilitation phase at home (with follow‐up in the outpatient department). </p> <p>A challenge for treating children with SAM in low‐ and middle‐income countries (LMICs) is that prolonged hospital care of children with acute malnutrition may not always be possible. In these settings ready‐to‐use therapeutic food (RUTF) ‐ energy‐dense foods with a low moisture content that can be eaten directly from the packaging ‐ has been introduced for home‐based treatment during the rehabilitation phase. (Because of its high energy and protein content, RUTF is not suitable for the stabilisation phase.) </p> <p>RUTF, a solid or semi‐solid product, was originally developed by Nutriset and the Institute for Research and Development in France, as a home‐based follow‐up treatment after F‐100 (<a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>). <a href="#CD009000-tbl-0005">Table 2</a> shows the nutritional contents of RUTF as recommended by the WHO, referred to in this review as standard RUTF; for example, see <a href="#CD009000-tbl-0006">Table 3</a> for a typical peanut‐based RUTF recipe. </p> <div class="table" id="CD009000-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Nutritional composition of ready‐to‐use therapeutic food, as recommended by the World Health Organizationa </span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nutritional element</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Amount</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moisture content</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.5% maximum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>520‐550 kCal/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10%‐12% total energy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lipids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45%‐60% total energy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sodium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>290 mg/100 g maximum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Potassium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1110‐1400 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Calcium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300‐600 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phosphorus (excluding phytate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300‐600 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Magnesium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80‐140 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10‐14 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Zinc</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11‐14 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Copper</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4‐1.8 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selenium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20‐40 μg</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70‐140 μg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.8‐1.1 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15‐20 μg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin E</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin K</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 to 30 μg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin B1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin B2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.6 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin B6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin B12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.6 μg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200 μg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Niacin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pantothenic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Biotin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 μg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n‐6 fatty acids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3%‐10% of total energy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n‐3 fatty acids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3%‐2.5% of total energy</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>. </p> </div> </div> <div class="table" id="CD009000-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">A typical recipe for a WHO‐recommended ready‐to‐use therapeutic fooda </span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ingredient</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>% weight</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Full‐fat milk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sugar</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vegetable oil</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peanut butter<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mineral‐vitamin mix</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.6</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD009000-bbs2-0117" title="ManaryMJ . Local production and provision of ready‐to‐use therapeutic food (RUTF) spread for the treatment of severe childhood malnutrition. Food and Nutrition Bulletin2006;27(3 Suppl):S83‐9. [DOI: 10.1177/15648265060273S305; PUBMED: 17076214] ">Manary 2006</a><br/> <sup>b</sup>Strict quality control is essential. </p> </div> </div> <p>Where RUTF is used for home‐based rehabilitation, it can be provided to meet all of the nutritional requirements of a child recovering from SAM; for example, in low‐income settings where food security may be a significant issue. Alternatively, RUTF may be provided for SAM children as a supplement to the usual family diet. </p> <p>RUTF can be formulated and produced in various ways. It can be cheaper to produce RUTF with less or no milk powder, or more acceptable if locally or indigenous ingredients are used. Furthermore, fatty acid composition (specifically, omega‐3 fatty acids) may play a role in infection and inflammation, and thus might be a beneficial ingredient in therapeutic food. Similarly, as children with SAM may have compromised gastrointestinal function, the addition of pre‐ and probiotics may be advantageous. </p> <p>RUTF is often produced on a commercial scale, but can also be produced locally on a small scale (e.g. in an institution kitchen such as that of a research centre or clinic) with ingredients that may differ from commercially produced RUTF (<a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>). Two examples of commercially produced RUTF are a peanut‐based paste called Plumpy'nut® (Nutriset, France; <a href="#CD009000-tbl-0007">Table 4</a>), and a solid biscuit made from cooked wheat called BP100® (developed by Compact, Denmark) (<a href="./references#CD009000-bbs2-0078" title="CollinsS , HenryJ . Alternative RUTF formulations (special supplement 2). Community‐based Therapeutic Care2004;Suppl 2:35. [www.ennonline.net/fex/102/4‐3‐2] ">Collins 2004</a>; <a href="./references#CD009000-bbs2-0043" title="Navarro‐ColoradoC , LaquièreS . Clinical trial of BP100 vs F100 milk for rehabilitation of severe malnutrition. Field Exchange2005;24:22‐4. [www.ennonline.net/fex/24/clinical] ">Navarro‐Colorado 2005</a>). Both are fortified with micronutrients and have very low water activity, which discourages microbial growth (<a href="./references#CD009000-bbs2-0075" title="BrewsterDR . Critical appraisal of the management of severe malnutrition: 2. Dietary management. Journal of Paediatrics and Child Health2006;42(10):575‐82. [DOI: 10.1111/j.1440‐1754.2006.00932.x; PUBMED: 16972962] ">Brewster 2006</a>; <a href="./references#CD009000-bbs2-0112" title="KrugerHS , HendricksM , PuoaneT . Nutritional management of multiple nutrient deficiencies. In: SteynNP , TempleNJ editor(s). Community Nutrition Textbook for South Africa: A Rights‐Based Approach. Tygerberg (ZA): Chronic Diseases of Lifestyle Unit, Medical Research Council, 2008:674‐9. ">Kruger 2008</a>; <a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>). Children as young as six months of age can consume RUTF with a homogenous paste texture (<a href="./references#CD009000-bbs2-0082" title="Department for International Development (DFID). The Neglected Crisis of Undernutrition: Evidence for Action. London (UK): Department for International Development, 2009. ">DFID 2009</a>). Solid RUTF can also be soaked in clean, boiling water and eaten as porridge by young infants and as a biscuit by older children. Infants younger than six months should not be given RUTF (<a href="./references#CD009000-bbs2-0082" title="Department for International Development (DFID). The Neglected Crisis of Undernutrition: Evidence for Action. London (UK): Department for International Development, 2009. ">DFID 2009</a>). </p> <div class="table" id="CD009000-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Nutritional information of Plumpy'nut® by Collins and Henry in 2004*</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nutrient</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unit</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Plumpy'nut® (100 g)</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Energy<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>kCal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>530</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Energy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>kJ</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2218</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Protein</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.5 (11% of product's energy)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Carbohydrate<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43 (32% of product's energy)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fat</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.5 (57% of product's energy)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ash</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moisture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 5</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Water activity</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a<sub>w</sub> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.241</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Copper</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.7</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zinc</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calcium</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>310</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sodium</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 290</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Magnesium</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.45</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>*</sup><a href="./references#CD009000-bbs2-0078" title="CollinsS , HenryJ . Alternative RUTF formulations (special supplement 2). Community‐based Therapeutic Care2004;Suppl 2:35. [www.ennonline.net/fex/102/4‐3‐2] ">Collins 2004</a> </p> <p><sup>a</sup>Atwater factors used to calculate energy.<br/> <sup>b</sup>Carbohydrate is by difference assuming protein to be nitrogen multiplied by 6.25. </p> </div> </div> <p>A total of about 10 to 15 kg of RUTF over a period of six to eight weeks is considered necessary for recovery from SAM (<a href="./references#CD009000-bbs2-0138" title="United Nations Children's Fund(UNICEF) . Ready‐to‐use therapeutic food for children with severe acute malnutrition. www.unicef.org/media/files/Current_Issues_Paper_‐_Ready_To_Use_Therapeutic_Food.pdf (accessed 4 August 2017). ">UNICEF 2013b</a>; <a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>). RUTF as home‐based rehabilitation is not recommended as stand‐alone care, but rather as part of a treatment protocol that provides full medical consultation in conjunction with nutritional counselling, routine medical care (such as immunisations, essential drugs, etc.) and referral to hospital‐based treatment where needed (<a href="./references#CD009000-bbs2-0138" title="United Nations Children's Fund(UNICEF) . Ready‐to‐use therapeutic food for children with severe acute malnutrition. www.unicef.org/media/files/Current_Issues_Paper_‐_Ready_To_Use_Therapeutic_Food.pdf (accessed 4 August 2017). ">UNICEF 2013b</a>). </p> <section id="CD009000-sec-0040"> <h4 class="title">Challenges with the use of RUTF</h4> <p>RUTF, especially when made with disaccharide sucrose rather than polysaccharide dextromaltose, has a relatively high, renal solute load (a high load of substances that need to be eradicated in the urine) (<a href="./references#CD009000-bbs2-0047" title="SandigeH , NdekhaMJ , BriendA , AshornP , ManaryMJ . Home‐based treatment of malnourished Malawian children with locally produced or imported ready‐to‐use food. Journal of Pediatric Gastroenterology and Nutrition2004;39(2):141‐6. [PUBMED: 15269617] ">Sandige 2004</a>). Because excretion of these solutes requires water, there are concerns that RUTF might exacerbate dehydration and increase the risk of mortality in SAM (<a href="./references#CD009000-bbs2-0091" title="GrelletyY . Management of Severe Malnutrition in Africa [PhD thesis]. Aberdeen (UK): University of Aberdeen, 2000. ">Grellety 2000</a>; <a href="./references#CD009000-bbs2-0147" title="World Health Organization (WHO). Guideline: updates on the management of severe acute malnutrition in infants and children. apps.who.int/iris/bitstream/10665/95584/1/9789241506328_eng.pdf (accessed 18 September 2017). ">WHO 2013</a>). It is therefore recommended that children consuming RUTF receive additional, free water (<a href="./references#CD009000-bbs2-0090" title="GreinerT . Breastfeeding Briefs N° 56/57, September 2014. The advantages, disadvantages and risks of ready‐to‐use foods. ibfan.org/breastfeedingbreafs/BB%2056‐57‐The%20advantages‐disadvantages‐and‐risks‐of‐ready‐to‐use%20foods.pdf (accessed 4 August 2017). ">Greiner 2014</a>). However, this increases the risk of bacterial contamination in some settings. </p> <p>In 2010, when the Nutriset patent was made available in developing countries, UNICEF ‐ the largest international procurer of RUTF (<a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>) ‐ published manufacturing standards for RUTF production (<a href="./references#CD009000-bbs2-0110" title="KomrskaJ . UNICEF requirements for RUTF manufacturers. www.unicef.org/supply/files/Technical_Requirements_for_RUTF_Manufacturers.pdf (accessed 4 August 2017). ">Komrska 2010a</a>; <a href="./references#CD009000-bbs2-0111" title="KomrskaJ . Overview of UNICEF’s RUTF procurement in 2010 and past years. www.unicef.org/supply/files/Overview_of_UNICEF_RUTF_Procurement_in_2010.pdf (accessed 4 August 2017). ">Komrska 2010b</a>). UNICEF further launched competitive bidding to ensure that local suppliers were used. While this reduced the transportation time and cost, it introduced the need for additional quality assurance to ensure optimal products (<a href="./references#CD009000-bbs2-0140" title="United Nations Children’s Fund(UNICEF) . Management of severe acute malnutrition in children: working towards results at scale. www.childrenandaids.org/sites/default/files/2017‐05/SAM%20Guidance.pdf (accessed 4 August 2017). ">UNICEF 2015a</a>). </p> <p>Recipes for RUTF do not necessarily include peanut or milk powder, although the WHO recommends that at least half of the proteins should come from a milk source (<a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>). Peanuts can cause allergic reactions in susceptible individuals, and are known be at high risk for aflatoxin contamination. Milk powder on the other hand, is expensive and often needs to be imported (<a href="./references#CD009000-bbs2-0078" title="CollinsS , HenryJ . Alternative RUTF formulations (special supplement 2). Community‐based Therapeutic Care2004;Suppl 2:35. [www.ennonline.net/fex/102/4‐3‐2] ">Collins 2004</a>). The cost of milk powder in Malawi constitutes more than half of the final cost of the RUTF (<a href="./references#CD009000-bbs2-0078" title="CollinsS , HenryJ . Alternative RUTF formulations (special supplement 2). Community‐based Therapeutic Care2004;Suppl 2:35. [www.ennonline.net/fex/102/4‐3‐2] ">Collins 2004</a>). <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a> reported that the removal of milk powder and the inclusion of locally available grains and pulses can reduce the cost of ingredients by about a third. </p> <p>For non‐commercial production of RUTF, the following basic ingredients are required (<a href="./references#CD009000-bbs2-0078" title="CollinsS , HenryJ . Alternative RUTF formulations (special supplement 2). Community‐based Therapeutic Care2004;Suppl 2:35. [www.ennonline.net/fex/102/4‐3‐2] ">Collins 2004</a>). </p> <p> <ol id="CD009000-list-0003"> <li> <p>Staple food as the main ingredient (preferably a cereal).</p> </li> <li> <p>Protein supplement from a plant or animal food (for example, beans, groundnuts, milk, meat, chicken, fish, egg). For economic reasons, legumes and oilseeds are mostly used. </p> </li> <li> <p>Vitamin and mineral supplement (a vegetable or fruit, or both).</p> </li> <li> <p>Energy supplement (a fat, oil or sugar) to increase the energy density.</p> </li> </ol> </p> <p>The food safety of the production process is an important issue, with strict monitoring and careful attention needed to avoid contamination by microorganisms or other harmful substances (for example, heavy metals, pesticides, anti‐nutritional factors such as phytate or protease inhibitors) (<a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>). </p> <p>For young children diagnosed with SAM for the first time and newly exposed to RUTF, acceptability may be a problem (<a href="./references#CD009000-bbs2-0090" title="GreinerT . Breastfeeding Briefs N° 56/57, September 2014. The advantages, disadvantages and risks of ready‐to‐use foods. ibfan.org/breastfeedingbreafs/BB%2056‐57‐The%20advantages‐disadvantages‐and‐risks‐of‐ready‐to‐use%20foods.pdf (accessed 4 August 2017). ">Greiner 2014</a>). However, progress has been made in terms of increasing the acceptability of RUTF; for example, by using locally grown ingredients (<a href="./references#CD009000-bbs2-0143" title="WeberJ , CallaghanM . Optimizing ready‐to‐use therapeutic foods for protein quality, cost, and acceptability. Food and Nutrition Bulletin2016;37(Suppl 1):S37‐46. [DOI: 10.1177/0379572116629257; PUBMED: 26864957] ">Weber 2016</a>). </p> <p>The demand for RUTF increased from less than 9000metric tonne in 2009, to over 30,000 metric tonne in 2014 (<a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>; <a href="./references#CD009000-bbs2-0141" title="United Nations Children’s Fund (UNICEF) SupplyDivision . Ready‐to‐use therapeutic food demand. www.unicef.org/supply/files/UNICEF_RUTF_Demand.pdf (accessed 11 August 2017). ">UNICEF 2015b</a>). Yet, despite the increased demand and growing competition amongst suppliers, the price is still high (<a href="./references#CD009000-bbs2-0140" title="United Nations Children’s Fund(UNICEF) . Management of severe acute malnutrition in children: working towards results at scale. www.childrenandaids.org/sites/default/files/2017‐05/SAM%20Guidance.pdf (accessed 4 August 2017). ">UNICEF 2015a</a>). According to <a href="./references#CD009000-bbs2-0138" title="United Nations Children's Fund(UNICEF) . Ready‐to‐use therapeutic food for children with severe acute malnutrition. www.unicef.org/media/files/Current_Issues_Paper_‐_Ready_To_Use_Therapeutic_Food.pdf (accessed 4 August 2017). ">UNICEF 2013b</a>, the cost to rehabilitate one child with SAM is around USD 100. An Ethiopian case study conducted by UNICEF in 2013 found that the purchase of RUTF accounted for approximately half of the operating costs of a community‐based management programme for acute malnutrition (<a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>; <a href="./references#CD009000-bbs2-0139" title="United Nations Children's Fund (UNICEF) Evaluation Office. Evaluation of community management of acute malnutrition: global synthesis report. www.unicef.org/evaldatabase/files/Final_CMAM_synthesis_FINAL_VERSION_with_ExSum_translations.pdf (accessed 11 August 2017). ">UNICEF 2013c</a>). Cost‐effectiveness, however, is related to factors such as SAM prevalence, population density and coverage (<a href="./references#CD009000-bbs2-0140" title="United Nations Children’s Fund(UNICEF) . Management of severe acute malnutrition in children: working towards results at scale. www.childrenandaids.org/sites/default/files/2017‐05/SAM%20Guidance.pdf (accessed 4 August 2017). ">UNICEF 2015a</a>). Producing RUTF locally presents a variety of challenges, including the cost of high‐quality ingredients, currency fluctuations, value‐added tax and quality control (<a href="./references#CD009000-bbs2-0129" title="SegrèJ , LiuG , KomrskaJ . Local versus offshore production of ready‐to‐use therapeutic foods and small quantity lipid‐based nutrient supplements. Maternal &amp; Child Nutrition2017;13(4):e12376. [DOI: 10.1111/mcn.12376; PUBMED: 27863004] ">Segré 2017</a>; <a href="./references#CD009000-bbs2-0140" title="United Nations Children’s Fund(UNICEF) . Management of severe acute malnutrition in children: working towards results at scale. www.childrenandaids.org/sites/default/files/2017‐05/SAM%20Guidance.pdf (accessed 4 August 2017). ">UNICEF 2015a</a>). However, there are options to address some of these challenges. One example is a programming tool developed by Weber and Callaghan, to help facilitate the manufacturing of more cost‐effective, alternative RUFTs, without compromising on quality (<a href="./references#CD009000-bbs2-0143" title="WeberJ , CallaghanM . Optimizing ready‐to‐use therapeutic foods for protein quality, cost, and acceptability. Food and Nutrition Bulletin2016;37(Suppl 1):S37‐46. [DOI: 10.1177/0379572116629257; PUBMED: 26864957] ">Weber 2016</a>). This tool also allows for incorporating cultural and religious preferences. </p> <p>The use of RUTF, however, remains a controversial issue (<a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>; <a href="./references#CD009000-bbs2-0090" title="GreinerT . Breastfeeding Briefs N° 56/57, September 2014. The advantages, disadvantages and risks of ready‐to‐use foods. ibfan.org/breastfeedingbreafs/BB%2056‐57‐The%20advantages‐disadvantages‐and‐risks‐of‐ready‐to‐use%20foods.pdf (accessed 4 August 2017). ">Greiner 2014</a>; <a href="./references#CD009000-bbs2-0138" title="United Nations Children's Fund(UNICEF) . Ready‐to‐use therapeutic food for children with severe acute malnutrition. www.unicef.org/media/files/Current_Issues_Paper_‐_Ready_To_Use_Therapeutic_Food.pdf (accessed 4 August 2017). ">UNICEF 2013b</a>). Apart from the cost of RUTF, as described above, there are concerns about commercial exploitation beyond SAM therapy (<a href="./references#CD009000-bbs2-0138" title="United Nations Children's Fund(UNICEF) . Ready‐to‐use therapeutic food for children with severe acute malnutrition. www.unicef.org/media/files/Current_Issues_Paper_‐_Ready_To_Use_Therapeutic_Food.pdf (accessed 4 August 2017). ">UNICEF 2013b</a>). The increased demand for RUTF has led to expansion of the commercial product range, such as ready‐to‐use supplementary foods (RUSFs; for instance, lipid‐based nutritional supplements (LNS)) (<a href="./references#CD009000-bbs2-0090" title="GreinerT . Breastfeeding Briefs N° 56/57, September 2014. The advantages, disadvantages and risks of ready‐to‐use foods. ibfan.org/breastfeedingbreafs/BB%2056‐57‐The%20advantages‐disadvantages‐and‐risks‐of‐ready‐to‐use%20foods.pdf (accessed 4 August 2017). ">Greiner 2014</a>; <a href="./references#CD009000-bbs2-0114" title="LazzeriniM , RubertL , PaniP . Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009584.pub2; PUBMED: 23794237] ">Lazzerini 2013</a>). RUSFs are used in treating MAM and stunting, as well as meeting nutritional needs and preventing malnutrition (<a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>). Conflict of interest issues, with supported examples from industry, have been extensively described in <a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>. </p> </section> </section> <section id="CD009000-sec-0041"> <h3 class="title" id="CD009000-sec-0041">How the intervention might work</h3> <p>Recovery from SAM during the rehabilitation phase requires high energy intake accompanied by high‐quality protein and micronutrients. Locally available foods, if not fortified, often do not meet the requirements of children recovering from SAM and are prone to bacterial contamination. Infants and young children can eat limited amount of food at a time (<a href="./references#CD009000-bbs2-0116" title="LinCA , ManaryMJ , MaletaK , BriendA , AshornP . An energy‐dense complementary food is associated with a modest increase in weight gain when compared with a fortified porridge in Malawian children aged 8‐18 months. Journal of Nutrition2008;138(3):593‐8. [DOI: 10.1093/jn/138.3.593] ">Lin 2008</a>). Lower energy‐density foods, together with a low frequency of feeding, can result in an energy intake that is insufficient to enable recovery. </p> <p>RUTF, a nutrient‐dense feed, has been developed to meet these increased requirements and limits the probability of bacterial contamination. The following characteristics of RUTF may contribute to its possible beneficial effects in the rehabilitation of SAM (<a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>; <a href="./references#CD009000-bbs2-0020" title="BriendA , LacsalaR , PrudhonC , MounierB , GrelletyY , GoldenMH . Ready‐to‐use therapeutic food for treatment of marasmus. Lancet1999;353(9166):1767‐8. [DOI: 10.1016/S0140‐6736(99)01078‐8; PUBMED: 10347999] ">Briend 1999</a>). </p> <p> <ol id="CD009000-list-0004"> <li> <p>Balanced, nutritious, home‐based therapy</p> </li> <li> <p>Affordable, compared to facility‐based rehabilitation</p> </li> <li> <p>Can be eaten safely at home, even where hygienic conditions are poor (<a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>) </p> </li> <li> <p>Long shelf life (up to two years)</p> </li> <li> <p>No special storage (for example, refrigeration) or preparation required</p> </li> </ol> </p> <p>Due to these properties, RUTF has become pivotal to the implementation of community‐based programmes for the management of malnutrition. </p> </section> <section id="CD009000-sec-0042"> <h3 class="title" id="CD009000-sec-0042">Why it is important to do this review</h3> <p>Both the WHO and UNICEF recommend the use of RUTF in the community as therapeutic feeding for outpatient rehabilitation for children with uncomplicated SAM (<a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009;</a> see <a href="#CD009000-tbl-0008">Table 5</a>). Furthermore, the WHO is committed to ensuring the inclusion of RUTF in the essential medicine lists (<a href="./references#CD009000-bbs2-0148" title="World Health Organization (WHO). Ambition and action in nutrition 2016–2025. www.who.int/nutrition/publications/nutrition‐strategy‐2016to2025/en/ (accessed 11 August 2017). ">WHO 2017a</a>). </p> <div class="table" id="CD009000-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Severe acute malnutrition management as recommended by the WHO and UNICEFa </span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Independent additional criteria</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0005"> <li> <p>No appetite</p> </li> <li> <p>Medical complications</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0006"> <li> <p>Appetite</p> </li> <li> <p>No medical complications</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>↓</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>↓</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type of therapeutic feeding</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Facility‐based feeding</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community‐based feeding</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0007"> <li> <p>F75 (Phase 1)</p> </li> <li> <p>F100/RUTF (Phase 2)</p> </li> <li> <p>24‐hour medical care</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0008"> <li> <p>RUTF</p> </li> <li> <p>Basic medical care</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Discharge criteria (transition criteria from facility‐ to community‐based care)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0009"> <li> <p>Reduced oedema</p> </li> <li> <p>Good appetite (with acceptable<sup>b</sup> intake of RUTF) </p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0010"> <li> <p>15%‐20% weight gain</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>RUTF:</b> ready‐to‐use therapeutic food; <b>UNICEF:</b> United Nations Children's Fund; <b>WHO:</b> World Health Organization </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009</a><br/> <sup>b</sup>Children who eat at least 75% of their calculated RUTF ration for the day. </p> </div> </div> <p>RUTF and RUSFs may pose risks for undermining best nutrition practices for infants and young children, such as compromising breastfeeding after the age of six months, despite disclaimers provided by industry (<a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>; <a href="./references#CD009000-bbs2-0138" title="United Nations Children's Fund(UNICEF) . Ready‐to‐use therapeutic food for children with severe acute malnutrition. www.unicef.org/media/files/Current_Issues_Paper_‐_Ready_To_Use_Therapeutic_Food.pdf (accessed 4 August 2017). ">UNICEF 2013b</a>). Furthermore, increased consumption of RUTF in a young child's diet may lead to alteration of the epigenome (which is involved in regulating gene expression and can be affected by changing environments), thereby potentially programming metabolic and physiological function throughout the life cycle (<a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>). Also, countries utilising RUTF are undergoing a nutrition transition, suffering a double burden of under‐ and overnutrition (<a href="./references#CD009000-bbs2-0072" title="BazzanoAN , PottsKS , BazzanoLA , MasonJB . The life course implications of ready to use therapeutic food for children in low‐income countries. International Journal of Environmental Research and Public Health2017;14(4):403. [DOI: 10.3390/ijerph14040403; PMC5409604; PUBMED: 28398257] ">Bazzano 2017</a>). Careful consideration should therefore be given to programmes aimed at combating undernutrition, to prevent the undesirable long‐term effects of overweight and obesity. </p> <p>In the previous version of our review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>), the limited evidence‐base identified precluded definitive conclusions regarding differences in clinical outcomes in children with SAM who were given home‐based RUTF compared to other home‐based nutritional approaches, or who received RUTF in different daily amounts or formulations. A number of new studies have since been conducted and are included in this review update. The findings of this systematic review will be of special interest to people in LMICs where SAM is a particular challenge, as well as to organisations involved in the preparation of clinical guidelines for practitioners and policy makers dealing with SAM (for example, WHO, UNICEF and government health departments). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009000-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009000-sec-0043"></div> <p>To assess the effects of home‐based RUTF used during the rehabilitation phase of SAM in children aged between six months and five years on recovery, relapse, mortality and rate of weight gain. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009000-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009000-sec-0044"></div> <section id="CD009000-sec-0045"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009000-sec-0046"> <h4 class="title">Types of studies</h4> <p>A randomised controlled trial (RCT) is the optimal study design for answering questions about intervention effects. Because there are a number of existing RCTs that address our primary outcomes we have, as in the earlier version of this review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>), included only RCTs and studies defined as quasi‐randomised (that is, studies that used an inadequate method of randomisation, such as alternation or date of birth). We included studies regardless of whether the unit of randomisation was individuals or clusters (that is, studies randomised by groups such as clinics, villages or families). </p> </section> <section id="CD009000-sec-0047"> <h4 class="title">Types of participants</h4> <p>Children aged between six months and five years with SAM, regardless of country, setting or disease status, and irrespective of the method of diagnosis employed. </p> <p>Where a potentially eligible study included children with both SAM and MAM (or other types of malnutrition), we included studies where SAM children made up 50% or more of the randomised trial participants. Where results were not available separately for children with SAM and could not be obtained by contacting the study authors, we excluded the trial. </p> </section> <section id="CD009000-sec-0048"> <h4 class="title">Types of interventions</h4> <section id="CD009000-sec-0049"> <h5 class="title">Experimental</h5> <p> <ol id="CD009000-list-0011"> <li> <p>Home‐based rehabilitation with standard RUTF (meeting the WHO recommendations (<a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>) for nutritional composition; either commercially or non‐commercially produced) as total nutrition or supplement </p> </li> </ol> </p> <p>In some settings, RUTF is provided in dosages that meet the child's full daily nutritional requirements (i.e. RUTF is the only food provided), while in other settings RUTF is given as a supplement only (i.e. caregivers are instructed that children should consume the RUTF in addition to the family's home diet). We considered both approaches in this review. </p> <p>We included studies where children with SAM started F‐100 or RUTF treatment in the rehabilitation phase as inpatients, provided 50% or more of the rehabilitation phase and treatment with RUTF occurred at home. </p> </section> <section id="CD009000-sec-0050"> <h5 class="title">Control</h5> <p> <ol id="CD009000-list-0012"> <li> <p>Dietary rehabilitation as usual (e.g. home‐based foods that are often energy dense and fortified, alternative dietary approach, etc.) </p> </li> <li> <p>Similar RUTF to the experimental RUTF, but used as a supplement only</p> </li> <li> <p>Alternative RUTF type (i.e. RUTF differs meaningfully in terms of ingredients, nutritional content, or both) </p> </li> </ol> </p> <p>We excluded studies in which the effects of RUTF were potentially confounded by another intervention; that is, where multiple interventions were involved, comparison groups should have received the same rehabilitation apart from the experimental RUTF. Furthermore, we excluded studies where standard (i.e. WHO‐recommended), commercially produced RUTF was compared to a locally produced RUTF with similar ingredients and nutrition content. </p> </section> </section> <section id="CD009000-sec-0051"> <h4 class="title">Types of outcome measures</h4> <section id="CD009000-sec-0052"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD009000-list-0013"> <li> <p>Recovery, during and beyond the intervention period, as defined by study authors</p> </li> <li> <p>Deterioration or relapse, during and beyond the intervention period, as defined by study authors </p> </li> <li> <p>Mortality, during and beyond the intervention period</p> </li> </ol> </p> </section> <section id="CD009000-sec-0053"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD009000-list-0014"> <li> <p>Rate of weight gain, during the intervention period (to standardise weight gain across different ages, baseline weight or lengths and heights) </p> </li> <li> <p>Time to recovery, during the intervention period</p> </li> <li> <p>Anthropometrical status, at the end of the intervention period and beyond (assessed with, for example, WHZ, weight‐for‐age z score (WAZ), height‐for‐age z score (HAZ), MUAC) </p> </li> <li> <p>Cognitive function and development, at the end of the intervention period and beyond (assessed with, for example, the Denver II (<a href="./references#CD009000-bbs2-0084" title="FrankenburgW , DoddsJ , ArcherP , ShapiroH , BresnickB . The Denver II: a major revision and restandardization of the Denver Developmental Screening Test. Pediatrics1992;89(1):91‐7. ">Frankenburg 1992</a>), Bayley Scales of Infant and Toddler Development (<a href="./references#CD009000-bbs2-0101" title="HoskensJ , KlingelsK , Smits‐EngelsmanB . Validity and cross‐cultural differences of the Bayley Scales of Infant and Toddler Development, Third Edition in typically developing infants. Early Human Development2018;25:17‐25. ">Hoskens 2018</a>)) </p> </li> <li> <p>Adverse outcomes (such as allergic reactions and diarrhoea), during and beyond the intervention period, as reported by study authors </p> </li> <li> <p>Acceptability of RUTF, during the intervention period, as defined by study authors</p> </li> </ol> </p> <section id="CD009000-sec-0054"> <h6 class="title">Economic commentary</h6> <p>In this update, we expanded our review by searching for studies that evaluated the cost‐effectiveness of home‐based RUTF as treatment for children (between six months and five years of age) with SAM. We included studies regardless of whether they had carried out a formal cost‐effectiveness assessment (i.e. whether or not the study included an effectiveness component). Furthermore, we included studies where RUTF was only one component of a community‐based treatment, but reported results separately for the RUTF component. </p> </section> </section> </section> </section> <section id="CD009000-sec-0055"> <h3 class="title">Search methods for identification of studies</h3> <p>We used a comprehensive search strategy to identify all relevant studies regardless of language or publication status. Searches for the first version of the review took place in April 2013 (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>). For this update, we ran searches in May and June 2017, and again in October 2018. We also expanded our search to find cost‐effectiveness studies. </p> <section id="CD009000-sec-0056"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases and trials registers using the search strategies in <a href="./appendices#CD009000-sec-0180">Appendix 1</a>. </p> <p> <ol id="CD009000-list-0015"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 12) in the Cochrane Library (searched 9 October 2018) </p> </li> <li> <p>MEDLINE(R), Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Daily and Versions(R) Ovid (1946 to 8 October 2018) </p> </li> <li> <p>Embase Ovid (1980 to 8 October 2018)</p> </li> <li> <p>African Index Medicus (<a href="http://indexmedicus.afro.who.int" target="_blank">indexmedicus.afro.who.int</a>; searched 9 October 2018) </p> </li> <li> <p>CINAHL EBCSOhost (Cumlative Index to Nursing and Allied Health Literature; 1937 to 9 October 2018) </p> </li> <li> <p>Science Citation Index Web of Science (1970 to 9 October 2018)</p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database; <a href="http://lilacs.bvsalud.org/en/" target="_blank">lilacs.bvsalud.org/en</a>; searched 9 October 2018) </p> </li> <li> <p>ZETOC (<a href="http://zetoc.jisc.ac.uk/" target="_blank">zetoc.jisc.ac.uk</a>; limited to conference search; searched 9 October 2018) </p> </li> <li> <p>Epistemonikos (<a href="https://www.epistemonikos.org/" target="_blank">www.epistemonikos.org</a>; last five years; searched 9 October 2018) </p> </li> <li> <p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>; searched 10 October 2018) </p> </li> <li> <p>ISRCTN registry (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com;</a> searched 9 October 2018) </p> </li> <li> <p>WHO International Clinical Trials Registry Platform (ICTRP; <a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>; searched 10 October 2018) </p> </li> </ol> </p> <p>We developed separate strategies to identify cost‐effectiveness studies and ran them in them in the following databases (<a href="./appendices#CD009000-sec-0193">Appendix 2</a>). </p> <p> <ol id="CD009000-list-0016"> <li> <p>MEDLINE OVID (1946 to 8 October 2018)</p> </li> <li> <p>MEDLINE Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Daily and Versions Ovid (1946 to 8 October 2018) </p> </li> <li> <p>Embase Ovid (1947 to 8 October 2018)</p> </li> <li> <p>NHS Economic Evaluation Database (NHS EED; 2015, Issue 2), part of the Cochrane Library (searched 12 June 2017; no new records added to NHS EED since March 2015) </p> </li> <li> <p>ECONLIT EBSCOHost (1969 to 9 October 2018)</p> </li> </ol> </p> <p><a href="./appendices#CD009000-sec-0199">Appendix 3</a> shows the search strategies used in the previous version of this review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>). </p> </section> <section id="CD009000-sec-0057"> <h4 class="title">Searching other resources</h4> <p>We contacted researchers and healthcare professionals working in the field, sending them the list of our included and excluded studies, and asking whether they were aware of any additional studies. We also checked the reference lists of included studies, appropriate reviews and cost‐effectiveness studies to identify additional studies. Furthermore, we contacted the authors of each relevant study identified in the studies registries to establish whether the study had been completed (and if so, whether or not there was a published or unpublished manuscript they could share with us), and the authors of all included studies to determine if they were aware of additional studies (published, unpublished or ongoing) in the field. </p> </section> </section> <section id="CD009000-sec-0058"> <h3 class="title" id="CD009000-sec-0058">Data collection and analysis</h3> <section id="CD009000-sec-0059"> <h4 class="title">Selection of studies</h4> <p>Three review authors (AS, AM and ML) independently and in duplicate screened the titles and abstracts of all studies identified by the electronic searches and selected those that met the prespecified eligibility criteria (<a href="#CD009000-sec-0045">Criteria for considering studies for this review</a>). We used the software <a href="./references#CD009000-bbs2-0081" title="Veritas Health Innovation. Covidence. Version accessed 27 February 2019. Melbourne, Australia: Veritas Health Innovation. ">Covidence</a> for screening (titles and abstracts, and full‐text articles) and discussed disparate judgements until we reached consensus. For studies deemed potentially eligible, we obtained the full‐text reports and two review authors (AS and AM or ML) independently assessed these for eligibility. We contacted the authors of the primary studies where there was missing information or if clarification was needed. In the event of no response, or incomplete or irrelevant information being received, we categorised the study as awaiting classification (<a href="./references#CD009000-sec-0242" title="">Characteristics of studies awaiting classification</a>). We resolved any disagreements by discussion among the review authors. Two review authors (AS and AM or ML) also independently screened the results of the cost‐effectiveness searches. We have presented the results of the screening process in a PRISMA flow diagram (<a href="./references#CD009000-bbs2-0121" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , the PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA Statement. Annals of Internal Medicine2009;151:264‐9. ">Moher 2009)</a>. We listed studies we initially thought to be relevant but that we later excluded in the <a href="./references#CD009000-sec-0241" title="">Characteristics of excluded studies</a> tables, with reasons for exclusion. </p> </section> <section id="CD009000-sec-0060"> <h4 class="title">Data extraction and management</h4> <p>Three review authors (AS, ML and AM) extracted data from included studies in duplicate and independently, using a pre‐piloted electronic data extraction sheet. We resolved disagreements by discussion and reaching consensus. For each included trial, we extracted information on each of the following: general (for example, ethics approval, funding and study period); methods (for example, study design and number of participants randomised per group); participants (for example, country, setting, age and comorbidity); interventions (for example, description, dose, duration, and concomitant treatment); outcomes (for example, description and time point collected); results (for example, numerical results for prespecified outcomes); and miscellaneous information (for example, testing for peanut allergies and quality of anthropometrical measurements). In addition, EN, AS and ML extracted data (one review author per trial, with AS double‐checking data across studies for consistency) using the Template of Intervention Description and Replication (TIDieR) table in <a href="./references#CD009000-bbs2-0100" title="HoffmannTC , OxmanAD , IoannidisJP , MoherD , LassersonTJ , ToveyDI , et al. Enhancing the usability of systematic reviews by improving the consideration and description of interventions. BMJ2017;357:j2998. [DOI: 10.1136/bmj.j2998; PUBMED: 28729459] ">Hoffmann 2017</a>. </p> <p>We emailed the study authors where reported information was unclear or contradictory, or where important data were missing. </p> <p>We entered the extracted data into one of the following tables:</p> <p> <ol id="CD009000-list-0017"> <li> <p><a href="./references#CD009000-sec-0240" title="">Characteristics of included studies</a> tables; </p> </li> <li> <p><a href="./references#CD009000-sec-0241" title="">Characteristics of excluded studies</a> tables; </p> </li> <li> <p><a href="./references#CD009000-sec-0242" title="">Characteristics of studies awaiting classification</a> tables; and </p> </li> <li> <p><a href="./references#CD009000-sec-0243" title="">Characteristics of ongoing studies</a> tables. </p> </li> </ol> </p> <p>With the exception of data from ongoing studies, we extracted data in duplicate at all times. </p> <p>We used the Cochrane Review by Sinclair and colleagues to inform our approach to presenting the data from the included cost‐effectiveness studies (<a href="./references#CD009000-bbs2-0133" title="SinclairD , DoneganS , IsbaR , LallooDG . Artesunate versus quinine for treating severe malaria. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD005967.pub4; PUBMED: 22696354] ">Sinclair 2012</a>). One review author (EN for studies identified with the 2017 search, and AM for studies identified with the 2018 search), extracted and tabularised the data from the included studies on cost. AS double‐checked the extracted data across studies for consistency. We have provided further information about the economic commentary in the <a href="#CD009000-sec-0167">Discussion</a> section. </p> </section> <section id="CD009000-sec-0061"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (AS and ML) independently assessed each included study for risk of bias using the guidelines provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009000-bbs2-0099" title="HigginsJP , AltmanDG , SterneJA , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>), and the criteria set out in <a href="./appendices#CD009000-sec-0212">Appendix 4</a>. They assessed studies for bias across the following domains: sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting and other potential sources of bias. For each domain, both review authors independently rated each included study at low risk of bias, high risk of bias or unclear risk of bias. They discussed any disagreements with a third review author (JV). </p> <p>We evaluated cluster studies across the following, additional domains, using the specific criteria set out in <a href="./appendices#CD009000-sec-0219">Appendix 5</a>: recruitment bias, baseline imbalance, loss of clusters, incorrect analysis and comparability with individually randomised studies (<a href="./references#CD009000-bbs2-0099" title="HigginsJP , AltmanDG , SterneJA , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>). </p> <p>We decided on overall risk of bias per study by taking into consideration the domains addressing selection bias, attrition bias (specifically large or differential attrition between groups) and 'other bias'. </p> </section> <section id="CD009000-sec-0062"> <h4 class="title">Measures of treatment effect</h4> <p>We used Review Manager 5 (RevMan 5) to manage the data and to conduct the analyses (<a href="./references#CD009000-bbs2-0125" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We calculated risk ratios (RR) for dichotomous data and mean differences (MD) for continuous data, and presented all results with 95% confidence intervals (CI). In cases where we could not extract raw data to calculate treatment effects, we reported results according to study authors. </p> </section> <section id="CD009000-sec-0063"> <h4 class="title">Unit of analysis issues</h4> <section id="CD009000-sec-0064"> <h5 class="title">Cross‐over trials</h5> <p>Because of the nature of the condition involved (SAM), we did not find any cross‐over trials. </p> </section> <section id="CD009000-sec-0065"> <h5 class="title">Cluster trials</h5> <p>For cluster trials, we followed the method of adjusting for clustering, described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009000-bbs2-0098" title="HigginsJP , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). None of the four included cluster trials had properly accounted for the cluster design. Therefore, we used an 'approximate method', which entailed calculation of an 'effective sample size' for the comparison groups, by dividing the original sample size by the 'design effect', which is 1 + (c‐1)ICC, where c is the average cluster size and ICC is the intra‐cluster correlation coefficient. For dichotomous data, we divided both the number of participants and the number who experienced the event by the same design effect, while for continuous data, we adjusted only the sample size (we left means and SDs unchanged). The number of clusters was available for three of the four cluster trials and we contacted the study author of the fourth study to obtain the number of clusters (<a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). We imputed a low ICC of 0.001 for two studies because we did not anticipate large between‐cluster variability (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). The clusters in these studies were either the number of weeks of discharge or the days of discharge in the month. In this way, children from the same community were assessed in the same facility. We imputed a higher ICC of 0.005 for <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a> because seven different facilities represented seven clusters. We, therefore, expected a certain degree of between‐cluster variability in this trial. Although these values might seem arbitrary, we preferred to use them to adjust the sample sizes as they are more plausible than an ICC of 0. The authors of <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a> reported an ICC of 0.015, which we used to adjust the raw counts provided in the paper. We had initially intended to use the generic inverse variance method in RevMan 5, but since we had values for the totals, means and SDs per group from each study for continuous data, it became unnecessary to do so. </p> </section> <section id="CD009000-sec-0066"> <h5 class="title">Multiple treatment groups</h5> <p>In three studies there were three arms that were all relevant to our review (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a> had two experimental RUTF arms compared to the same control; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> and <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> had one experimental arm compared to two controls), and a fourth study had three arms that each included RUTF (<a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>). In <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> and <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> the experimental arm received standard RUTF in a dose that meets daily nutritional requirements whereas another arm received a similar RUTF but given as a supplement to the children's usual diet. Therefore, we could not combine these two arms into a single pair‐wise comparison (<a href="./references#CD009000-bbs2-0098" title="HigginsJP , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), and, as they relate to different comparisons, we analysed them separately. In Comparison 1, we thus selected the arm that received standard RUTF in sufficient quantity to meet daily nutritional requirements compared to the arm that received a maize and soy flour blend as intervention (adjusted for clustering using the abovementioned design effects). In Comparison 2, we also selected the arm that received standard RUTF in sufficient quantity to meet daily nutritional requirements, but compared it to the arm that received a similar RUTF but given as a supplement (adjusted for clustering using the above‐mentioned design effects). </p> <p><a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>, which addresses our Comparison 1, had two experimental arms that are both relevant to our question and compared it to a control of home‐prepared locally available foods ("A‐HPF"). The experimental interventions were "RUTF‐C", which is standard RUTF prepared in a factory and "RUTF‐L", which is standard RUTF that trained research staff prepared in a local site kitchen. We used both these arms in the same meta‐analyses and compared it against the control group, where for dichotomous outcomes we divided the control group's number of events and sample size by two and for continuous outcomes divided the control group's sample size by two and left the means and SDs unchanged. </p> <p><a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>, which addresses our Comparison 3, had an arm that received standard RUTF ("S‐RUTF"), an arm that received a flax seed‐containing RUTF ("F‐RUTF") and an arm that received the flax seed‐containing RUTF plus fish oil capsules ("FFO‐RUTF"). Because we could not combine the two latter arms, we chose the most appropriate comparison, which is standard RUTF versus "F‐RUTF". We considered the FFO‐RUTF arm not relevant to our question as the fish oil capsules were not part of the RUTF formulation and thus a potential confounding intervention. </p> <p>We reported data from the latest time point during or at the end of the intervention period, and at the latest time point after the intervention period (follow‐up), as stipulated in the <a href="#CD009000-sec-0051">Types of outcome measures</a> section (unless otherwise stated). We could not group time points as planned in our protocol (<a href="./references#CD009000-bbs2-0153" title="SchooneesA , LombardM , NelE , VolminkJ . Ready‐to‐use therapeutic food for treating undernutrition in children from 6 months to 5 years of age. Cochrane Database of Systematic Reviews2011, Issue 2. [DOI: 10.1002/14651858.CD009000] ">Schoonees 2011</a>), owing to the data available (one month or less of RUTF treatment, less than one to two or more months of RUTF treatment and more than two to six months of RUTF treatment). (In hindsight, these prespecified time points are not that practical, as treatment with RUTF lasting less than two months or more than four months seldom takes place in practice.) The primary outcomes in the included studies were either measured at the time of recovery (which varied between participants and such individual data were not reported unless time to recovery was an outcome in the trial), or at the end of a predetermined time period. We did not distinguish in the analyses between such studies; however, we reported what time points were used with each outcome in each trial. </p> </section> </section> <section id="CD009000-sec-0067"> <h4 class="title">Dealing with missing data</h4> <p>We attempted to obtain essential missing data (for example, standard deviations, units in which outcomes were measured, results for outcomes pre‐specified but not reported, whether or not participants were stabilised in hospital before the trial, intervention duration) by contacting the study authors via email. We classified attrition per study as (1) pre‐randomisation, (2) immediately post‐randomisation or (3) dropouts during the intervention phase, supplemented with reasons for the absence where these were reported in the article (<a href="#CD009000-tbl-0009">Table 6</a>). We imputed values for the ICC where we could not obtain them from published data. </p> <div class="table" id="CD009000-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Classification of attrition from included studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants recruited (n)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pre‐randomisation attrition (n)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Immediate post‐randomisation attrition (n)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dropouts during the intervention period (n)</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>619</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 = allocated to an arm prior to randomisation</p> <p>1 = re‐admission (had SAM before and return from defaulting)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (all from the control group) = 3 had no baseline data and 2 were older than 59 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 = dropped out; reasons not reported</p> <p>7 = deaths; reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1190</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>193 = complicated SAM</p> <p>3 = allergic to animal milk</p> <p>29 = family moving away</p> <p>35 = non‐consent</p> <p>22 = siblings already enrolled</p> <p>2 = incorrectly identified as SAM</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48 = withdrew consent</p> <p>3 = moved away</p> <p>3 = deaths; reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1178 (includes children with MAM and SAM)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41 = reasons not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 = reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 = deaths; reasons not reported</p> <p>8 = lost to follow‐up; reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unlikely</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2462</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>265 = not meeting eligibility criteria</p> <p>153 = required inpatient care</p> <p>70 = relapsed</p> <p>47 = refused</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>251 = deaths; reasons not reported</p> <p>543 = "defaulters"; 116 could be traced and 427 moved from the location</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1268</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>947 = reasons not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106 = dropped out over first 2 weeks; reasons not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>183 = dropped out; reasons not reported; deaths not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>236</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 = not residing in area</p> <p>33 = age not eligible</p> <p>23 = HIV‐infected</p> <p>19 = not SAM</p> <p>6 = treated for TB</p> <p>5 = already on lipid‐based supplements</p> <p>6 = discharged/screened before screening was finalised</p> <p>2 = previously enrolled in the study</p> <p>18 = refused</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><sup>b</sup>4 = deaths </p> <p><sup>b</sup>1 = ineligible </p> <p><sup>b</sup>5 = voluntarily withdrew; reasons not reported </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><sup>b</sup>4 = deaths; reasons not reported </p> <p><sup>b</sup>6 = voluntarily withdrew; reasons not reported </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1024 (eligible age was 5 to 168 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>124 = deaths</p> <p>21 = absconded from ward</p> <p>13 = not SAM</p> <p>67 = refused</p> <p>4 = "other"</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><sup>b</sup>175 = deaths; reasons not reported </p> <p><sup>b</sup>53 = dropped out; outpatient defaulters or ward absconders; reasons not reported </p> <p><sup>b</sup>8 = "other"; transfers out or final outcome unknown </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>* </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>452</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 = refused</p> <p>93 = HIV infected</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 = deaths; reasons not reported</p> <p>47 = dropped out; reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 = deaths; reasons not reported</p> <p>17 = dropped outs; reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1961</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87 = reasons not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64 = deaths; reasons not reported</p> <p>51 = lost to follow‐up; no reasons reported other than "those lost were more likely to be younger and marasmic" (quote) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 = refused</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 = Down Syndrome</p> <p>1 = cerebral palsy</p> <p>1 = had a stoma</p> <p>1 = fever</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 = deaths; 1 related to HIV and 1 related to TB</p> <p>47 = dropped out, "mainly due to long traveling distances" (quote)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 = sick</p> <p>5 = migrants</p> <p>3 = refused</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>MAM:</b> moderate acute malnutrition; <b>SAM:</b> severe acute malnutrition; <b>TB:</b> tuberculosis </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>For cluster‐randomised trials: actual values reported here (not adjusted for design effect).<br/> <sup>b</sup>Only data for relevant study arms/eligible study participants were reported here. </p> </div> </div> <p>For dichotomous data (for example, recovery and mortality during the intervention period), we used the intention‐to‐treat (ITT) principle to calculate effect sizes for individual studies or to pool more than one trial. We assumed that the participants who were lost to follow‐up or dropped out of the study did not experience the event of interest. However, for the outcome of 'relapse', we assumed that those who dropped out did not receive any treatment (RUTF or the control diet) and therefore experienced the event. Furthermore, when assessing dichotomous outcomes (e.g. recovery) at follow‐up (e.g. six months after the children initially recovered), we employed the available‐case principle; that is, we assessed only those who recovered during the intervention period and came back for follow‐up, as opposed to all children who recovered. We did not consider it plausible to assume that those who did not come back deteriorated. For continuous data, we calculated MDs for studies based on the available‐case principle. </p> </section> <section id="CD009000-sec-0068"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity by visual inspection of forest plots and statistically by means of the Chi<sup>2</sup> test for heterogeneity (significance level P value &lt; 0.10). We quantified heterogeneity using the I<sup>2</sup> test (<a href="./references#CD009000-bbs2-0096" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;21(11):1539‐58. [DOI: 10.1002/sim.1186; PUBMED: 12111919] ">Higgins 2002</a>), where I<sup>2</sup> values of 50% or more indicated a substantial level of heterogeneity (<a href="./references#CD009000-bbs2-0097" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analysis. BMJ2003;327(7414):557‐60. [DOI: 10.1136/bmj.327.7414.557; PMC192859; PUBMED: 12958120] ">Higgins 2003</a>). </p> <p>We considered the following characteristics as possible sources of clinical heterogeneity (and therefore used these in subgroup analyses; <a href="#CD009000-sec-0071">Subgroup analysis and investigation of heterogeneity</a>): whether or not participants were stabilised as inpatients before they received home‐based RUTF; differences in RUTF (e.g. commercially produced or not); differences in age across participants, and differences in comorbidity across participants. </p> </section> <section id="CD009000-sec-0069"> <h4 class="title">Assessment of reporting biases</h4> <p>We had planned to assess the likelihood of reporting bias with funnel plots using at least 10 studies per comparison and outcome (<a href="./references#CD009000-bbs2-0134" title="SterneJA , EggerM , MoherD , BoutronI (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Sterne 2017</a>). However, we identified too few studies to allow for this. </p> </section> <section id="CD009000-sec-0070"> <h4 class="title">Data synthesis</h4> <p>We anticipated a high degree of heterogeneity due to the inclusion of children across different settings, some of whom were hospitalised before enrolment into the study and others not; intervention periods across studies being of differing duration; and the use of different definitions (e.g. for recovery and the rate of weight gain). For this reason, we used a random‐effects model to combine the results per comparison and outcome across studies, with inverse‐variance weighting for continuous outcomes and Mantel‐Haenszel weighting for dichotomous outcomes. Where substantial statistical heterogeneity existed, we investigated the potential sources of heterogeneity through subgroup analysis as reported below (<a href="#CD009000-sec-0071">Subgroup analysis and investigation of heterogeneity</a>). </p> <p>Using the GRADE tool (<a href="./references#CD009000-bbs2-0092" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [DOI: 10.1016/j.jclinepi.2010.04.026; PUBMED: 21195583] ">Guyatt 2011</a>), AS and ML evaluated the quality of evidence (high, moderate, low or very low) of the four most important outcomes (recovery, relapse, mortality and the rate of weight gain) for all three comparisons: </p> <p> <ol id="CD009000-list-0018"> <li> <p>standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach; </p> </li> <li> <p>standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet; and </p> </li> <li> <p>standard RUTF versus RUTF using an alternative formulation.</p> </li> </ol> </p> <p>We considered five reasons for possible downgrading of the quality of the evidence, namely limitations in study design or execution (risk of bias), inconsistency of results, indirectness of evidence, imprecision and publication bias. We have reported these ratings in 'Summary of findings' tables, which we created using <a href="./references#CD009000-bbs2-0089" title="McMaster University (developed by Evidence Prime). GradePro GDT. Version (accessed 27 February 2019). Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEPro GDT 2015</a> software. </p> </section> <section id="CD009000-sec-0071"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We considered heterogeneity to be statistically significant when I<sup>2</sup> was 50% or higher and P value was under 0.10. We performed subgroup analyses when we detected statistical heterogeneity, or, in the case of pre‐trial hospitalisation, regardless of statistical heterogeneity. We considered the following subgroups. </p> <p> <ol id="CD009000-list-0019"> <li> <p>Pre‐trial hospital stabilisation versus no pre‐trial hospitalisation: clinical heterogeneity could exist between children diagnosed with complicated SAM (requiring stabilisation in hospital) compared to those with uncomplicated SAM (who usually do not require hospitalisation) </p> </li> <li> <p>Commercial (i.e. factory) versus non‐commercial (i.e. institution kitchen) RUTF: it is generally cheaper to produce RUTF non‐commercially in a local site kitchen than in a food factory (commercially); however, there are concerns about batch consistency and microbiological safety in the case of non‐commercial production </p> </li> <li> <p>Different types of RUTF products (for example, corn and soy‐based versus peanut‐based RUTF) </p> </li> <li> <p>Age of children: 6 to 12 months, as this is the ideal period to start weaning from a milk‐based diet; 13 months to 5 years, as these children consume a mixed diet (mostly not breast milk although the child may still be taking some </p> </li> <li> <p>Children with or without comorbid disease (for example, HIV/AIDS, tuberculosis, malaria)</p> </li> </ol> </p> <p>Because subgroup analyses should be interpreted with caution, we applied the following criteria when interpreting the results: consideration of the direction of the point estimate per subgroup; overlap of the CIs of different subgroups; and statistical tests for differences between subgroups. </p> <p>The available data did not allow subgroup analyses in relation to age (i.e. the individual studies included in our review did not stratify or report data in a way that allowed us to conduct such analyses). In Comparison 1, we assessed subgroups 1, 2 and 5, where data allowed. In Comparison 2, with only two studies, we could only apply subgroup 5; and in Comparison 3, we assessed subgroups 1, 3 and 5, where data allowed. More detail per comparison, as available data allowed, follows below (<a href="#CD009000-sec-0076">Included studies</a>). </p> </section> <section id="CD009000-sec-0072"> <h4 class="title">Sensitivity analysis</h4> <p>Where data allowed, we performed sensitivity analyses on the four outcomes reported in the 'Summary of findings' tables, to assess the influence of study quality (using low risk of bias in selection bias, attrition bias, and other bias as markers) and study design (cluster trials versus individually randomised controlled trials) on the findings. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009000-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009000-sec-0073"></div> <section id="CD009000-sec-0074"> <h3 class="title">Description of studies</h3> <section id="CD009000-sec-0075"> <h4 class="title">Results of the search</h4> <p>We recorded the results of the search and screening process in a PRISMA flow diagram; see <a href="#CD009000-fig-0002">Figure 2</a>. Briefly, we screened 2830 search results in 2013 (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>), and, for this update, an additional 2729 records (of which 526 were from the searches for cost‐effectiveness studies) in 2017 and 2018. For this update, we scrutinised 39, new, full‐text reports that we identified as potentially eligible for the effects (main) part of our review, and of these, selected 12 new reports (11 new studies) for inclusion (<a href="#CD009000-sec-0076">Included studies</a>); categorised two new reports (two studies) as <a href="./references#CD009000-bbs1-0003" title="">Studies awaiting classification</a>; identified 10 new reports (eight studies) of <a href="./references#CD009000-bbs1-0004" title="">Ongoing studies</a>; and excluded 15 reports with reasons (<a href="#CD009000-sec-0089">Excluded studies</a>). We used Google Translate to conduct a preliminary assessment of non‐English abstracts, but did not need to obtain the full texts for any of these studies. </p> <div class="figure" id="CD009000-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="PRISMA flow diagram of search for effectiveness section of the review" data-id="CD009000-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow diagram of search for effectiveness section of the review</p> </div> </div> </div> </section> <section id="CD009000-sec-0076"> <h4 class="title">Included studies</h4> <p>This review includes 7976 children from a total of 15 studies: four from our 2013 review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>) namely <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>, <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>, <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> and <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; and 11 that are new to this update (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>). Of these 15 studies, two were reported in the same article (<a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>). We contacted the study authors and established that a detailed manuscript for <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a> does not exist. In addition, we have included two reports of the same study as separate studies (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>), as they involved different children, namely those with and without HIV. Four of the 15 included studies are cluster trials (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). After calculating their respective effective sample sizes, the total number of children analysed in this review is 6630. </p> <p>Our 2013 review, <a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>, included only studies conducted in Malawi (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>). This review update includes an additional four studies from Malawi (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>), as well as four studies from India (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>), and one study apiece from Zambia (<a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>), Kenya (<a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>), and Cambodia (<a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>). </p> <p>Overall, the duration of the intervention periods ranged from eight (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>) to 16 weeks (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>). One trial, which only assessed acceptability, did not report the duration of the intervention (<a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>), and two studies did not specify a maximum intervention duration (<a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). Only five studies followed up children after the intervention period (maximum of six months), and generally reported on a limited number of outcomes (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). </p> <p>The section below provides a list of the included studies grouped according to the comparison assessed. Further details are given in the <a href="./references#CD009000-sec-0240" title="">Characteristics of included studies</a> tables, as well as in <a href="#CD009000-tbl-0010">Table 7</a> (Comparison 1), <a href="#CD009000-tbl-0011">Table 8</a> (Comparison 2) and <a href="#CD009000-tbl-0012">Table 9</a> (Comparison 3), which are based on the TIDieR table in <a href="./references#CD009000-bbs2-0100" title="HoffmannTC , OxmanAD , IoannidisJP , MoherD , LassersonTJ , ToveyDI , et al. Enhancing the usability of systematic reviews by improving the consideration and description of interventions. BMJ2017;357:j2998. [DOI: 10.1136/bmj.j2998; PUBMED: 28729459] ">Hoffmann 2017</a>. </p> <div class="table" id="CD009000-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">TIDieR table: Comparison 1</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] "><b>Bhandari 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] "><b>Ciliberto 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] "><b>Jadhav 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] "><b>Manary 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] "><b>Ndekha 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] "><b>Shewade 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] "><b>Thapa 2017</b> </a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study period and brief comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2012 ‐ April 2015 Commercially‐ and non‐commercially produced S‐RUTF compared to energy‐dense, micronutrient‐enriched, locally available, home‐prepared foods. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>December 2002 ‐ June 2003. S‐RUTF, commercially produced, versus maize/soy flour prepared by caregivers as a porridge. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2011‐June 2013. S‐RUTF, non‐commercially produced, versus locally available, home‐prepared foods high in energy and protein. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January‐October 2001. S‐RUTF, factory produced, compared to caregiver‐prepared flour porridge (made from a maize and soy flour blend). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January‐September 2001. S‐RUTF, factory produced, compared to caregiver‐prepared flour porridge (made from a maize and soy flour blend). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2011. S‐RUTF, non‐commercially produced, "supplementary nutrition" (quote) and nutrition counselling versus "supplementary nutrition" (quote) and nutrition counselling. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>August 2013‐March 2014. S‐RUTF, non‐commercially produced, versus locally available foods precooked and packaged non‐commercially and prepared at home by caregivers. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Why?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐commercially produced RUTF may be less expensive and more sustainable in some countries. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>To investigate whether home‐based therapy with RUTF results in higher rates of recovery and lower rates of relapse or death than the (then) standard therapy in Malawi. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There is a need in India for "indigenously" (quote) produced RUTF.</p> <p>To investigate the efficacy of such RUTF in children with SAM when compared to "standard nutritional therapy" (quote). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the time the study started, the WHO recommended inpatient therapy until recovery for the treatment of children with SAM. For many families this was not feasible. </p> <p>To investigate the effects of home‐based RUTF compared to ample amounts of the local staple food (porridge) in HIV‐uninfected children with SAM. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the time the study started, the WHO recommended inpatient therapy until recovery for the treatment of children with SAM. For many families this was not feasible. </p> <p>To investigate the effects of home‐based RUTF compared to ample amounts of the local staple food (porridge) in HIV‐infected children (not on ARV) with SAM. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>To investigate the effectiveness of RUTF in therapeutic doses in community‐based management of uncomplicated SAM. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There is a need in India for "indigenously" (quote) produced RUTF equivalent to the WHO RUTF recommendations. </p> <p>The study authors carried out a preliminary study to investigate the acceptance and efficacy of such a RUTF among SAM children in informal settlements in India. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What educational materials were provided to caregivers? </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Government trained health educators and promoters visited families weekly, and used site‐specific counselling cards (of which the families received copies) in the local language to convey messages regarding frequency, amount and how to feed the study foods; as well as on continuing breastfeeding, good hygiene and advice on family meals. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All caregivers were counselled about nutritional requirements and good feeding practices. However, it is unclear who performed the counselling and whether caregivers received educational material. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children in both groups received weekly feeding counselling at the OTP site. Unclear if caregivers received counselling material. Study staff were 2 medical doctors, 1 social worker and "anganwadi workers" (quote) (community health workers); it is unclear who performed the nutrition counselling. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All study staff (2 nutritionists, 2 anthropometrists, 3 technical assistants, 3 "lady health workers" (quote), and "4 other helpers" (quote)) were trained regarding all aspects of the study. They were also instructed to guide the caregivers (of children in both groups) regarding the schedule, method and hygienic conditions of feeding; and the cooking of the control intervention to the relevant caregivers. It is unclear whether caregivers were provided with educational material. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What procedures?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications, or those with complications but who were stabilised first in hospital, were eligible. </p> <p>Follow‐up of those who dropped out of the study was not reported. However, health workers, peer supporters and community leaders were involved in the study and thus tracing of and motivating those who dropped out of the study was probably done. </p> <p>Health workers referred sick children, those whose WHZ did not improve in 4 weeks, and children who deteriorated for 2 consecutive weeks to physicians. Children with severe illness were admitted to hospital, and the study intervention was restarted after the child returned home. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All children from the maize/soy flour group and less than half of children from the RUTF group were stabilised in hospital pre‐trial. </p> <p>Children who failed to attend their follow‐up visits (3 weeks after their previous visit) were sought through local village health workers, to determine whether the child had died or relapsed. Children who relapsed exited the study and were treated as in‐patients. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All children were hospitalised for 2 weeks or longer based on their complications.</p> <p>Study staff did not carry out regular home visits, and it is not reported whether children who were lost to follow‐up were traced. It is also unclear whether children who deteriorated stayed in the study and were admitted to hospital. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM were eligible, after they were stabilised as inpatients.</p> <p>Study staff did not make home visits; children who were lost to follow‐up were not traced at home. </p> <p>Children who deteriorated were admitted to hospital.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM were eligible, after they were stabilised as inpatients.</p> <p>Study staff did not make home visits; children who got lost to follow‐up were not traced at home. </p> <p>Children who deteriorated were admitted to hospital.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications were eligible. Children who missed their weekly appointment at the OTP were followed up at their homes by Anganwadi workers. Children with complications were referred to inpatient care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications were eligible.</p> <p>It appears as if no children were lost to follow‐up, and that no children were admitted to hospital for complications. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Who provided the intervention?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trained health educators dispensed RUTF, and families of children in the comparison group were given raw ingredients to prepare foods. </p> <p>Caregivers at home fed the children, but neighbourhood peer support workers visited homes (of children across all 3 groups) several times a day to help caregivers feed their children. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is unclear who dispensed the RUTF to caregivers.</p> <p>The maize/soy flour was given in one 50 kg bag to caregivers. The flour intervention was supplemented with micronutrients. </p> <p>Caregivers at home fed their children.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not explicitly reported, but it seems as if RUTF was dispensed at the NRU. It is not clear who dispensed the RUTF or who dispensed the ingredients for the control diet. </p> <p>After hospital discharge, caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is not reported who dispensed the study interventions to the caregivers. Caregivers of children in the maize and soy flour group also received a micronutrient supplement to give to their children daily. </p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is not reported who dispensed the study interventions to the caregivers. Caregivers of children in the maize and soy flour group also received a micronutrient supplement to give to their children daily. </p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The RUTF dose per child was prescribed by a doctor and dispensed by study staff (including Anganwadi workers) at the OTP. </p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily, caregivers fed their children at home under supervision of nutritionists and "lady health visitors" (quote). Mothers were asked to feed their child as much as they could eat over half an hour. </p> <p>In both groups, nutritionists weighed the amount of food children needed to take daily.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>How was the intervention provided?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly, an independent trained team measured children's weight, height, MUAC, skinfold thickness and assessed for oedema on feet. It is not explicitly reported, but it seems that these measurements were done at the children's homes and not at a health facility's outpatient department. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 2 weeks, children were assessed at the NRU. Weight, length and MUAC were measured. It is unclear who did the measurements. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is unclear whether anthropometrical measurements (weight, length/height and MUAC) were done weekly or biweekly, and by whom. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 2 weeks, caregivers and children had to visit the outpatient department for anthropometrical measurements (weight, statural growth and MUAC) and "health assessment" (quote) ‐ it is unclear who performed these assessments. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 2 weeks, caregivers and children had to visit the outpatient department for anthropometrical measurements (weight, statural growth and MUAC) and "health assessment" (quote) ‐ it is unclear who performed these assessments. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly, at the OTP, the social worker measured the children's weight, length/height and MUAC. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight was measured daily by "anthropometrists" (quote) at the children's homes. It is unclear how often measurements of length/height and MUAC were taken. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 diverse geographical settings in India, with a mix of rural and urban areas. The study populations were low‐income households, and most study activities took place at the families' homes. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The participating NRUs were mission and public facilities in small towns and rural areas of southern Malawi. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study was conducted at an urban health centre associated with a tertiary hospital in Mumbai, India. Most participants were from lower socio‐economic status backgrounds due to the centre's close proximity to a very large informal settlement. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients to NRU at the teaching hospital in Blantyre, Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients to NRU at the teaching hospital in Blantyre, Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OTP site at an urban health and training centre near a densely populated urban resettlement colony in Chandigarh, India. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 informal settlements in North India. Most study activities took place at the families' homes. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>When and how much?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In all groups, 175 kCal/kg/day of the interventions were dispensed weekly until recovery or a maximum of 16 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided as 175 kCal/kg/day and dispensed every 2 weeks until recovery or a maximum of 8 weeks. The control group were told to consume the flour porridge 7 times a day (portion sizes not reported). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once weekly, children across groups received their dietary intervention at 175 kCal/kg/day for 8 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The interventions were dispensed every 2 weeks, with the RUTF at 733 kJ/kg/day and the maize and soy flour blend at 2400 g raw product/day. Caregivers were instructed to feed the RUTF over the course of the day, while those in the control group were instructed to feed their children porridge 7 times/day, with the aim of reaching 1500 g of cooked porridge (about 733 kJ/kg/day) daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The interventions were dispensed every 2 weeks, with the RUTF at 733 kJ/kg/day and the maize and soy flour blend at 2400 g raw product per day. Caregivers were instructed to feed the RUTF over the course of the day, while those in the control group were instructed to feed their children porridge 7 times a day, with the aim of reaching 1500 g of cooked porridge (about 733 kJ/kg/day) daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children in the experimental group received RUTF at 200 kCal/kg/day weekly, in addition to "nutritional supplementation" (quote) of 500 kcal and 12‐15 g protein per day, which all children received. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both diets were dispensed daily.</p> <p>The RUTF provided 2280 kJ/100 g, with protein 15.7% of product, while the control diet provided from 1556 kJ to 1887 kJ/100 g, with protein from 6.8% to 13.6% of product. </p> <p>Children from both groups could consume as much as they wanted, and were offered the foods 6 times/day. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tailoring?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Modifications of intervention throughout the trial?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the original protocol, the intervention duration was set at 8 weeks. However, after 20 children were enrolled and an independent Data Safety Monitoring Board reviewed their results, they recommended that the intervention period be extended for another 8 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The intervention foods were continued for 6 weeks. Since these were liked by the children, these were extended for 2 weeks more" (quote). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Strategies to improve/maintain intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Consumption data for children in the 2 RUTF groups were collected weekly by trained health educators, as were the amounts of ingredients used for children in the control group. The total amount of calories consumed could only be estimated for the RUTF groups. </p> <p>Study authors reported that, in addition to providing the diets, extra support for feeding seems important in their setting. Enhanced engagement and sharing of skills of local, experienced women (peer supporters) seemed to improve children's food intake. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The intake of RUTF, but not the control diet, was monitored. However, detail regarding this was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No measurements of home dietary intake were conducted.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No measurements of home dietary intake were conducted.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is unclear what the children's adherence to the "nutritional supplementation" (quote) was, which both groups received. </p> <p>"Objective assessment of RUTF compliance was done by noting down the amount of RUTF consumed in previous week" (quote). However, it is unclear who of the study staff collected data on RUTF adherence. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily, after the meals, study staff (presumably nutritionists as they weighed the portions for the meals) weighed the leftover food. The amount of food consumed daily was then estimated and recorded. </p> <p>Intake of energy and protein was calculated from the amount of food eaten daily, throughout the study period. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Extent of intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "The mean (SD) amount of RUTF‐L [con‐commercial] consumed was<br/> 193.27 (94.03) g/day and RUTF‐C [commercial] 172.83 (89.10). The<br/> mean (SD) kcal/kg/day consumed was 140.19 (65.41)<br/> and 129.69 (65.09), respectively. Consumption was not<br/> measured in the A‐HPF [control] group" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study authors reported that children in the RUTF group consumed significantly more food, energy and protein in comparison to the control group (P &lt; 0.001). </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>A‐HPF:</b> augmented energy‐dense home‐prepared foods; <b>ARV:</b> antiretroviral therapy; <b>MUAC:</b> mid‐upper arm circumference; <b>NRU:</b> Nutritional Rehabilitation Unit; <b>OTP:</b> outpatient therapeutic programme; <b>RUTF:</b> Ready‐to‐use therapeutic food; <b>RUTF‐C:</b> commercially produced ready‐to‐eat therapeutic food; <b>RUTF‐L:</b> locally produced ready‐to‐eat therapeutic food; <b>S‐RUTF:</b> standard ready‐to‐use therapeutic food; <b>SAM:</b> severe acute malnutrition; <b>SD:</b> standard deviation; <b>WHO:</b> World Health Organization; <b>WHZ:</b> weight‐for‐height z score </p> </div> </div> <div class="table" id="CD009000-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">TIDieR table: Comparison 2</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] "><b>Manary 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] "><b>Ndekha 2005</b> </a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study period and brief comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January‐October 2001.</p> <p>S‐RUTF (factory‐produced), at a dose that met total daily nutritional requirements compared to a similar RUTF given as a supplement to the habitual diet. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January‐September 2001.</p> <p>S‐RUTF (factory‐produced) compared to caregiver‐prepared flour porridge (made from a maize and soy flour blend). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Why?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the time the study started, the WHO recommended inpatient therapy until recovery for the treatment of children with SAM. For many families this was not feasible. </p> <p>The study sought to investigate the effects of home‐based RUTF compared to a similar RUTF but given as a supplement in HIV‐uninfected children with SAM. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the time the study started, the WHO recommended inpatient therapy until recovery for the treatment of children with SAM. For many families this was not feasible. </p> <p>The study sought to investigate the effects of home‐based RUTF compared to a similar RUTF but given as a supplement in HIV‐infected children (who were not on ARV therapy) with SAM. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What educational materials were provided to caregivers? </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What procedures?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM were eligible for intervention after they were stabilised as inpatients.</p> <p>Study staff did not make home visits; children who were lost to follow‐up were not traced at home. </p> <p>Children who deteriorated during the study were admitted to hospital.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM were eligible for intervention after they were stabilised as inpatients.</p> <p>Study staff did not make home visits; children who got lost to follow‐up were not traced at home. </p> <p>Children who deteriorated during the study were admitted to hospital.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Who provided the intervention?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is not reported who dispensed the study interventions to the caregivers.</p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is not reported who dispensed the study interventions to the caregivers.</p> <p>Caregivers fed their children at home.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>How was the intervention provided?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 2 weeks, caregivers and their children had to visit the outpatient department for anthropometrical measurements (weight, statural growth and MUAC) and "health assessment" (quote) ‐ it is unclear who performed these assessments. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 2 weeks, caregivers and their children had to visit the outpatient department for anthropometrical measurements (weight, statural growth and MUAC) and "health assessment" (quote) ‐ it is unclear who performed these assessments. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients of the NRU at the teaching hospital in Blantyre, Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients of the NRU, at the teaching hospital in Blantyre, Malawi.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>When and how much?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The interventions were dispensed every 2 weeks, with the RUTF at 733 kJ/kg/day and the RUTF supplement at 2090 kJ/day (about 92 g per child). Caregivers in the RUTF group were instructed to feed the RUTF over the course of the day, while those in the RUTF supplement group were instructed to give their children the RUTF in addition to their usual diet daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The interventions were dispensed every 2 weeks, with the RUTF at 733 kJ/kg/day and the RUTF supplement at 2090 kJ/day (about 92 g per child). Caregivers in the RUTF group were instructed to feed the RUTF over the course of the day, while those in the RUTF supplement group were instructed to give their children the RUTF in addition to their usual diet daily. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tailoring?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Modifications of intervention throughout the trial?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Strategies to improve/maintain intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No measurements of home dietary intake were conducted.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No measurements of home dietary intake were conducted.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Extent of intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured.</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>ARV:</b> antiretroviral therapy; <b>MUAC:</b> mid‐upper arm circumference; <b>NRU:</b> Nutritional Rehabilitation Unit; <b>RUTF:</b> Ready‐to‐use therapeutic food; <b>S‐RUTF:</b> standard ready‐to‐use therapeutic food; <b>SAM:</b> severe acute malnutrition; <b>WHO:</b> World Health Organization </p> </div> </div> <div class="table" id="CD009000-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">TIDieR table: Comparison 3</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] "><b>Bahwere 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] "><b>Hsieh 2015a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] "><b>Irena 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] "><b>Jones 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] "><b>Kerac 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] "><b>Oakley 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] "><b>Sigh 2018</b> </a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study period and brief comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2010‐March 2011RUTF prepared from whey protein concentrate versus S‐RUTF (prepared from dried skimmed milk). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January‐May 2014RUTF with high oleic acid content versus S‐RUTF.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>June 2009‐August 2010Milk‐free soy‐maize‐sorghum based RUTF versus S‐RUTF.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>June 2012‐July 2013RUTF with elevated omega‐3 fatty acids versus S‐RUTF.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>July 2006‐March 2007RUTF with added pre‐ and probiotics versus S‐RUTF.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>July 2008‐April 2009RUTF containing 10% milk with soy versus S‐RUTF (25% milk).</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>September 2015‐January 2017Fish‐based RUTF versus S‐RUTF (BP100).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Why?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dried skimmed milk is the most expensive component of RUTF. This study assessed the effectiveness of a RUTF using whey protein (a cheaper alternative) instead. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This study assessed the effect of a RUTF with high oleic acid content on plasma DHA and eicosapentaenoic acid status. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The milk content of S‐RUTF increases the cost. The use of alternative sources of protein will reduce the cost of RUTF. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Current RUTF formulations do not provide significant ALA or omega‐3 long chain polyunsaturated fatty acids. Previous studies have found low omega‐3 fatty acids levels in children recovering from SAM. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probiotics and prebiotics may be of benefit in SAM by correcting dysbiosis and improving intestinal function. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Milk is the most expensive component of RUTF. Reducing the milk content will reduce the cost of the RUTF. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There is low acceptability in Cambodia for the S‐RUTF Plumpy'nut® ; therefore, this study assessed the effects of RUTF made with locally‐available fish. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What educational materials were provided to caregivers? </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health and nutrition advice was provided once after enrolment in the study; unclear by whom and if materials were provided. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“…focused nutritional counselling and instructions on therapeutic feeding were provided by the nurses” (quote). Nurses were “experienced pediatric nutrition nurses” (quote). It is unclear if materials were provided to caregivers. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health and nutrition advice was provided as a one‐off after enrolment in the study; unclear by whom and if materials were provided. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers were told that no food should be consumed during the treatment period other than the RUTF or breast milk. It is unclear who conveyed this information to caregivers, and whether materials were provided. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Senior research nurses gave instruction on the administration and importance of RUTF, that no other foods were required and that the RUTF must not be mixed or diluted with porridge. It is unclear if this was done as a one off or regularly, and whether materials were provided. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers received general health and nutrition advice; unclear by whom and if materials were provided. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What procedures?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications, or those with complications but who were stabilised first in hospital, were eligible. </p> <p>Defaulters (absent for 3 consecutive visits) were followed up by trained volunteers and invited back into the study. Children whose condition deteriorated as outpatients were referred to inpatient care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No children were stabilised in hospital before the study. Nothing reported on whether defaulters were traced or whether children with complications were referred to inpatient care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No children were stabilised in hospital before the study.</p> <p>Defaulters (absent for 3 consecutive visits) were</p> <p>followed up and invited back into the programme by trained volunteers. SAM children with complications were referred to inpatient care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications, or those with complications but who were stabilised first in hospital, were eligible. Participants’ homesteads were mapped </p> <p>and defaulters (definition not provided) were traced in the community. Participants who required </p> <p>ongoing inpatient care were reviewed by a member of</p> <p>the study team daily until discharge to the outpatient programme.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All children were stabilised in hospital with F‐75 for 2‐4 days and started RUTF as rehabilitation in hospital. Upon easily finishing at least 75% of their daily RUTF, they were discharged to continue rehabilitation at home. Defaulters (having missed 2 consecutive outpatient visits) were followed up by a mobile team. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No children were stabilised in hospital before the study. Children who remained wasted after 4 visits, or clinically worsened during outpatient treatment, were referred for inpatient care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications, or those with complications but who were stabilised first in hospital, were eligible. Nothing reported on whether defaulters were traced. </p> <p>Participants who refused</p> <p>to eat the RUTF for &gt; 4 days/week over 2 consecutive weeks or who lost weight during 2 consecutive visits were excluded from the trial. </p> <p>Participants received an incentive after finishing the trial.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Who provided the intervention?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear who among the study staff (trained study nurses, nurses, CHW) dispensed the RUTF to caregivers. </p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear who dispensed the RUTF to caregivers.</p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear who among the study staff dispensed the RUTF to caregivers.</p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear who among the study staff dispensed the RUTF to caregivers.</p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear who among the study staff dispensed the RUTF to caregivers.</p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF was distributed by field assistants. Senior research nurses instructed caretakers on amount to feed. </p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study staff were a combination of trained doctors, nurses, midwives and Masters in nutrition students, but it is unclear who dispensed the RUTF to caregivers. </p> <p>Caregivers fed their children at home.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>How was the intervention provided?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly visits to the outpatient department. MUAC, oedema and weight were recorded and children were screened for medical problems, including appetite and RUTF side effects. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fortnightly visits to the outpatient department. Anthropometrical measurements were taken, and caregivers were asked about their child’s health status. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly visits to the outpatient department. MUAC, oedema and weight were recorded and children were screened for medical problems, including appetite and RUTF side effects. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly visits to the outpatient department during the first month, and monthly visits for the second and third month of the intervention period. MUAC, weight and length/height were probably measured. Monitoring for side effects or </p> <p>adverse events was conducted at all scheduled and unscheduled visits. (No information on unscheduled visits was reported.) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In hospital, trained staff used a pre‐piloted, standardised questionnaire to obtain caregiver‐reported clinical outcome indicators of children. During outpatient rehabilitation, this was collected at each 2‐weekly visit. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fortnightly visits to the outpatient department. Weight, length/height and MUAC were measured, and children were assessed for oedema. Caregivers were asked how many days in the last 2 weeks the child had had fever, cough, and diarrhoea. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fortnightly visits to the outpatient department; “all anthropometrical measures and oedema were assessed” (quote) and children were also screened for medical complications, including possible side effects of the RUTFs. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient treatment programmes in central Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient treatment programme in rural, southern Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient treatment programmes around Lusaka, Zambia.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An outpatient treatment programme at a hospital in coastal Kenya, where the majority of the community is involved in rural subsistence farming. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient and outpatient programmes in a large, urban teaching and referral hospital in Malawi. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient treatment programme in rural, southern Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the national paediatric hospital in Cambodia and its outpatient programme.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>When and how much?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided at 175 kCal/kg and dispensed weekly until recovery or maximum 4 months of intervention. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided at 175 kCal/kg/day (735 kJ/kg/day) and dispensed every 2 weeks until recovery or a maximum of 12 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided at 200 kCal/kg/day and dispensed every week until recovery (no maximum intervention period specified). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided as per national Kenyan guidelines and dispensed once a week for the first month and then once a month for the other 2 months until recovery or a maximum of 84 days. Children who recovered before day 84 were given 50% of the therapeutic dose (to be taken alongside family foods) until day 84. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided at 200 kCal/kg/day and dispensed every second week until recovery or a maximum of 5 visits (about 10 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided as 175 kCal/kg/day and dispensed every 2 weeks until recovery or a maximum of 8 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided at 160‐180 kCal/kg/day and dispensed every 2 weeks until recovery or a maximum of 8 weeks. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tailoring?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the child was still hungry, additional RUTF was offered.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Modifications of intervention throughout the trial?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In May 2013, provision of all study RUTF was stopped due to peroxidation of the control group's F‐RUTF. The children who were still on RUTF at that time were switched to S‐RUTF supplied by Kenya's Ministry of Health. All of these participants were followed up for the full study duration and included in the intention‐to‐treat analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If children did not eat the RUTF to which they were assigned, they were offered the alternative RUTF. This happened in both groups, with 2/61 children from the experimental group and 1/60 child from the control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Strategies to improve/maintain intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers were interviewed at each visit on the acceptability of the RUTF, and whether the child had eaten a RUTF formulation other than the one that they had been allocated. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twins were given a RUTF ration to limit sharing. Also, where there were study participants from the same household, they received the same food to prevent contamination of the allocated RUTF. </p> <p>At every visit, caregivers were asked about their child’s feeding habits (no more detail provided). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers were interviewed at each visit on the acceptability of the RUTF, and whether the child had eaten a RUTF formulation other than the one that they had been allocated. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was monitored by interviews with caregivers and counting full and empty sachets of RUTF. Adherence was calculated according to “'full ration’ taking account of the participant’s weight and stage of treatment” (quote). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers reported on adherence and non‐sharing to trained staff.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twins were given a RUTF ration to limit sharing. Children with MAM from the same household were given the same food as the SAM child. Also, where there were study participants from the same household, they received the same food to prevent contamination of the allocated RUTF. It is unclear if information on participant adherence was collected. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers were asked to bring the remaining RUTF to each visit, to check for adherence.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Extent of intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43 children switched from the SMS‐RUTF (control) to the P‐RUTF (S‐RUTF, experimental) arm. No children switched from P‐RUTF to SMS‐RUTF. The amount of RUTF consumed (adherence results) was not measured. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The median compliance on day 84 was 90% (range 80‐101) in the experimental arm and 96% (range 67‐100) in the control arm. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean utilisation of RUTF was 51.7% in the experimental arm and 48.1% in the control arm. Upon questioning, 41% of caregivers in the experimental arm versus 27% in the control arm reported they had either sold, given away, thrown away, lost the RUTF, or that it was eaten by animals. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>ALA:</b> alpha‐linolenic acid; <b>BP100:</b> solid biscuit made from cooked wheat; <b>CHW:</b> community health workers; <b>DHA:</b> docosahexaenoic acid; <b>F‐RUTF</b> : flax‐seed containing ready‐to‐use therapeutic food; <b>MAM:</b> Moderate acute malnutrition; <b>MUAC:</b> mid‐upper arm circumference; <b>P‐RUTF:</b> standard peanut‐based ready‐to‐eat therapeutic food; <b>RUTF:</b> Ready‐to‐use therapeutic food; <b>S‐RUTF:</b> standard ready‐to‐use therapeutic food; <b>SAM:</b> severe acute malnutrition; <b>SMS‐RUTF:</b> milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food </p> </div> </div> <section id="CD009000-sec-0077"> <h5 class="title">Comparison 1: standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach </h5> <p>We included seven studies in this comparison (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>). </p> <p> <ol id="CD009000-list-0020"> <li> <p><a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>: an individually randomised, controlled trial, with 906 children aged 6 to 59 months in India. The study compared a standard peanut‐ and milk‐based RUTF in two arms (one factory‐produced and one produced in an institution kitchen) to caregiver‐prepared, locally available foods (with energy‐dense and nutrient‐rich recipes). </p> </li> <li> <p><a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>: a stepped‐wedge design (which we treated as a cluster, quasi‐randomised trial) with children aged between 10 and 60 months in Malawi. Of the 1178 children that were randomised, 645 had SAM, with an effective sample size of 352. The study compared a standard peanut‐ and milk‐based RUTF (factory‐produced) to F‐100 (start of rehabilitation as inpatients) and a caregiver‐prepared flour porridge (maize and soy flour blend) at home. </p> </li> <li> <p><a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>: an individually randomised, controlled trial with 321 children aged six months to five years in India. The study compared a standard peanut‐ and milk‐based RUTF (produced in an institution kitchen) to an energy‐dense and high protein diet from locally available foods (prepared in a hospital kitchen during admission, and by caregivers at home after discharge). </p> </li> <li> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>: a cluster, quasi‐randomised trial of 186 children (effective sample size = 182) older than 12 months of age who were not infected with HIV (HIV‐uninfected) in Malawi. The study compared a standard peanut‐ and milk‐based RUTF (factory‐produced) to a caregiver‐prepared flour porridge (maize and soy flour blend) at home. </p> </li> <li> <p><a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>: a cluster, quasi‐randomised trial of 65 children (effective sample size = 65) aged between 12 and 60 months who were infected with HIV (HIV‐infected) in Malawi. The study compared a standard peanut‐ and milk‐based RUTF (factory‐produced) to a caregiver‐prepared flour porridge (maize and soy flour blend) at home. </p> </li> <li> <p><a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>: an individually randomised, controlled trial with 26 children aged six months to five years in India. Each of the two groups received the same care (anthropometry, case management, feeding counselling, supplementary nutrition), but the experimental group also received a standard peanut‐ and milk‐based RUTF produced in an institution kitchen. </p> </li> <li> <p><a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>: an individually randomised, controlled trial with 112 children aged six months to five years in India. The study compared a standard peanut‐ and milk‐based RUTF (produced in an institution kitchen) to caregiver‐prepared, precooked, locally available foods. </p> </li> </ol> </p> </section> <section id="CD009000-sec-0078"> <h5 class="title">Comparison 2: standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet </h5> <p>We included two studies in this comparison (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). </p> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> and <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>: these are the same studies reported under Comparison 1, except for this Comparison, we used the RUTF and RUTF supplement groups in our analyses. The studies used similar RUTF products but in different portions. </p> </section> <section id="CD009000-sec-0079"> <h5 class="title">Comparison 3: standard RUTF versus RUTF using an alternative formulation</h5> <p>We included eight studies in this comparison (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>). </p> <p> <ol id="CD009000-list-0021"> <li> <p><a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>: an individually randomised, controlled trial of 600 children aged 6 to 59 months in Malawi. The study compared a standard milk‐based RUTF (peanuts; factory‐produced) to a RUTF containing whey protein (factory‐produced). </p> </li> <li> <p><a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>: an individually randomised, controlled trial of 141 children aged between six months and five years in Malawi. The study compared a standard milk‐based RUTF (peanuts; factory‐produced) to a RUTF containing high oleic fatty acids (factory‐produced). </p> </li> <li> <p><a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>: an individually randomised, controlled trial of 148 children aged between six months and five years in Malawi. The study compared a standard milk‐based RUTF (peanuts; factory‐produced) to a RUTF containing high oleic fatty acids (factory‐produced). </p> </li> <li> <p><a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>: a cluster‐RCT of 1927 children (effective sample size = 881) across 12 clusters and aged between 6 and 60 months in Zambia. The study compared a standard milk‐based RUTF (peanuts; factory‐produced) to a RUTF containing soy, maize and sorghum (factory‐produced). </p> </li> <li> <p><a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>: an individually randomised, controlled trial of 61 children aged between 6 and 60 months in Kenya. The study compared a standard milk‐based RUTF (peanuts; factory‐produced) to a RUTF containing flax seed oil (factory‐produced). </p> </li> <li> <p><a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>: an individually randomised, controlled trial with 795 children aged between 5 and 168 months in Malawi. The study compared a standard milk‐based RUTF (peanuts; factory‐produced) to a RUTF containing pre‐ and probiotics (factory‐produced). </p> </li> <li> <p><a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>: an individually randomised, controlled trial of 1874 children aged between 6 and 59 months in Malawi. The study compared a standard milk‐based RUTF (peanuts; factory‐produced) to a RUTF containing only 10% milk and soy flour (factory‐produced). </p> </li> <li> <p><a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>: an individually randomised, controlled trial of 121 children aged between 6 to 59 months in Cambodia. The study compared a standard milk‐based RUTF (cereal; factory‐produced) to a RUTF containing locally available fish, mung beans, rice, soybeans and rice flour (factory‐produced). </p> </li> </ol> </p> <p>Although <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a> was published in 2009, and we identified it in our earlier search, we did not include it in the original review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>), because the abstract specified that the study included children aged 5 to 168 months, and we rejected the study during the titles and abstracts screening stage. For this review update, we obtained the full‐text article for this study and determined that the majority of the children were in the six‐month‐to‐five‐year age group, and that the study authors had done a separate analysis for this group. </p> </section> <section id="CD009000-sec-0080"> <h5 class="title">Subgroup analyses</h5> <p>With the exception of one study (<a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>), we were able to use data from our included studies to conduct four of our five, preplanned subgroup analyses (<a href="./references#CD009000-bbs2-0153" title="SchooneesA , LombardM , NelE , VolminkJ . Ready‐to‐use therapeutic food for treating undernutrition in children from 6 months to 5 years of age. Cochrane Database of Systematic Reviews2011, Issue 2. [DOI: 10.1002/14651858.CD009000] ">Schoonees 2011</a>). </p> <section id="CD009000-sec-0081"> <h6 class="title">Pre‐trial hospital stabilisation versus no pre‐trial hospitalisation</h6> <p>We conducted an analysis of the following subgroups for Comparisons 1 and 3 using data from 14 studies (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>). </p> <p> <ol id="CD009000-list-0022"> <li> <p>All participants received in‐hospital stabilisation before study enrolment</p> <ol id="CD009000-list-0023"> <li> <p>Comparison 1: three studies (<a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>) </p> </li> <li> <p>Comparison 3: one study (<a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>) </p> </li> </ol> </li> <li> <p>Some of the participants received in‐hospital stabilisation before study enrolment</p> <ol id="CD009000-list-0024"> <li> <p>Comparison 1: two studies (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>) </p> </li> <li> <p>Comparison 3: three studies (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>) </p> </li> </ol> </li> <li> <p>No pre‐trial inpatient stabilisation occurred</p> <ol id="CD009000-list-0025"> <li> <p>Comparison 1: two studies (<a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>) </p> </li> <li> <p>Comparison 3: three studies (<a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>) </p> </li> </ol> </li> </ol> </p> </section> <section id="CD009000-sec-0082"> <h6 class="title">Commercial (i.e. factory) versus non‐commercial (i.e. institution kitchen) RUTF</h6> <p>We conducted an analysis of the following subgroups for Comparison 1 using data from six studies (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>). </p> <p> <ol id="CD009000-list-0026"> <li> <p>Factory‐produced RUFT</p> <ol id="CD009000-list-0027"> <li> <p>Comparison 1: three studies (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>) </p> </li> </ol> </li> <li> <p>Local site‐kitchen‐produced RUFT</p> <ol id="CD009000-list-0028"> <li> <p>Comparison 1: three studies (<a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>) </p> </li> </ol> </li> </ol> </p> </section> <section id="CD009000-sec-0083"> <h6 class="title">Different types of RUTF products (for example, corn and soy‐based versus peanut‐based RUTF) </h6> <p>We conducted an analysis of the following subgroups for Comparison 3 using data from seven studies (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>). </p> <p> <ol id="CD009000-list-0029"> <li> <p>Studies where the control RUTF contained less or no milk powder: four studies (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>) </p> </li> <li> <p>Studies where the control RUTF contained specific fatty acids: two studies (<a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>) </p> </li> <li> <p>Studies where the control RUTF contained pre‐ and probiotics: one study (<a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>) </p> </li> </ol> </p> </section> <section id="CD009000-sec-0084"> <h6 class="title">Age of children: 6 to 12 months</h6> <p>The data from the included studies did not allow subgroup analyses of age.</p> </section> <section id="CD009000-sec-0085"> <h6 class="title">Children with or without comorbid disease (for example, HIV/AIDS, TB)</h6> <p>We conducted an analysis of the following subgroups for Comparisons 1 and 2 using the data from four studies (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). </p> <p> <ol id="CD009000-list-0030"> <li> <p>HIV‐uninfected or untested children</p> <ol id="CD009000-list-0031"> <li> <p>Comparison 1: three studies (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>) </p> </li> <li> <p>Comparison 2: one study (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>) </p> </li> </ol> </li> <li> <p>HIV‐infected children</p> <ol id="CD009000-list-0032"> <li> <p>Comparison 1: one study (<a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>) </p> </li> <li> <p>Comparison 2: one study (<a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>) </p> </li> </ol> </li> </ol> </p> </section> </section> <section id="CD009000-sec-0086"> <h5 class="title">Sensitivity analysis</h5> <p>With the exception of one study (<a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>), we were able to use data from our included studies to conduct our preplanned sensitivity analyses (<a href="./references#CD009000-bbs2-0153" title="SchooneesA , LombardM , NelE , VolminkJ . Ready‐to‐use therapeutic food for treating undernutrition in children from 6 months to 5 years of age. Cochrane Database of Systematic Reviews2011, Issue 2. [DOI: 10.1002/14651858.CD009000] ">Schoonees 2011</a>). </p> <section id="CD009000-sec-0087"> <h6 class="title">Study quality (using low risk of bias in selection bias, attrition bias, and other bias as marker of quality) </h6> <p>We conducted sensitivity analyses for Comparisons 1 and 3 using data from five studies (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>). </p> <p> <ol id="CD009000-list-0033"> <li> <p>Comparison 1: one study (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>) </p> </li> <li> <p>Comparison 3: four studies (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>) </p> </li> </ol> </p> </section> <section id="CD009000-sec-0088"> <h6 class="title">Study design (cluster trials versus individually randomised, controlled trials)</h6> <p>We conducted sensitivity analyses for Comparisons 1 and 2 using data from 14 studies (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>). </p> <p> <ol id="CD009000-list-0034"> <li> <p>individually randomised, controlled trials</p> <ol id="CD009000-list-0035"> <li> <p>Comparison 1: four studies (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>) </p> </li> <li> <p>Comparison 3: six studies (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>) </p> </li> </ol> </li> <li> <p>Cluster trials</p> <ol id="CD009000-list-0036"> <li> <p>Comparison 1: three studies (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>) </p> </li> <li> <p>Comparison 3: one study (<a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>) </p> </li> </ol> </li> </ol> </p> </section> </section> </section> <section id="CD009000-sec-0089"> <h4 class="title">Excluded studies</h4> <p>In total, we excluded 37 studies with reasons from this review; 22 studies from our 2013 review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>), and a further 15 studies from this update (<a href="./references#CD009000-bbs2-0017" title="AshrafM , MahmoodS , ChaudhryMA . Effect of F‐75, F‐100 and RUTF (ready to use therapeutic food) supplementation in children with severe malnutrition. Pakistan Journal of Medical &amp; Health Sciences2017;11(1):339‐42. [www.pjmhsonline.com/2017/jan_march/pdf/339.pdf] ">Ashraf 2017</a>; <a href="./references#CD009000-bbs2-0018" title="BahwereP , BalalukaB , WellsJC , MbiribindiCN , SadlerK , AkomoP , et al. Cereals and pulse‐based ready‐to‐use therapeutic food as an alternative to the standard milk‐ and peanut paste‐based formulation for treating severe acute malnutrition: a noninferiority, individually randomized controlled efficacy clinical trial. American Journal of Clinical Nutrition2016;103(4):1145‐61. [DOI: 10.3945/ajcn.115.119537; PUBMED: 26984485] ">Bahwere 2016</a>; <a href="./references#CD009000-bbs2-0019" title="BahwereP , AkomoP , MwaleM , MurakamiH , BandaC , KathumbaS , et al. Soya, maize, and sorghum–based ready‐to‐use therapeutic food with amino acid is as efficacious as the standard milk and peanut paste–based formulation for the treatment of severe acute malnutrition in children: a noninferiority individually randomized controlled efficacy clinical trial in Malawi. Americal Journal of Clinical Nutrition2017;106(4):1100–12. [DOI: doi:10.3945/ajcn.117.156653; PUBMED: 28814393] ">Bahwere 2017</a>; <a href="./references#CD009000-bbs2-0021" title="BrownM , NgaTT , HoangM‐A , Maalouf‐ManassehZ , HammondW , ThucTM , et al. Acceptability of two ready‐to‐use therapeutic foods by HIV‐positive patients in Vietnam. Food and Nutrition Bulletin2015;36(2):102‐10. [DOI: 10.1177/0379572115587498; PUBMED: 26121696] ">Brown 2015</a>; <a href="./references#CD009000-bbs2-0022" title="ChoudhuryN , AhmedT , HossainI , IslamMM , SarkerSA , ZeilaniM , et al. Ready‐to‐use therapeutic food made from locally available food ingredients is well accepted by children having severe acute malnutrition in Bangladesh. Food and Nutrition Bulletin2018;39(1):116‐26. [DOI: 10.1177/0379572117743929; PUBMED: 29258336] ">Choudhury 2018</a>; <a href="./references#CD009000-bbs2-0023" title="CTRI/2013/02/003418 . Effectiveness of ready to eat food in treating severely malnourished children in community settings, a study from Puducherry [Effectiveness of indigenous ready to use therapeutic food (RUTF) in community‐based management of uncomplicated severe acute malnutrition (SAM): a randomized trial from Puducherry, India]. www.ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=6017&amp;EncHid=&amp;modid=&amp;compid=%27,%276017det%27 (first received 21 February 2013). ">CTRI/2013/02/003418</a>; <a href="./references#CD009000-bbs2-0024" title="DaniV , SatavK , PendharkarJ , SatavA , UghadeS , AdhavA , et al. Community‐based management of severe malnutrition: SAM and SUW in the tribal area of Melghat, Maharashtra, India. Clinical Epidemiology and Global Health2017;5(2):62‐9. [DOI: 10.1016/j.cegh.2016.11.003] ">Dani 2017</a>; <a href="./references#CD009000-bbs2-0029" title="IgeOK , OladokunRE , KikelomoO . Comparative weight gain with ready‐to‐use therapeutic food in stunted HIV‐infected and ‐uninfected children in a Nigerian Hospital. South African Journal of Child Health2014;8(3):104‐7. [DOI: 10.7196/SAJCH.723] ">Ige 2014</a>; <a href="./references#CD009000-bbs2-0036" title="MalikS , MittalM , KushwahaKP . WHO/UNICEF recommended therapeutic food versus home based therapeutic food in the management of severe acute malnutrition: a randomized controlled trial. Sudanese Journal of Paediatrics2016;16(2):21‐7. [PMC5237831; www.sudanjp.org; PUBMED: 28096555] ">Malik 2016</a>; <a href="./references#CD009000-bbs2-0037" title="MallewaJ , SzubertAJ , MugyenyiP , ChidzivaE , ThomasonMJ , ChepkorirP , et al. Effect of ready‐to‐use supplementary food on mortality in severely immunocompromised HIV‐infected individuals in Africa initiating antiretroviral therapy (REALITY): an open‐label, parallel‐group, randomised controlled trial. Lancet HIV2018;5(5):e231–40. [DOI: 10.1016/S2352‐3018(18)30038‐9; PMC5932190; PUBMED: 29653915] ">Mallewa 2018</a>; <a href="./references#CD009000-bbs2-0039" title="ManaryM . Protein source and quality in therapeutic foods affect the immune response and outcome in severe acute malnutrition. Food and Nutrition Bulletin2013;34(2):256‐8. [PUBMED: 23964405] ">Manary 2013</a>; <a href="./references#CD009000-bbs2-0041" title="MaustA , KoromaAS , AblaC , MolokwuN , RyanKN , SinghL , et al. Severe and moderate acute malnutrition can be successfully managed with an integrated protocol in Sierra Leone. Journal of Nutrition2015;145(11):2604‐9. [DOI: 10.3945/jn.115.214957; PUBMED: 26423737] ">Maust 2015</a>; <a href="./references#CD009000-bbs2-0044" title="NgaTT , NguyenM , MathisenR , HoaDT , MinhHN , HopLT , et al. Effectiveness of a locally produced ready‐to‐use‐therapeutic food for the treatment of children with acute malnutrition in Vietnam. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):1084. [DOI: 10.1159/000354245; PO1727; www.karger.com/Article/Pdf/354245] ">Nga 2013</a>; <a href="./references#CD009000-bbs2-0048" title="SatoW , FurutaC , MatsunagaK , BahwereP , CollinsS , SadlerK , et al. Amino‐acid‐enriched cereals ready‐to‐use therapeutic foods (RUTF) are as effective as milk‐based RUTF in recovering essential amino acid during the treatment of severe acute malnutrition in children: an individually randomized control trial in Malawi. PLoS ONE2018;13(8):e0201686. [DOI: 10.1371/journal.pone.0201686; PMC6086422; PUBMED: 30096200] ">Sato 2018</a>; <a href="./references#CD009000-bbs2-0052" title="WasnikVR , RathiM . Effect of locally made ready‐to‐use therapeutic food (mushpro health drink powder – MHDP) for treatment of malnutrition on children aged 6 to 72 months in tribal area of Amravati district of Maharashtra, India: a randomized control trial. International Journal of Collaborative Research on Internal Medicine &amp; Public Health2012;4(7):1472‐87. [internalmedicine.imedpub.com/effect‐of‐locally‐made‐readytouse‐therapeutic‐foodmushpro‐health‐drink‐powder‐‐mhdp‐for‐treatment‐ofmalnutrition‐on‐children‐aged‐6‐to‐72‐months‐in‐tribalarea‐of‐amravati‐district‐of‐maharashtra‐india‐arandomized‐control‐trial.pdf] ">Wasnik 2012</a>). The most common reasons for exclusion were that the study design was neither an RCT nor a quasi‐randomised trial (n = 10); the intervention was not RUTF (n = 8); the participant population was not eligible (n = 8); and ineligible comparisons (n = 8). In addition, one study included an ineligible participant population and had an ineligible comparison, one study was about prevention and not rehabilitation, and one registered trial entry that appeared eligible was never conducted due to a lack of funding. See the <a href="./references#CD009000-sec-0241" title="">Characteristics of excluded studies</a> tables. </p> <section id="CD009000-sec-0090"> <h5 class="title">Studies awaiting classification</h5> <p>In this update, we identified two studies that are awaiting classification (<a href="./references#CD009000-bbs2-0053" title="HuqS , HossainMI , IslamMM , AhmedT . Acceptability and efficacy of ready‐to‐use therapeutic food in 6‐24 months old children with severe acute malnutrition in Bangladesh. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):309. [DOI: 10.1159/000354245; PO109] ">Huq 2013</a>; <a href="./references#CD009000-bbs2-0054" title="KaleemR , AzizN , ZamanS , SalimiMA . Nutritional rehabilitation of severely malnourished children by high density diet in comparison to ready to use therapeutic food. Pakistan Paediatric Journal2014;38(4):235‐43. [ISSN 2305‐820X; www.pakmedinet.com/22343] ">Kaleem 2014</a>). </p> <p><a href="./references#CD009000-bbs2-0053" title="HuqS , HossainMI , IslamMM , AhmedT . Acceptability and efficacy of ready‐to‐use therapeutic food in 6‐24 months old children with severe acute malnutrition in Bangladesh. Annals of Nutrition &amp; Metabolism2013;63(Suppl 1):309. [DOI: 10.1159/000354245; PO109] ">Huq 2013</a> is a conference abstract of a study conducted in Bangladesh between 2009 and 2012. Detailed information about the interventions used (RUTF versus "rice‐lentils based traditional‐diets (khichuri and halwa") is not available. We emailed the study authors at least twice, requesting a copy of the full manuscript, but have yet to receive a response. </p> <p><a href="./references#CD009000-bbs2-0054" title="KaleemR , AzizN , ZamanS , SalimiMA . Nutritional rehabilitation of severely malnourished children by high density diet in comparison to ready to use therapeutic food. Pakistan Paediatric Journal2014;38(4):235‐43. [ISSN 2305‐820X; www.pakmedinet.com/22343] ">Kaleem 2014</a> is an individually randomised, controlled trial with 270 children aged 6 to 59 months in Pakistan, with three intervention groups: RUTF produced in a factory in France (n = 90), a "Homemade High Density Diet" (n = 90), and "Homemade High Density diet along with Micronutrient supplements" (n = 90). After careful consideration, we decided to place this study in the 'awaiting assessment' category, because the main results reported for the two relevant groups in our Comparison 1 were identical and we feel this unusual scenario requires further clarification. We also found a discrepancy in the article for weight gain, where slightly different results were provided in the table compared to text, and an instance where the percentage events had not been calculated correctly. We are engaging with the study author in order to clarify these findings. </p> <p>See the <a href="./references#CD009000-sec-0242" title="">Characteristics of studies awaiting classification</a> tables. </p> </section> <section id="CD009000-sec-0091"> <h5 class="title">Ongoing studies</h5> <p>In our 2013 review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>), there were nine ongoing studies. Of these, four entries are now included in this review as <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a> (CTRI/2012/10/003054 and NCT01705769), <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a> (ISRCTN62376241) and <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a> (CTRI/11/12/002259). One ongoing study entry (NCT01785680) in our 2013 review has been excluded with its published record, <a href="./references#CD009000-bbs2-0041" title="MaustA , KoromaAS , AblaC , MolokwuN , RyanKN , SinghL , et al. Severe and moderate acute malnutrition can be successfully managed with an integrated protocol in Sierra Leone. Journal of Nutrition2015;145(11):2604‐9. [DOI: 10.3945/jn.115.214957; PUBMED: 26423737] ">Maust 2015</a>, due to the study having had an ineligible study population and ineligible comparison. Regarding the other four ongoing studies from our 2013 review, we emailed the study authors to obtain available (published or unpublished) manuscripts (<a href="./references#CD009000-bbs2-0060" title="NCT00131417 . Ready to use therapeutic food in the rehabilitation of severely malnourished children [Comparison of the efficacy of a ready‐to‐use therapeutic food with a milk‐based diet in the rehabilitation of severely malnourished Ugandan children]. www.clinicaltrials.gov/ct2/show/NCT00131417 (first received 17 August 2005). ">NCT00131417</a>; <a href="./references#CD009000-bbs2-0061" title="NCT00941434 . Community based management of malnutrition [Community based management of malnutrition. A proposal for Pakistan initiative for mothers and newborns]. www.clinicaltrials.gov/ct2/show/NCT00941434 (first received 16 July 2009). ">NCT00941434</a>; <a href="./references#CD009000-bbs2-0062" title="NCT01144806 . Evaluation of energy expenditure, body composition and recovery rates in children with severe acute malnutrition [Evaluation of energy expenditure, body composition and recovery rates in children with severe acute malnutrition (SAM) receiving community‐based nutritional rehabilitation therapy]. www.clinicaltrials.gov/show/NCT01144806 (first received 15 June 2010). ">NCT01144806</a>; <a href="./references#CD009000-bbs2-0064" title="NCT01634009 . Soy‐ready to use therapeutic food (RUTF) in severely malnourished children [Efficacy of ready to use therapeutic food using soy protein isolate in under‐5 children with severe acute malnutrition in Bangladesh]. www.clinicaltrials.gov/ct2/show/NCT01634009 (first received 12 June 2012). ">NCT01634009</a>). The author for <a href="./references#CD009000-bbs2-0060" title="NCT00131417 . Ready to use therapeutic food in the rehabilitation of severely malnourished children [Comparison of the efficacy of a ready‐to‐use therapeutic food with a milk‐based diet in the rehabilitation of severely malnourished Ugandan children]. www.clinicaltrials.gov/ct2/show/NCT00131417 (first received 17 August 2005). ">NCT00131417</a> responded saying that the study had not yet been published, but an unpublished manuscript could be provided by September 2017. However, this has not yet been received after following up with the author again. Two studies have the same contact author, to whom we have sent repeated email requests for information, and who has not responded (<a href="./references#CD009000-bbs2-0061" title="NCT00941434 . Community based management of malnutrition [Community based management of malnutrition. A proposal for Pakistan initiative for mothers and newborns]. www.clinicaltrials.gov/ct2/show/NCT00941434 (first received 16 July 2009). ">NCT00941434</a>; <a href="./references#CD009000-bbs2-0062" title="NCT01144806 . Evaluation of energy expenditure, body composition and recovery rates in children with severe acute malnutrition [Evaluation of energy expenditure, body composition and recovery rates in children with severe acute malnutrition (SAM) receiving community‐based nutritional rehabilitation therapy]. www.clinicaltrials.gov/show/NCT01144806 (first received 15 June 2010). ">NCT01144806</a>). The author of <a href="./references#CD009000-bbs2-0064" title="NCT01634009 . Soy‐ready to use therapeutic food (RUTF) in severely malnourished children [Efficacy of ready to use therapeutic food using soy protein isolate in under‐5 children with severe acute malnutrition in Bangladesh]. www.clinicaltrials.gov/ct2/show/NCT01634009 (first received 12 June 2012). ">NCT01634009</a> informed us in 2017 that their "final analysis is ongoing" and that the researchers "may be able to share [the manuscript] after a couple of months"; however, we have not yet received it. </p> <p>We identified six studies by searching trials registers in 2017 (<a href="./references#CD009000-bbs2-0055" title="CTRI/2014/09/004958 . To establish effective nutrition protocol for community based management of children with severe acute malnutrition and to demonstrate operational feasibility through the existing Government system in Nandurbar district of Maharashtra in India [Community based management of acute malnutrition (CMAM) using global protocol ‐ MNT/RUTF in Nandurbar ‐ CMAM]. apps.who.int/trialsearch/Trial2.aspx?trialid=CTRI/2014/09/004958 (first received 2 September 2014). [www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=10011] ">CTRI/2014/09/004958</a>; <a href="./references#CD009000-bbs2-0056" title="CTRI/2016/02/006656 . Gut inflammation markers as determinants of response to recovery in uncomplicated severely malnourished children [Gut inflammation markers as determinants of response to treatment and recovery in children with uncomplicated severe acute malnutrition undergoing community based rehabilitation ‐ gut markers predictor of recovery in SAM children]. apps.who.int/trialsearch/Trial2.aspx?trialid=CTRI/2016/02/006656 (first received 17 February 2016). [www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=7346] ">CTRI/2016/02/006656</a>; <a href="./references#CD009000-bbs2-0057" title='BaileyJ , LelijveldN , MarronB , OnyooP , HoLS , ManrayM , et al. Combined protocol for acute malnutrition study (ComPAS) in rural South Sudan and urban Kenya: study protocol for a randomized controlled trial. Trials2018;19(1):251. [DOI: 10.1186/s13063‐018‐2643‐2; PMC5978994; PUBMED: 29690916] ISRCTN30393230 . Combined protocol for acute malnutrition study (ComPAS) [Combined protocol for acute malnutrition study (ComPAS) ‐ effectiveness of a combined and simplified protocol for the treatment of acute malnutrition: a prospective, multi‐center cluster‐randomized controlled non‐inferiority trial in Kenya and South Sudan]. www.isrctn.com/ISRCTN30393230?q=&amp;filters=recruitmentCountry:South%20Sudan&amp;sort=&amp;offset=1&amp;totalResults=1&amp;page=1&amp;pageSize=10&amp;searchType=basic‐search (first received 18 January 2017). [DOI: 10.1186/ISRCTN30393230] LelijveldN , BaileyJ , MayberryA , TrenouthL , N’DiayeDS , Haghparast‐BidgoliH , et al. The "ComPAS Trial" combined treatment model for acute malnutrition: study protocol for the economic evaluation. Trials2018;19(1):252. [DOI: 10.1186/s13063‐018‐2594‐7; PMC5916722; PUBMED: 29690899] '>ISRCTN30393230</a>; <a href="./references#CD009000-bbs2-0059" title="ISRCTN50039021 . Modelling an alternative nutrition protocol generalizable for outpatient (MANGO) [Modelling an alternative nutrition protocol generalizable for outpatient (MANGO) ‐ effectiveness of an optimized dosage of RUTF for the treatment of severe acute malnutrition: a randomized controlled, non‐inferiority trial in Burkina Faso]. www.isrctn.com/ISRCTN50039021 (first received 13 April 2016). [DOI: 10.1186/ISRCTN50039021] ">ISRCTN50039021</a>; <a href="./references#CD009000-bbs2-0063" title="NCT01331044 . Ready to use therapeutic food (RUTF) in severe malnourished children (RUTF) [Efficacy and acceptability of ready to use therapeutic food (RUTF) in children aged 6‐24 months with severe acute malnutrition in Bangladesh]. clinicaltrials.gov/ct2/show/NCT01331044 (first received 6 April 2011). ">NCT01331044</a>; <a href="./references#CD009000-bbs2-0065" title="NCT03094247 . Feeding malnourished children different types of fatty acids to promote neurocognitive development [Improved polyunsaturated ready‐to‐use therapeutic food for improved neurocognitive outcomes in severe acute malnutrition]. clinicaltrials.gov/ct2/show/NCT03094247 (first received 23 March 2017). ">NCT03094247</a>). The authors of four studies informed us that their studies are still ongoing (<a href="./references#CD009000-bbs2-0056" title="CTRI/2016/02/006656 . Gut inflammation markers as determinants of response to recovery in uncomplicated severely malnourished children [Gut inflammation markers as determinants of response to treatment and recovery in children with uncomplicated severe acute malnutrition undergoing community based rehabilitation ‐ gut markers predictor of recovery in SAM children]. apps.who.int/trialsearch/Trial2.aspx?trialid=CTRI/2016/02/006656 (first received 17 February 2016). [www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=7346] ">CTRI/2016/02/006656</a>; <a href="./references#CD009000-bbs2-0057" title='BaileyJ , LelijveldN , MarronB , OnyooP , HoLS , ManrayM , et al. Combined protocol for acute malnutrition study (ComPAS) in rural South Sudan and urban Kenya: study protocol for a randomized controlled trial. Trials2018;19(1):251. [DOI: 10.1186/s13063‐018‐2643‐2; PMC5978994; PUBMED: 29690916] ISRCTN30393230 . Combined protocol for acute malnutrition study (ComPAS) [Combined protocol for acute malnutrition study (ComPAS) ‐ effectiveness of a combined and simplified protocol for the treatment of acute malnutrition: a prospective, multi‐center cluster‐randomized controlled non‐inferiority trial in Kenya and South Sudan]. www.isrctn.com/ISRCTN30393230?q=&amp;filters=recruitmentCountry:South%20Sudan&amp;sort=&amp;offset=1&amp;totalResults=1&amp;page=1&amp;pageSize=10&amp;searchType=basic‐search (first received 18 January 2017). [DOI: 10.1186/ISRCTN30393230] LelijveldN , BaileyJ , MayberryA , TrenouthL , N’DiayeDS , Haghparast‐BidgoliH , et al. The "ComPAS Trial" combined treatment model for acute malnutrition: study protocol for the economic evaluation. Trials2018;19(1):252. [DOI: 10.1186/s13063‐018‐2594‐7; PMC5916722; PUBMED: 29690899] '>ISRCTN30393230</a>; <a href="./references#CD009000-bbs2-0059" title="ISRCTN50039021 . Modelling an alternative nutrition protocol generalizable for outpatient (MANGO) [Modelling an alternative nutrition protocol generalizable for outpatient (MANGO) ‐ effectiveness of an optimized dosage of RUTF for the treatment of severe acute malnutrition: a randomized controlled, non‐inferiority trial in Burkina Faso]. www.isrctn.com/ISRCTN50039021 (first received 13 April 2016). [DOI: 10.1186/ISRCTN50039021] ">ISRCTN50039021</a>; <a href="./references#CD009000-bbs2-0065" title="NCT03094247 . Feeding malnourished children different types of fatty acids to promote neurocognitive development [Improved polyunsaturated ready‐to‐use therapeutic food for improved neurocognitive outcomes in severe acute malnutrition]. clinicaltrials.gov/ct2/show/NCT03094247 (first received 23 March 2017). ">NCT03094247</a>). The author of <a href="./references#CD009000-bbs2-0063" title="NCT01331044 . Ready to use therapeutic food (RUTF) in severe malnourished children (RUTF) [Efficacy and acceptability of ready to use therapeutic food (RUTF) in children aged 6‐24 months with severe acute malnutrition in Bangladesh]. clinicaltrials.gov/ct2/show/NCT01331044 (first received 6 April 2011). ">NCT01331044</a> informed us that their manuscript is underway and will be available after peer review. We also contacted the author of <a href="./references#CD009000-bbs2-0055" title="CTRI/2014/09/004958 . To establish effective nutrition protocol for community based management of children with severe acute malnutrition and to demonstrate operational feasibility through the existing Government system in Nandurbar district of Maharashtra in India [Community based management of acute malnutrition (CMAM) using global protocol ‐ MNT/RUTF in Nandurbar ‐ CMAM]. apps.who.int/trialsearch/Trial2.aspx?trialid=CTRI/2014/09/004958 (first received 2 September 2014). [www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=10011] ">CTRI/2014/09/004958</a> in October 2017, but did not receive a response at the time of publication. In our 2018 search, we found two additional ongoing studies (<a href="./references#CD009000-bbs2-0058" title="ISRCTN31143316 . Treatment of severe acute malnutrition delivered by community health workers in Niger [A cohort study comparing treatment for severe acute malnutrition (SAM) in children between 6‐59 months, delivered by community health workers (CHWs) compared to a traditional facility based model in Mayahi district, Niger]. www.isrctn.com/ISRCTN31143316 (first received 31 July 2018). [10.1186/ISRCTN31143316] ">ISRCTN31143316</a>; <a href="./references#CD009000-bbs2-0066" title="NCT03407326 . Comparison of an alternative therapeutic food for the international food aid market to a standard ready‐to‐use therapeutic food (RUTF) for the treatment of severe acute malnutrition in children [Comparison of an alternative therapeutic food for the international food aid market to a standard ready‐to‐use therapeutic food (RUTF) for the treatment of severe acute malnutrition in children of the Western Rural Region and Pujehun District of Sierra Leone]. clinicaltrials.gov/ct2/show/NCT03407326 (first received 16 January 2018). ">NCT03407326</a>), for which the start dates in the trial registry entries are indicated as October 2017 and September 2018, respectively. </p> <p>See <a href="./references#CD009000-sec-0243" title="">Characteristics of ongoing studies</a> tables. </p> </section> <section id="CD009000-sec-0092"> <h5 class="title">Funding sources and conflicts of interest</h5> <p>Of our 15 included studies, six were linked to funding or donations from industry (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>), one did not report the source of funding (<a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>), and eight studies reported funding from non‐industry sponsors (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>). </p> <p>One study declared a conflict of interest that was not industry‐linked (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>). Two studies declared that one or more authors have a link to industry (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>), while two other studies reported that the authors have links to industry but declared no conflict of interest (<a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>). Six studies declared no conflict of interest (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>). The four remaining studies did not report on this matter (<a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>). </p> </section> </section> </section> <section id="CD009000-sec-0093"> <h3 class="title">Risk of bias in included studies</h3> <p>We have presented our judgements regarding the risk of bias in each of the included studies in the 'Risk of bias' tables beneath the <a href="./references#CD009000-sec-0240" title="">Characteristics of included studies</a> tables. We rated the overall risk of bias as high for six studies (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>), unclear for three studies (<a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>), and low for six studies (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>). <a href="#CD009000-fig-0003">Figure 3</a> and <a href="#CD009000-fig-0004">Figure 4</a> provide graphical summaries of the 'Risk of bias' assessments. For the four cluster studies, we have presented additional risk of bias information in <a href="#CD009000-tbl-0013">Table 10</a>. </p> <div class="figure" id="CD009000-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies" data-id="CD009000-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD009000-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD009000-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> </div> <div class="table" id="CD009000-tbl-0013"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Additional assessment of risk of bias in included cluster‐randomised trials</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recruitment bias</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Baseline imbalance</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Loss of clusters</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incorrect analysis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparability with individually‐randomised trials</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Inadequate</b> </p> <p>Being a stepped‐wedge design, recruitment occurred after sites were assigned a specific treatment. All children eventually ended up with RUTF, although the time point at which conversion from standard care to RUTF took place was unknown. The study authors recognised that recruitment bias was possible: "a source of bias might have been that a mother of a moderately malnourished child might have visited the NRU for screening when she heard that home‐based therapy was being offered" (quote). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>Baseline characteristics per intervention arm were reported, but similarities and differences between clusters were not mentioned. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>All randomised children were included in the analyses.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>The study authors did not adjust their analyses for clustering, but did provide sufficient information to allow us calculate and apply an estimated design effect. However, we are unsure how close to the truth the estimated ICC is. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>For the 4 most important outcomes, the findings of this trial are in line with that of the individually‐randomised trials. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Inadequate</b> </p> <p>Children were recruited after randomisation of clusters (healthcare clinics). The study authors indicate that recruitment bias may have resulted in greater numbers of children attending the S‐RUTF sites: “....preferential referral to or attendance at the sites of the P‐RUTF arm” (quote). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>The study authors reported "...that many important baseline characteristics, such [as] prevalence of oedema, average MUAC, the presence of diarrhoea and presence of dehydration, differed<br/> between the two arms" (quote). However, they performed multivariable analyses to assess the effect of these differences on the outcomes and found that these variables did not appear to interact with the outcomes. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>All randomised children were included in the analyses.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>The study authors adjusted for clustering in their multivariate analyses and provided the ICC that they used. We used this ICC to adjust the raw counts provided in the paper. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>For the 4 most important outcomes, the findings of this trial are in line with that of the individually‐randomised trials. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>The unit of systematic allocation was clusters, according to the day of discharge in the month. Children were recruited after discharge days and were allocated to a specific treatment. However, an independent doctor discharged the children without knowing which discharge days matched which treatment. Therefore, the risk of recruitment bias was minimised. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>Baseline characteristics per intervention arm were reported, but similarities and differences between children discharged on different days (i.e. clusters) were not mentioned. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>All randomised children were included in the analyses.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>The study authors did not adjust their analyses for clustering, but did provide sufficient information to calculate and apply an estimated design effect. However, we are unsure how close to the truth the estimated ICC is. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>The findings of this trial are in line with that of the individually randomised trial for the outcomes of 'recovery' and 'mortality', but not for the outcomes of 'relapse' and 'weight gain'. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>The unit of systematic allocation was clusters, according to the week of discharge. Children were recruited after the weeks of discharge were allocated to a specific treatment. However, an independent doctor discharged the children without knowing which discharge weeks matched which treatment. Therefore, the risk of recruitment bias was minimised. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>Baseline characteristics per intervention arm were reported, but similarities and differences between children discharged during different weeks (i.e. clusters) were not mentioned. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>All randomised children were included in the analyses.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>The study authors did not adjust their analyses for clustering, but did provide us with the number of clusters, which allowed us to calculate and apply an estimated design effect. However, we are unsure how close to the truth the estimated ICC is. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>For 3 of the 4 most important outcomes, the findings of this trial are in line with that of the individually randomised trial. However, the findings for the outcome of 'relapse' were different, but this could be due to factors other than the study design as all children in this trial were HIV‐infected. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>ICC:</b> intracluster correlation coefficient; <b>MUAC:</b> mid‐upper arm circumference; <b>NRU:</b> nutrition rehabilitation unit; <b>RUTF:</b> ready‐to‐use therapeutic food; <b>S‐RUTF:</b> standard ready‐to‐use therapeutic food </p> </td> </tr> </tbody> </table> </div> <section id="CD009000-sec-0094"> <h4 class="title">Allocation</h4> <p>Here, we refer to both the generation of the random allocation sequence and concealment of the allocation code. </p> <p>We judged seven studies to be at low risk of selection bias (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>); three studies to be a high risk of selection bias as they were quasi‐randomised (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>); and five studies to be at unclear risk of bias as they either did not report the method of sequence generation (<a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>) or did not report adequate allocation concealment (<a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>). </p> </section> <section id="CD009000-sec-0095"> <h4 class="title">Blinding</h4> <section id="CD009000-sec-0096"> <h5 class="title">Blinding of participants and personnel (performance bias)</h5> <p>We judged 13 studies at low risk of performance bias because the participants across groups received the same amount of contact time with study personnel: it is not likely that children in one group performed better because they received more care (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>). Also, for the eight studies in which blinding was not done, we judged that the outcome measurements in children were not likely to be influenced by the lack of blinding of caregivers and study personnel (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>). </p> <p>For the two studies where acceptability was the main focus, we judged one, <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>, at high risk of performance bias and the other, <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>, at unclear risk. In these studies, if caregivers knew what intervention their child was getting, we feel they could have influenced children to eat more or less RUTF, based on their own taste preferences or perception of the product. In addition, <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a> did not perform blinding, while <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a> reported 'double‐blinding' but did not explain how the blinding had been done. </p> </section> <section id="CD009000-sec-0097"> <h5 class="title">Blinding of outcome assessment (detection bias)</h5> <p>Seven studies reported that outcome assessors were unaware of the intervention that the child received (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>). We rated three of these studies, which did not explain how blinding was ensured, at unclear risk of detection bias (<a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>). We considered the remaining four studies to be at low risk of detection bias. </p> <p>We judged the eight remaining studies to be at unclear risk of detection bias (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>), as the outcome assessors were not blinded and the majority of the primary and secondary outcomes were dependent on physical anthropometric measurements by outcome assessors. </p> </section> </section> <section id="CD009000-sec-0098"> <h4 class="title">Incomplete outcome data</h4> <p>We rated four studies at low risk of attrition bias as they either did not have differential loss to follow‐up in the two groups or they did not have substantial overall attrition (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>). Although <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>, had differential losses (8.6% versus 2.8%), we judged the study at low risk of attrition bias as the proportions were based on small numbers. </p> <p>We considered four studies to have a high risk of attrition bias (<a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>). <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a> and <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a> had substantial overall attrition, while <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> and <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> had differential loss to follow‐up between two arms. Both <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> and <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> each had three arms: RUTF at a dose meeting total daily nutritional requirements, RUTF supplement in addition to the usual diet and flour porridge as control. In both studies, the RUTF supplement arm had more than double the percentage attrition compared to the other two arms. </p> <p>We rated six studies at unclear risk of attrition bias; three because the study authors did not report how missing data for the ITT analyses were handled (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>); two because only a subgroup of the randomised participants was eligible for inclusion in our review and it is unclear whether randomisation was preserved in this smaller group (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>); and one because it was not clear what were the sample size(s) for the different acceptability outcomes (<a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>). </p> <p>We provided a summary of missing data in <a href="#CD009000-tbl-0009">Table 6</a>. </p> </section> <section id="CD009000-sec-0099"> <h4 class="title">Selective reporting</h4> <p>For each included trial, we searched for the protocol in the trials registries mentioned under <a href="#CD009000-sec-0055">Search methods for identification of studies</a>, and contacted the primary study authors asking whether their studies had been registered. We judged five studies for which no protocol was available to be at unclear risk of reporting bias (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). We judged another trial, <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>, which reported a trial registration number, to be at unclear risk of reporting bias also, because we could not find the registration entry on the Internet and the author did not respond to our communication. We judged a further eight studies at unclear risk of reporting bias because we found discrepancies between the prespecified outcomes (as per the protocol) and those that were addressed, and whether this affected the validity of the outcome data is unclear (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>). </p> <p>We judged one trial, <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>, to be at low risk of reporting bias because all expected outcomes were prespecified and reported. </p> </section> <section id="CD009000-sec-0100"> <h4 class="title">Other potential sources of bias</h4> <p>We assessed the included studies for differences in baseline characteristics between comparison groups. We judged three studies to have a low risk of other bias as the baseline characteristics in the two groups appeared similar (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>). We judged an additional four studies to be at low risk of other bias (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>); although there were differences in important baseline characteristics, these were likely due to chance. </p> <p>We judged two individually randomised trials at unclear risk of other bias because they did not report on important baseline characteristics (<a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>). We rated five studies at unclear risk of other bias; three studies ‐ <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>, <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a> and <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a> ‐ used blocked randomisation that, in combination with a lack of blinding, could have posed a risk to selection bias (see section 8.15.1.3 in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> version 5.2 (<a href="./references#CD009000-bbs2-0099" title="HigginsJP , AltmanDG , SterneJA , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>), and two studies did not report the baseline characteristics for the subgroups eligible to our review (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>). </p> <p>We rated two studies at high risk of other bias (<a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>). <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a> reported baseline characteristics only for the children who remained in the study after two weeks (75.4%), and in <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>, there were substantial differences in the important baseline characteristics age and weight. It is likely that these influenced the results of all outcomes (except for acceptability). </p> <p>In cluster trials, it is important to consider the unit of allocation to avoid potential bias. We investigated this for the four cluster trials (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). While three of these studies did not adjust for clustering, one study adjusted for clustering in their multivariate analyses and provided the ICC used (<a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>). We also assessed recruitment bias, cluster baseline imbalances, loss of clusters, incorrect analysis and comparability with individually randomised trials for these four studies (<a href="#CD009000-tbl-0013">Table 10</a>). We judged two studies to have a low risk of recruitment bias because, although the children were recruited after the different clusters were allocated a specific intervention, an independent doctor discharged the children without knowing which discharge days or week matched which intervention (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). We judged two studies to have a high risk of recruitment bias because children were recruited after sites were assigned a specific intervention (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>). In terms of baseline imbalances, we judged three cluster trials to have an unclear risk of bias because no relevant information was provided to assess this particular aspect. We judged the fourth trial, <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>, to have a low risk of baseline imbalances because the author performed multivariate analyses to assess the effects of clusters and detected no interactions. All clusters in the four cluster trials were retained and, therefore, we judged all of them to be at low risk of bias for loss of clusters. For the incorrect analysis domain, we judged one study to be at low risk of bias because the study authors provided the ICC that we used to calculate the design effect (<a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>). However, for the other three studies, we had to estimate the ICC and are unsure how close our estimate is to the truth. In terms of comparability with individually randomised trials, we judged two studies to be at low risk of bias because for the four most important outcomes the findings of these studies are in line with that of the individually randomised trials (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>). We judged the other two studies to be at an unclear risk of bias for this aspect, as for some of the most important outcomes, the findings of the cluster trials were not in line with that of the individually randomised trials and it could possibly be because of aspects other than the study design (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). </p> </section> </section> <section id="CD009000-sec-0101"> <h3 class="title" id="CD009000-sec-0101">Effects of interventions</h3> <p>See: <a href="./full#CD009000-tbl-0001"><b>Summary of findings for the main comparison</b> Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach</a>; <a href="./full#CD009000-tbl-0002"><b>Summary of findings 2</b> Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet</a>; <a href="./full#CD009000-tbl-0003"><b>Summary of findings 3</b> Standard ready‐to‐use therapeutic food (RUTF) versus RUTF using an alternative formulation</a> </p> <p>In this section, we report on all eligible outcomes addressed by the included studies for each of the pre‐specified comparisons. We also provide a 'Summary of findings' table per comparison, each of which contains our three primary outcomes and an important secondary outcome, namely rate of weight gain (<a href="./full#CD009000-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD009000-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD009000-tbl-0003">summary of findings Table 3</a>). </p> <p>Data did not allow us to analyse results by different age groups, and only a few studies (<a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>), tested participants' HIV status, which limited the number of subgroup analyses we were able to do for this important comorbidity. No included study measured our secondary outcome 'cognitive function and development'. Nor did they specifically assess allergic reactions as an adverse outcome. Although three studies explicitly excluded children with known allergies (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>), only one study reported that a child was lost to follow‐up due to being diagnosed with an allergy (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>). </p> <section id="CD009000-sec-0102"> <h4 class="title">Comparison 1: standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach </h4> <p>Seven studies with a total of 2261 children (effective sample size = 1964) evaluated the effects of RUTF meeting total daily nutritional requirements versus alternative dietary approaches (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>). Four studies randomised participants individually, and three studies assigned their participants in clusters (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). The three cluster trials were also quasi‐randomised trials. </p> <section id="CD009000-sec-0103"> <h5 class="title">Primary outcomes</h5> <section id="CD009000-sec-0104"> <h6 class="title">Recovery during intervention</h6> <p>Six studies measured and reported on recovery (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>). These studies measured recovery in different ways: achieving WHZ of −2 or more and absence of oedema (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>); reaching a WHZ score more than −2 and disappearance of oedema (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>); WHZ more than −2 (<a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>); having a WHZ score more than 0 (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>); reaching 100% weight for height (<a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>); and reaching 115% of baseline weight (<a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>). Three studies were cluster trials (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>), and we adjusted the results for clustering as described above (<a href="#CD009000-sec-0063">Unit of analysis issues</a>). </p> <p>A random‐effects meta‐analysis of these six studies showed that RUTF significantly improved recovery compared to the alternative diet (RR 1.33, 95% CI 1.16 to 1.54; n = 1852; <a href="./references#CD009000-fig-0007" title="">Analysis 1.1</a>; <a href="#CD009000-fig-0005">Figure 5</a>); there was no significant heterogeneity between the studies (Chi<sup>2</sup> = 7.54, degrees of freedom (df) = 5; P = 0.18; I<sup>2</sup> = 34%). </p> <div class="figure" id="CD009000-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of Comparison 1. Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, outcome: 1.1 recovery during intervention" data-id="CD009000-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of Comparison 1. Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, outcome: 1.1 recovery during intervention </p> </div> </div> </div> <section id="CD009000-sec-0105"> <p><b>Subgroup and sensitivity analyses</b></p> <p>There was also no heterogeneity between the findings in subgroup analysis based on pre‐trial hospitalisation (Chi<sup>2</sup> = 2.42, df = 2; P = 0.30; I<sup>2</sup> = 17.3%; <a href="./references#CD009000-fig-0008" title="">Analysis 1.2</a>). </p> <p>The sensitivity analysis with <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>, the only study at low risk of bias, showed a difference in favour of the RUTF group (RR 1.22, 95% CI 1.04 to 1.42; n = 906; analysis not shown), which is in the same direction as the overall pooled effect estimate. A sensitivity analysis with individually randomised trials showed no difference between the RUTF and the alternative diet groups, although the CI was wide and is compatible with a potentially substantial benefit (RR 1.73, 95% CI 0.92 to 3.26; 3 studies, n = 1253; Chi<sup>2</sup> = 5.7, df = 2; P = 0.06; I<sup>2</sup> = 65%; analysis not shown). However, in the analysis of cluster trials only, the pooled difference in effect favoured RUTF (RR 1.3, 95% CI 1.14 to 1.48; 3 studies, n = 599; Chi<sup>2</sup> = 1.89, df = 2; P = 0.39; I<sup>2</sup> = 0%; analysis not shown). </p> </section> </section> <section id="CD009000-sec-0106"> <h6 class="title">Recovery at follow‐up</h6> <p>Two studies measured recovery at follow‐up (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>). <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a> measured recovery (WHZ ≥ −2) at 16 weeks after the intervention ended, and <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a> measured recovery (WHZ &gt; −2) six months after the intervention period. We found no significant difference between the RUTF and alternative diet groups (RR 1.10, 95% CI 0.83 to 1.46; 2 studies, n = 970; <a href="./references#CD009000-fig-0009" title="">Analysis 1.3</a>) and detected no heterogeneity between the studies (Chi<sup>2</sup> = 0.75, df = 1; P = 0.39; I<sup>2</sup> = 0%). </p> </section> <section id="CD009000-sec-0107"> <h6 class="title">Relapse during intervention</h6> <p>Three studies defined relapse as admission to inpatient therapeutic care or recurrence of oedema or systematic infections during the study period (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). Specifically, <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> reported results as "died or relapsed". We contacted the study authors who sent us the separate data for "relapsed" and "died". A fourth trial, <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>, reported hospitalisation during the treatment period, which we interpreted to be relapse. </p> <p>A meta‐analysis of these four studies showed no significant difference in relapse between the RUTF and alternative diet groups (RR 0.55, 95% CI 0.30 to 1.01; n = 1505; <a href="./references#CD009000-fig-0010" title="">Analysis 1.4</a>); however, there was significant heterogeneity between findings across studies (Chi<sup>2</sup> = 8.10, df = 3; P = 0.04; I<sup>2</sup> = 63%). </p> <p>One trial, <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>, did not set out to measure relapse, but large losses occurred during the intervention period. Because we applied the ITT principle, where we assumed that those who dropped out did not receive any treatment (RUTF or the control diet), and therefore experienced the event (relapsed), we have reported the losses of this study here for this outcome. In the RUTF group 98/174 (56.3%) dropped out of the trial, compared with 85/147 (57.8%) in the alternative diet group. </p> <section id="CD009000-sec-0108"> <p><b>Subgroup and sensitivity analyses</b></p> <p>A subgroup analysis showed that when all children were hospitalised before the trial, the RUTF group was favoured (RR 0.34, 95% CI 0.17 to 0.66; n = 247; <a href="./references#CD009000-fig-0011" title="">Analysis 1.5</a>) and there was no heterogeneity between studies (Chi<sup>2</sup> = 0.17, df = 1; P = 0.68; I<sup>2</sup> = 0%). In contrast, in the subgroup where some children were stabilised as inpatients prior to the trial, no significant difference was detected (RR 0.83, 95% CI 0.53 to 1.30; n = 1258; <a href="./references#CD009000-fig-0011" title="">Analysis 1.5</a>), and there was no significant heterogeneity (Chi<sup>2</sup> = 1.40, df = 1; P = 0.24; I<sup>2</sup> = 28%). However, between subgroups, despite a slight overlap of CI, we detected significant heterogeneity (Chi<sup>2</sup> = 4.73, df = 1; P = 0.03; I<sup>2</sup> = 78.9%). </p> <p>There were no significant differences across subgroups in analyses of factory versus local site‐produced RUTF (Chi<sup>2</sup> = 0.94, df = 1; P = 0.33; I<sup>2</sup> = 0%; <a href="./references#CD009000-fig-0012" title="">Analysis 1.6</a>) and HIV status (Chi<sup>2</sup> = 1.25, df = 1; P = 0.26; I<sup>2</sup> = 20.1%; <a href="./references#CD009000-fig-0013" title="">Analysis 1.7</a>). </p> <p>A sensitivity analysis with <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>, the only individually randomised trial that was also at low risk of bias, showed no difference between the RUTF and alternative diet groups (RR 0.94, 95% CI 0.68 to 1.31; analysis not shown), which is in line with the finding of the overall pooled effect estimate. However, a sensitivity analysis of cluster trials only detected a difference in favour of RUTF (RR 0.41, 95% CI 0.24 to 0.69; 3 studies, n = 599; Chi<sup>2</sup> = 0.99, df = 2; P = 0.61; I<sup>2</sup> = 0%; analysis not shown). </p> </section> </section> <section id="CD009000-sec-0109"> <h6 class="title">Relapse at follow‐up</h6> <p>One trial, <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>, reported relapse during their "sustenance phase" (16 weeks after the end of intervention). They detected no significant difference between the RUTFs and alternative diet groups (RR 0.73, 95% CI 0.32 to 1.68; n = 838; see the illustrative forest plot in <a href="./references#CD009000-fig-0014" title="">Analysis 1.8</a>). Another trial, <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>, measured relapse at 6 and 12 months after the intervention period, defined as WHZ less than −2 or oedema. However, they did not report results separately for SAM children. Two studies, <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> and <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>, also reported this outcome six months after the intervention period; however, there were no separate results per intervention group (see Comparison 2 for the findings across all three study groups). </p> </section> <section id="CD009000-sec-0110"> <h6 class="title">Mortality during intervention</h6> <p>Four studies measured mortality (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). We detected no difference in mortality between the RUTF and alternative diet groups, with a wide CI around the point estimate (RR 1.05, 95% CI 0.51 to 2.16; 4 studies; n = 1505; <a href="./references#CD009000-fig-0015" title="">Analysis 1.9</a>), and no significant heterogeneity between the studies (Chi<sup>2</sup> = 2.20; df = 3; P value = 0.53; I<sup>2</sup> = 0%). Another trial, <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>, set out to measure mortality; however, they did not report any results. We contacted the study author but did not receive a response. </p> <section id="CD009000-sec-0111"> <p><b>Subgroup and sensitivity analyses</b></p> <p>There was no overall difference between subgroups based on pre‐trial hospitalisation (Chi<sup>2</sup> = 0.35, df = 1; P 0.56; I<sup>2</sup> = 0%; <a href="./references#CD009000-fig-0016" title="">Analysis 1.10</a>). </p> <p>The sensitivity analysis with <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>, the only individually randomised study that was also at low risk of bias, showed no difference between the RUTF and alternative diet groups (RR 3.49, 95% CI 0.18 to 67.32; analysis not shown). Similarly, a sensitivity analysis with cluster trials only also detected no difference between the groups (RR 0.97, 95% CI 0.46 to 2.05; 3 studies, n = 599; Chi<sup>2</sup> = 1.5, df = 2; P = 0.47; I<sup>2</sup> = 0%; analysis not shown). </p> </section> </section> </section> <section id="CD009000-sec-0112"> <h5 class="title">Secondary outcomes</h5> <section id="CD009000-sec-0113"> <h6 class="title">Rate of weight gain during intervention</h6> <p>All seven studies included in this comparison measured weight gain, four of which we could pool in a meta‐analysis. </p> <p>Three studies, <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>, <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a> and <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>, reported weight gain measured during the first four weeks of the intervention period (we obtained data on weight gain from the contact author of <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>). One trial, <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>, measured the same outcome between baseline and recovery or 16 weeks after enrolment, whichever was earlier. We found a significant difference in favour of the RUTF group (MD 1.12 g/kg/day, 95% CI 0.27 to 1.96; 4 studies; n = 1450; <a href="./references#CD009000-fig-0017" title="">Analysis 1.11</a>), but detected significant heterogeneity between the studies (Chi<sup>2</sup> = 7.40; df = 3; P = 0.06; I<sup>2</sup> = 59%). </p> <p>One trial, <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>, reported weight gain over eight weeks of intervention of 3.45 g/kg/day in the RUTF group and 2.38 g/kg/day in the alternative diet group; however, the corresponding SD were not reported and therefore we could not include the results in the meta‐analysis above. </p> <p>Another trial, <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>, reported a mean weight gain of 21.5 g/kg/week (range = 3.5 to 63; n = 13) for the RUTF group and 7.89 g/kg/week (range = 0.2 to 23.8; n = 13) for the alternative diet groups. From the linear regression results reported by the study authors, the RUTF group resulted in an average additional weight gain of 13 g/kg/week/child (95% CI 2 to 23), which was statistically significant. </p> <p>The final trial, <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>, reported that the RUTF group had significantly higher weight gain (23 g/day) in comparison with the alternative diet group (14 g/day); however, these results should be viewed with caution as the baseline weight per group was highly unbalanced and the time point at which this result was taken is unclear. We could not add these results to the meta‐analysis above because they did not report the results in g/kg/day and the study author did not respond to our communication. </p> <section id="CD009000-sec-0114"> <p><b>Subgroup and sensitivity analyses</b></p> <p>We attempted to determine the potential source of heterogeneity in <a href="./references#CD009000-fig-0017" title="">Analysis 1.11</a>, by conducting a subgroup analysis of pre‐trial hospitalisation (<a href="./references#CD009000-fig-0018" title="">Analysis 1.12</a>). We found results in favour of the RUTF group for studies where all children were stabilised in hospital (MD 1.57 g/kg/day, 95% CI 0.32 to 2.82; 4 studies, n = 243), but there was significant heterogeneity between the studies in this subgroup (Chi<sup>2</sup> = 2.21; df = 1; P = 0.14; I<sup>2</sup> = 55%). We also found a statistically significant difference in favour of RUTF for the subgroup where only some children were stabilised in hospital pre‐trial (MD 0.65 g/kg/day, 95% CI 0.16 to 1.14; n = 1207), and detected no significant heterogeneity between these studies (Chi<sup>2</sup> = 0.00; df = 1; P = 0.97; I<sup>2</sup> = 0%). We found no significant heterogeneity between the subgroups (Chi<sup>2</sup> = 1.80; df = 1; P = 0.18; I<sup>2</sup> = 44.5%). </p> <p>Subgroup analyses of factory versus local site‐produced RUTF (Chi<sup>2</sup> = 0.07, df = 1; P = 0.79; I<sup>2</sup> = 0%; <a href="./references#CD009000-fig-0019" title="">Analysis 1.13</a>) and HIV status (Chi<sup>2</sup> = 0.19, df = 1; P = 0.67; I<sup>2</sup> = 0%; <a href="./references#CD009000-fig-0020" title="">Analysis 1.14</a>) also showed no differences across subgroups (4 studies, n = 1450). </p> <p>The sensitivity analysis with <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>, the only individually randomised trial that was also at low risk of bias, showed a difference favouring the RUTF group (MD 0.65 g/kg/day, 95% CI 0.15 to 1.15; analysis not shown), which is in line with the overall pooled effect estimate. Similarly, a sensitivity analysis with the cluster trials only detected a significant difference in favour of RUTF (MD 1.47 g/kg/day, 95% CI 0.49 to 2.45; 3 studies, n = 595; Chi<sup>2</sup> = 2.92, df = 2; P = 0.23; I<sup>2</sup> = 32%; analysis not shown). </p> </section> </section> <section id="CD009000-sec-0115"> <h6 class="title">Time to recovery (days) among children who recovered</h6> <p>Four studies measured and reported on time to recovery (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). </p> <p>One trial, <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>, reported mean duration to treatment in weeks, which we converted to days. Another trial, <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>, which included HIV‐uninfected children, also reported time to recovery but results were displayed only in a graph from which we could not obtain accurate information for further analysis. We contacted the study authors, who provided us with the necessary information to add these data to the meta‐analysis. We pooled the results from these two studies and detected a significant difference in favour of the RUTF group (MD −7.61 days, 95% CI −12.84 to −2.37; n = 556; <a href="./references#CD009000-fig-0021" title="">Analysis 1.15</a>), with no significant heterogeneity between the two studies (Chi<sup>2</sup> = 0.03; df = 3; P = 0.87; I<sup>2</sup> = 0%). </p> <p>One trial, <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>, performed a time‐to‐event analysis to compare the rates of reaching a WHZ more than −2 over eight weeks, but did not report the results separately for children with SAM. </p> <p>Another trial, <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>, measured time to recovery and reported results in median days. HIV‐infected children in the RUTF group (n = 20) recovered within a median of 71 days (interquartile range 42 to 125) compared to 85 days (interquartile range 46 to 239) in the alternative diet group (n = 45). The study authors did not report a P value or significance for the difference in time to recovery between these two groups. </p> </section> <section id="CD009000-sec-0116"> <h6 class="title">Anthropometrical status at the end of the intervention period and beyond</h6> <section id="CD009000-sec-0117"> <p><b>Weight‐for‐height z score (WHZ) during intervention</b></p> <p>Two studies reported on this outcome (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>). <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a> reported WHZ in end values and did not find a significant difference between the RUTF and alternative diet groups (MD 0.00, 95% CI −0.28 to 0.28; n = 352; <a href="./references#CD009000-fig-0022" title="">Analysis 1.16</a>). <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a> measured WHZ and used the data in linear regression but did not report change or end values per group. </p> </section> <section id="CD009000-sec-0118"> <p><b>Weight‐for‐height z score (WHZ) at follow‐up</b></p> <p>Two studies reported on this outcome (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>). <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a> reported this outcome as change at follow‐up 16 weeks after the end of the intervention period. In <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>, HIV‐uninfected children who recovered and were discharged from the study were followed up for six months; we obtained end value data from the contact author. We pooled the results of these two studies in a meta‐analysis and found no significant difference in WHZ between the RUTF and alternative diet groups (MD 0.06, 95% −0.04 to 0.16; n = 937; <a href="./references#CD009000-fig-0023" title="">Analysis 1.17</a>) with no significant heterogeneity between the studies (Chi<sup>2</sup> = 0.43; df = 1; P value = 0.51; I<sup>2</sup> = 0%). </p> </section> <section id="CD009000-sec-0119"> <p><b>Length/height gain during intervention</b></p> <p>Four studies measured this outcome (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>). </p> <p><a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a> and <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> measured length/height gain during the intervention period. We pooled the data from these studies in a meta‐analysis and detected no significant difference between the RUTF and alternative diet groups (MD 0.12 mm/day, 95% 0.00 to 0.24; n = 417; <a href="./references#CD009000-fig-0024" title="">Analysis 1.18</a>), with no significant heterogeneity between the studies (Chi<sup>2</sup> = 1.58; df = 1; P value = 0.21; I<sup>2</sup> = 37%). </p> <p><a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a> reported height in centimetres at the end of the eight‐week intervention period but provided no SD of change. Therefore, we were unable to include this result in the above meta‐analysis. </p> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> also reported height gain (mm/day), but provided results in a bar chart format and not as numerical data. </p> </section> <section id="CD009000-sec-0120"> <p><b>Height‐for‐age z score (HAZ) at follow‐up</b></p> <p>One trial, <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>, reported HAZ score at 16 weeks after the end of the intervention period. There was no significant difference between the RUTF and alternative diet groups (MD −0.02, 95% −0.09 to 0.05; n = 838; see the illustrative forest plot in <a href="./references#CD009000-fig-0025" title="">Analysis 1.19</a>). </p> </section> <section id="CD009000-sec-0121"> <p><b>Mid‐upper arm circumference (MUAC) gain during intervention</b></p> <p>Three studies measured MUAC gain during the first four weeks of the intervention period (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> reported data only in graph form and we obtained the actual values from the contact author. We pooled these three studies in a meta‐analysis and found that children in the RUTF group had higher MUAC gain compared to those in the alternative diet group (MD 0.13 mm/day, 95% CI 0.04 to 0.21; n = 570; <a href="./references#CD009000-fig-0026" title="">Analysis 1.20</a>), with no significant heterogeneity between studies (Chi<sup>2</sup> = 2.30; df = 2; P value = 0.32; I<sup>2</sup> = 13%). </p> <p>One trial, <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>, reported MUAC at the end of the eight weeks of intervention, but there were no SD of change so we could not include this study in the meta‐analysis. </p> </section> <section id="CD009000-sec-0122"> <p><b>Mid‐upper arm circumference (MUAC) gain at follow‐up</b></p> <p>One trial, <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>, reported the MUAC gain (in cm) during their sustenance phase (16 weeks after the end of the intervention): there was no significant difference between the RUTF and the alternative diet groups (MD −0.04 cm, 95% CI −1.04 to 0.96, n = 838; see the illustrative forest plot in <a href="./references#CD009000-fig-0027" title="">Analysis 1.21</a>). </p> </section> </section> <section id="CD009000-sec-0123"> <h6 class="title">Cognitive function and development</h6> <p>No study presented data for this outcome.</p> </section> <section id="CD009000-sec-0124"> <h6 class="title">Adverse outcomes</h6> <p>Six studies reported on adverse outcomes (<a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>; <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>; <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>). </p> <p>One trial, <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a> reported the number of children having diarrhoea during the treatment phase; there was no significant difference in the frequency of diarrhoea between the RUTF and the alternative diet groups (RR 1.00, 95% CI 0.83 to 1.20, n = 727; see the illustrative forest plot in <a href="./references#CD009000-fig-0028" title="">Analysis 1.22</a>). </p> <p>Another trial, <a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>, measured the numbers of days of diarrhoea per group during the first two weeks of the treatment period and found that children who received RUTF had a similar frequency of diarrhoea as those on the alternative diet (MD −0.60 days, 95% CI −1.30 to 0.10; n = 352; see the illustrative forest plot in <a href="./references#CD009000-fig-0029" title="">Analysis 1.23</a>). </p> <p>A third trial, <a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a>, set out to measure infectious episodes; however, no results were reported. We contacted the study author but did not receive a response. </p> <p>Two studies, <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> and <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>, measured the "prevalence of diarrhoea": days of diarrhoea divided by the "total days" during the first two weeks of the treatment period. In HIV‐infected children (<a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>), the RUTF group (n = 20) had diarrhoea on 19 out of the 304 evaluated days compared to 57 out of 687 evaluated days for children (n = 45) in the alternative diet group. In HIV‐uninfected children (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>), those in the RUTF group (n = 67) had diarrhoea on 74/1959 days (3.8%) compared to 74/3228 days (2.3%) in the alternative diet group (n = 114). This outcome refers to the number of days children had diarrhoea, and not the number of children who had diarrhoea. Therefore, we could not adjust the data for clustering and thus could not calculate the treatment effect from these two studies. </p> <p>One trial, <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>, reported that no "adverse effects" were documented in the experimental group, while three (of 56) children in the control group had acute diarrhoea, which resolved without the administration of antibiotics. </p> </section> <section id="CD009000-sec-0125"> <h6 class="title">Acceptability</h6> <p>One trial, <a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a>, measured acceptance of the intervention and found that RUTF was more acceptable than the alternative diet (RR 1.37, 95% CI 1.13 to 1.66; n = 112; see the illustrative forest plot in <a href="./references#CD009000-fig-0030" title="">Analysis 1.24</a>). </p> <p>Although not explicitly measured as acceptability, another trial, <a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a>, measured compliance in the experimental group by asking mothers to return empty RUTF packets on a weekly basis. The average weekly consumption of RUTF was reported as 23.4% of that expected, with the range between 1.7% and 48.4%. </p> </section> </section> </section> <section id="CD009000-sec-0126"> <h4 class="title">Comparison 2: standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet </h4> <p>Two quasi‐randomised, cluster trials that used systematic sequence‐generation methods had the following three arms: </p> <p> <ol id="CD009000-list-0037"> <li> <p>standard RUTF meeting total daily nutritional requirements;</p> </li> <li> <p>a similar RUTF given supplementary to children's usual diet; and</p> </li> <li> <p>porridge made by caregivers from a maize and soy flour blend as control (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). </p> </li> </ol> </p> <p>Below, we compare the standard RUTF (total daily requirements) with RUTF as a supplement (213 children in total; effective sample size = 210). <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> included only HIV‐uninfected children while <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> only assessed HIV‐infected children. </p> <section id="CD009000-sec-0127"> <h5 class="title">Primary outcomes</h5> <section id="CD009000-sec-0128"> <h6 class="title">Recovery during intervention</h6> <p>Both studies in this comparison measured recovery, defined as WHZ more than 0 (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>), and 100% weight for height (<a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). Children who received standard RUTF were more likely to recover than those who received it as a supplement (RR 1.41, 95% CI 1.19 to 1.68; n = 210; <a href="./references#CD009000-fig-0031" title="">Analysis 2.1</a>). There was no significant heterogeneity between the studies (Chi<sup>2</sup> = 0.37; df = 1; P value = 0.54; I<sup>2</sup> = 0%). </p> <section id="CD009000-sec-0129"> <p><b>Subgroup analysis</b></p> <p>Recovery was in favour of standard RUTF in both the HIV‐uninfected (RR 1.38, 95% CI 1.15 to 1.67; 1 trial, n = 162; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>) and HIV‐infected (RR 1.62, 95% CI 1.01 to 2.59; 1 trial, n = 48; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>) subgroups. </p> </section> </section> <section id="CD009000-sec-0130"> <h6 class="title">Relapse during intervention</h6> <p>Both <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> and <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> measured relapse (admission to hospital) during the intervention period. Pooled results indicated that standard RUTF significantly reduced relapse compared to the supplementary group (RR 0.11, 95% CI 0.01 to 0.85; n = 210; <a href="./references#CD009000-fig-0032" title="">Analysis 2.2</a>), with no significant heterogeneity between the studies (Chi<sup>2</sup> = 0.30; df = 1; P value = 0.58; I<sup>2</sup> = 0%). </p> <section id="CD009000-sec-0131"> <p><b>Subgroup analysis</b></p> <p>When we separated the results into subgroups based on HIV status, there was no significant difference in relapse detected between the two groups in both HIV‐uninfected (RR 0.07, 95% CI 0.00 to 1.10; 1 trial, n = 162; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>), and HIV‐infected (RR 0.20, 95% CI 0.01 to 3.62; 1 trial, n = 48; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>), children. </p> </section> </section> <section id="CD009000-sec-0132"> <h6 class="title">Mortality during intervention</h6> <p>When comparing the standard RUTF with the RUTF supplement group (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>), we detected no significant difference in mortality (RR 1.36, 95% CI 0.46 to 4.04; n = 210; <a href="./references#CD009000-fig-0033" title="">Analysis 2.3</a>), and there was no significant heterogeneity between the studies (Chi<sup>2</sup> = 0.36; df = 1; P value = 0.55; I<sup>2</sup> = 0%). </p> <section id="CD009000-sec-0133"> <p><b>Subgroup analysis</b></p> <p>We detected no significant difference in mortality when assessing results for the subgroups of HIV‐uninfected (RR 2.07, 95% CI 0.36 to 12.07; 1 trial, n = 162; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>) and HIV‐infected (RR 1.05, 95% CI 0.26 to 4.18; 1 trial, n = 48; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>) children. </p> </section> </section> </section> <section id="CD009000-sec-0134"> <h5 class="title">Secondary outcomes</h5> <section id="CD009000-sec-0135"> <h6 class="title">Rate of weight gain during intervention</h6> <p>Both studies in this comparison measured weight gain during the first four weeks of the intervention period (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). We pooled the results in a meta‐analysis and found no significant difference in weight gain between the standard RUTF and the RUTF supplement group (MD 1.21 g/kg/day, 95% CI −0.74 to 3.16; 2 studies, n = 206; <a href="./references#CD009000-fig-0034" title="">Analysis 2.4</a>), with substantial heterogeneity between the studies (Chi<sup>2</sup> = 4.26; df = 1; P value = 0.04; I<sup>2</sup> = 76%). </p> <section id="CD009000-sec-0136"> <p><b>Subgroup analysis</b></p> <p>Subgroup analysis with respect to HIV status found that HIV‐uninfected children in the standard RUTF group gained significantly more weight compared to the RUTF supplement group (MD 2.10 g/kg/day, 95% CI 1.12 to 3.08; 1 trial, n = 158; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>); however, for HIV‐infected children, there was no significant difference in weight gain between the two groups (MD 0.10 g/kg/day, 95% CI −1.53 to 1.73; 1 trial, n = 48; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). </p> </section> </section> <section id="CD009000-sec-0137"> <h6 class="title">Time to recovery (days) during intervention</h6> <p>Among HIV‐uninfected children who recovered, those who received standard RUTF recovered more rapidly than children in the RUTF supplement group (MD −10.0 days, 95% CI −19.13 to −0.87; 1 trial, n = 116; see the illustrative forest plot in <a href="./references#CD009000-fig-0035" title="">Analysis 2.5</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>). Among all HIV‐infected participants in <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>, those in the standard RUTF group recovered within a median of 71 days (interquartile range 42 to 125) compared to the RUTF supplement group, which required a median of 115 days (interquartile range 59 to 195; P value not reported in the article). </p> </section> <section id="CD009000-sec-0138"> <h6 class="title">Anthropometrical status</h6> <section id="CD009000-sec-0139"> <p><b>Weight‐for‐height z scores (WHZ) at follow‐up</b></p> <p>One trial, <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>, followed up HIV‐uninfected children who recovered and were discharged from the study for six months. We obtained the results (as end values) from the study author, which indicated that there was no significant difference in WHZ between children who received standard RUTF and those who received a similar RUTF as a supplement (MD 0.10, 95% CI −0.36 to 0.56; n = 72; <a href="./references#CD009000-fig-0036" title="">Analysis 2.6</a>). </p> </section> <section id="CD009000-sec-0140"> <p><b>Length/height gain during intervention</b></p> <p>HIV‐uninfected children receiving standard RUTF gained more height than the children who received the RUTF as a supplement (MD 0.20 mm/day, 95% CI 0.00 to 0.40; 1 trial, n = 48; see the illustrative forest plot in <a href="./references#CD009000-fig-0037" title="">Analysis 2.7</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). </p> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> also reported height gain (mm/day), but provided results in a bar chart format and not as numerical data. </p> </section> <section id="CD009000-sec-0141"> <p><b>Mid‐upper arm circumference (MUAC) gain during intervention</b></p> <p>We detected no significant difference in MUAC gain during the first four weeks of the intervention period between the two intervention groups (MD 0.11 mm/day, 95% CI −0.01 to 0.22; 2 studies, n = 173; <a href="./references#CD009000-fig-0038" title="">Analysis 2.8;</a><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>), and no significant heterogeneity between the studies (Chi<sup>2</sup> = 1.35; df = 1; P value = 0.25; I<sup>2</sup> = 26%). When we separated the results by HIV status, in HIV‐uninfected children, the standard RUTF group had significantly higher MUAC gain than those in the RUTF supplement group (MD 0.15 mm/day, 95% CI 0.03 to 0.27; 1 trial, n = 125; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>), while in HIV‐infected children, there was no significant difference between the intervention groups (MD 0.03 mm/day, 95% CI −0.14 to 0.20; 1 study n = 48; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). </p> </section> </section> <section id="CD009000-sec-0142"> <h6 class="title">Cognitive function and development</h6> <p>No study presented data for this outcome.</p> </section> <section id="CD009000-sec-0143"> <h6 class="title">Adverse outcomes</h6> <p>Both studies reported on adverse outcomes (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>). </p> <p>In HIV‐uninfected children (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>), the standard RUTF group (n = 68) had diarrhoea on 74/1959 days (3.8%) compared to 181/2565 days (7.1%) in the RUTF supplement group (n = 94). This outcome refers to the number of days children had diarrhoea, and not the number of children who had diarrhoea. Therefore, we could not adjust the data for clustering and thus could not calculate the treatment effect from these two studies. </p> <p>In HIV‐infected children, <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> measured the "prevalence of diarrhoea": days of diarrhoea divided by the "total days" during the first two weeks of the intervention period. Study authors reported that children in the standard RUTF group had diarrhoea on 19 of the 304 evaluation days while those in the RUTF supplement group had diarrhoea on 38 of the 432 days. We were unsure about the meaning of "total days" as the figures did not correspond to the total number of days of each participant for each group. Since the corresponding numbers of participants were not reported, we could not calculate a treatment effect. </p> </section> <section id="CD009000-sec-0144"> <h6 class="title">Acceptability of RUTF</h6> <p>No study provided data on this outcome.</p> </section> </section> </section> <section id="CD009000-sec-0145"> <h4 class="title">Comparison 3: standard RUTF versus RUTF using an alternative formulation</h4> <p>Seven studies with a total of 5502 children (effective sample size = 4456) evaluated the effects of RUTF versus other types of RUTF (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>). A further study that randomised 148 children also addressed this comparison but only measured acceptability (<a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>). All but one study randomised participants individually; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a> was a cluster‐randomised trial. </p> <section id="CD009000-sec-0146"> <h5 class="title">Primary outcomes</h5> <section id="CD009000-sec-0147"> <h6 class="title">Recovery during intervention</h6> <p>Six studies measured recovery in different ways: <a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a> as weight gain of 15% or more of baseline weight; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a> as weight gain of 18% or more of baseline weight together with the absence of complications and MUAC more than 110 mm; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a> as MUAC more than 12.4 cm without oedema; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a> as WHZ of 80% or more for two consecutive visits; and <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a> as having a WHZ more than −2 and no oedema. <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a> also measured recovery but did not report the results in the manuscript. We obtained the data and definition from the study authors: MUAC more than 11.5 cm or WHZ more than −3 or no oedema (depending on admission criteria) on two consecutive visits. We pooled the data from these six studies in a meta‐analysis and found no significant difference in recovery between the two groups who received different formulations of RUTF (RR 1.03, 95% CI 0.99 to 1.08; n = 4188; <a href="./references#CD009000-fig-0039" title="">Analysis 3.1</a>; <a href="#CD009000-fig-0006">Figure 6</a>). We detected no significant heterogeneity between these studies (Chi<sup>2</sup> = 6.32; df = 5; P value = 0.28; I<sup>2</sup> = 21%). </p> <div class="figure" id="CD009000-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of Comparison 3. Standard RUTF versus RUTF using an alternative formulation, outcome: 3.1 recovery during intervention" data-id="CD009000-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of Comparison 3. Standard RUTF versus RUTF using an alternative formulation, outcome: 3.1 recovery during intervention </p> </div> </div> </div> <section id="CD009000-sec-0148"> <p><b>Subgroup and sensitivity analysis</b></p> <p>When exploring subgroups based on pre‐trial hospitalisation, we found no significant difference in recovery during the intervention between the different types of RUTF, in each of the subgroups. Overall, there was no difference between the subgroups (Chi<sup>2</sup> = 1.94, df = 2; P 0.38; I<sup>2</sup> = 0%; <a href="./references#CD009000-fig-0040" title="">Analysis 3.2</a>). </p> <p>A sensitivity analysis of studies at low risk of bias (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>), only showed no difference between the different types of RUTF formulations (RR 1.02, 95% CI 0.99 to 1.06; n = 3166; Chi<sup>2</sup> = 3.03, df = 3; P = 0.39; I<sup>2</sup> = 1%; 4 studies; analysis not shown), which is in line with the overall pooled effect estimate. A sensitivity analysis with individually randomised studies (all studies for this outcome except for <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>), also showed no difference between the groups (RR 1.02, 95% CI 0.99 to 1.06; 5 studies, n = 3307; Chi<sup>2</sup> = 3.10, df = 4; P = 0.54; I<sup>2</sup> = 0%; analysis not shown) while a sensitivity analysis of the cluster‐randomised trial (<a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>), showed a difference in favour of the standard RUTF (RR 1.14, 95% CI 1.02 to 1.28; 1 trial, n = 881; analysis not shown). </p> </section> </section> <section id="CD009000-sec-0149"> <h6 class="title">Relapse during intervention</h6> <p>Six studies defined relapse in different ways: <a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a> and <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a> defined relapse as being absent for three consecutive visits and could not be traced; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a> and <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a> as loss to follow‐up after 12 weeks; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a> as defaulters, readmissions to inpatient care and lost to follow‐up; and <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a> as remaining wasted after two consecutive visits. We pooled these six studies in a meta‐analysis and found that the standard RUTF significantly reduced relapse (RR 0.84, 95% CI 0.72 to 0.98; n = 4188; <a href="./references#CD009000-fig-0041" title="">Analysis 3.3</a>), with no significant heterogeneity between these studies (Chi<sup>2</sup> = 3.79; df = 5; P value = 0.58; I<sup>2</sup> = 0%). </p> <section id="CD009000-sec-0150"> <p><b>Subgroup and sensitivity analysis</b></p> <p>When exploring subgroups based on pre‐trial hospitalisation, we found no significant difference in relapse during the intervention between the different types of RUTF, in each of the subgroups. Overall, there was no difference between the subgroups (Chi<sup>2</sup> = 0.62, df = 2; P 0.73; I<sup>2</sup> = 0%; <a href="./references#CD009000-fig-0042" title="">Analysis 3.4</a>). </p> <p>A sensitivity analysis of studies at low risk of bias (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>), only showed no difference between the different types of RUTF formulations (RR 0.86, 95% CI 0.69 to 1.07; n = 3166; Chi<sup>2</sup> = 1.99, df = 3; P = 0.57; I<sup>2</sup> = 0%, 4 studies; analysis not shown), which is not in line with the overall pooled effect estimate. A sensitivity analysis with individually randomised studies (all studies for this outcome except <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>), also showed no difference between the groups (RR 0.88, 95% CI 0.71 to 1.09; 5 studies, n = 3307; Chi<sup>2</sup> = 3.52, df = 4; P = 0.48; I<sup>2</sup> = 0%; analysis not shown), while the cluster‐randomised trial, <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>, had a similar result to the overall pooled effect estimate (RR 0.81, 95% CI 0.66 to 1.0; 1 trial, n = 881; analysis not shown). </p> </section> </section> <section id="CD009000-sec-0151"> <h6 class="title">Mortality during intervention</h6> <p>We did not find a significant difference in the number of deaths between the standard and the other RUTFs (RR 1.00, 95% CI 0.80 to 1.24; 7 studies, n = 4309; <a href="./references#CD009000-fig-0043" title="">Analysis 3.5</a>; <a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>), and detected no significant heterogeneity between studies (Chi<sup>2</sup> = 6.60; df = 6; P value = 0.36; I<sup>2</sup> = 9%). </p> <section id="CD009000-sec-0152"> <p><b>Subgroup and sensitivity analysis</b></p> <p>When exploring subgroups based on pre‐trial hospitalisation, we found no significant difference in mortality during the intervention between the different types of RUTF in each of the subgroups. Overall, there was no difference between the subgroups (Chi<sup>2</sup> = 1.16, df = 2; P 0.56; I<sup>2</sup> = 0%; <a href="./references#CD009000-fig-0044" title="">Analysis 3.6</a>). </p> <p>A sensitivity analysis of studies at low risk of bias (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>), only showed no difference between the different types of RUTF formulations (RR 1.03, 95% CI 0.82 to 1.28; n = 3166; Chi<sup>2</sup> = 2.95, df = 3; P = 0.4; I<sup>2</sup> = 0%; 4 studies; analysis not shown), which is in line with the overall pooled effect estimate. A sensitivity analysis with individually randomised studies (all studies for this outcome except <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>), also showed no difference between the groups (RR 1.02, 95% CI 0.73 to 1.43; 6 studies, n = 3428; Chi<sup>2</sup> = 6.06, df = 5; P = 0.3; I<sup>2</sup> = 18%; analysis not shown) and we obtained a similar result for <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>, the cluster‐randomised trial (RR 0.91, 95% CI 0.64 to 1.28; 1 trial, n = 881; analysis not shown). </p> </section> </section> </section> <section id="CD009000-sec-0153"> <h5 class="title">Secondary outcomes</h5> <section id="CD009000-sec-0154"> <h6 class="title">Rate of weight gain during intervention</h6> <p>Six studies measured weight gain (g/kg/day) (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>). <a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a> did not report SD, but we obtained them from the study authors. There was no significant difference between the different RUTF groups (MD 0.11 g/kg/day, 95% CI −0.32 to 0.54; n = 3807; <a href="./references#CD009000-fig-0045" title="">Analysis 3.7</a>), with significant heterogeneity between the studies (Chi<sup>2</sup> = 19.17; df = 5; P value = 0.002; I<sup>2</sup> = 74%). </p> <section id="CD009000-sec-0155"> <p><b>Subgroup and sensitivity analysis</b></p> <p>We found no significant difference in rate of weight gain during the intervention between the different types of RUTF, in each of the subgroups, and no significant difference across pre‐trial hospitalisation subgroups (Chi<sup>2</sup> = 1.48; df = 2; P value = 0.48; I<sup>2</sup> = 0%; <a href="./references#CD009000-fig-0046" title="">Analysis 3.8</a>), where all children were stabilised as inpatients pre‐trial, where some children were hospitalised before the trial, and no children were hospitalised pre‐trial. </p> <p>When performing subgroup analyses for different types of RUTFs, we found significant differences across subgroups (Chi<sup>2</sup> = 5.63; df = 2; P value = 0.06; I<sup>2</sup> = 64.5%), but did not find a difference in favour of standard or other formulations of RUTF combined (<a href="./references#CD009000-fig-0047" title="">Analysis 3.9</a>). </p> <p> <ol id="CD009000-list-0038"> <li> <p>Less or no milk powder subgroup: MD 0.34 (95% CI −0.10 to 0.78; 4 studies, n = 3015), with significant heterogeneity (Chi<sup>2</sup> = 9.91; df = 3; P value = 0.002; I<sup>2</sup> = 70%) </p> </li> <li> <p>Fatty acids subgroup: MD −0.80 (95% CI −1.74 to 0.14; 1 trial, n = 141; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>) </p> </li> <li> <p>Pre‐ and probiotic subgroup: MD −0.25 (95% CI −0.87 to 0.37; 1 trial, n = 651; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>). </p> </li> </ol> </p> <p>Data did not allow us to perform a subgroup analysis by HIV status because the only study (<a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>), in this comparison, that performed HIV tests on almost all participant children, did not report the results separately for HIV‐infected and uninfected children in the subgroup of the study eligible to our review (participants aged 6 to 60 months, see table of <a href="./references#CD009000-sec-0240" title="">Characteristics of included studies</a> for more information on <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>), for this outcome. </p> <p>A sensitivity analysis with studies at low risk of bias only (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>), showed no difference between the different types of RUTF formulations (MD 0.09, 95% CI −0.48 to 0.65; n = 3100; Chi<sup>2</sup> = 7.32, df = 2; P = 0.03; I<sup>2</sup> = 73%; 3 studies; analysis not shown), which is in line with the overall pooled effect estimate. A sensitivity analysis with individually randomised trials (all studies for this outcome except <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>), also showed no difference between the groups (MD −0.05, 95% CI −0.5 to 0.4; 5 studies, n = 3316; Chi<sup>2</sup> = 13.91, df = 4; P = 0.008; I<sup>2</sup> = 71%; analysis not shown), while the cluster‐randomised trial (<a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>), found a difference in favour of the standard RUTF (MD 1.00, 95% CI 0.37 to 1.63; 1 trial, n = 491; analysis not shown). </p> <p><b>Time to recovery (days) during intervention</b> </p> <p>Three studies, <a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>, <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a> and <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>, measured this outcome in all children, with <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a> also reporting results for the subgroup of children who recovered. </p> <p><a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a> measured time to recovery in days, in all children, during the 16 weeks of intervention. Using the information provided in the trial, we calculated the effect size and found no significant difference between the two RUTF groups (MD 1.90 days, 95% CI −0.82 to 4.62; n = 595; <a href="./references#CD009000-fig-0048" title="">Analysis 3.10</a>). </p> <p><a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a> reported a length of stay of 35 days (interquartile range 23 to 49) in the standard RUTF group compared to 35 days (interquartile range 21 to 56) in the other RUTF group, with no significant difference between the groups (P = 0.49). Among the children who recovered, the median length of stay in the standard RUTF group was 35 days (interquartile range 28 to 52) and 47 days (interquartile range 29 to 70) in the RUTF with specific fatty acids group (P value &lt; 0.001; exact P value not reported). </p> <p><a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a> reported median days to cure in the eligible subgroup (n = 651) and found no difference (P = 0.66) between the standard RUTF group (median = 38 days; interquartile range 34 to 47) and the RUTF with fatty acids group (median = 37 days; interquartile range 34 to 48). </p> </section> </section> <section id="CD009000-sec-0156"> <h6 class="title">Anthropometrical status</h6> <section id="CD009000-sec-0157"> <p><b>Weight‐for‐height z score (WHZ) during intervention</b></p> <p>Two studies measured WHZ scores after eight weeks of intervention (<a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>), while one trial, <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>, measured the same outcome after 12 weeks of intervention. After pooling the results in a meta‐analysis, we found no significant difference between the groups (MD −0.13, 95% CI ‐0.36 to 0.09; 3 studies, n = 2090; <a href="./references#CD009000-fig-0049" title="">Analysis 3.11</a>), but there was significant heterogeneity between the studies (Chi<sup>2</sup> = 5.48; df = 2; P value = 0.06; I<sup>2</sup> = 63%). </p> <p>Another trial, <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>, also measured this outcome and we obtained the change in WHZ score after 12 weeks of intervention from the study authors. The median change in the standard RUTF group (n = 17) was 1.68 (interquartile range 1.17 to 2.73) compared to 1.80 (interquartile range 1.24 to 2.78) in the control RUTF containing specific fatty acids (n = 12). </p> </section> <section id="CD009000-sec-0158"> <p><b>Subgroup analysis</b></p> <p>In a subgroup analysis, we found no difference between the group in which some children were hospitalised before the study for stabilisation versus the group in which no children were hospitalised before the study for stabilisation (Chi<sup>2</sup> = 0.05; df = 1; P value = 0.83; I<sup>2</sup> = 0%; 3 studies, n = 2090; <a href="./references#CD009000-fig-0050" title="">Analysis 3.12</a>). However, in another subgroup analysis, we detected a significant difference (Chi<sup>2</sup> = 4.67; df = 1; P value = 0.03; I<sup>2</sup> = 78.6%; <a href="./references#CD009000-fig-0051" title="">Analysis 3.13</a>), between studies where the control RUTF had less or no milk powder (MD −0.02, 95% CI −0.11 to 0.08; 2 studies, n = 1949; Chi<sup>2</sup> = 0.81; df = 1; P value = 0.37; I<sup>2</sup> = 0%; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>), versus studies where the control RUTF was a standard formulation with specific fatty acids (MD −0.45, 95% CI −0.83 to −0.07; 1 trial, n = 141; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>). </p> </section> <section id="CD009000-sec-0159"> <p><b>Weight‐for‐age z score (WAZ) during intervention</b></p> <p>Two studies, <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a> and <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>, measured WAZ and reported it as end values at the end of eight weeks of intervention. We combined the data from both studies in a meta‐analysis and found no significant difference between the standard and other RUTF groups (MD 0.07, 95% CI −0.06 to 0.20; n = 1949), with no significant heterogeneity between the studies (Chi<sup>2</sup> = 1.13; df = 1; P value = 0.29; I<sup>2</sup> = 12%; <a href="./references#CD009000-fig-0052" title="">Analysis 3.14</a>). </p> </section> <section id="CD009000-sec-0160"> <p><b>Length/height gain (mm/day) during intervention</b></p> <p>Two studies measured length/height gain across eight weeks of intervention (<a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a> ), while one study measured the same outcome over 12 weeks of intervention (<a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>). After pooling the results in a meta‐analysis, we found no significant difference between the groups (MD 0.01, 95% CI −0.09 to 0.10; 3 studies, n = 2090; <a href="./references#CD009000-fig-0053" title="">Analysis 3.15</a>), but there was significant heterogeneity (Chi<sup>2</sup> = 4.85; df = 2; P value = 0.09; I<sup>2</sup> = 59%). </p> </section> <section id="CD009000-sec-0161"> <p><b>Subgroup analysis</b></p> <p>We found no significant difference between subgroups in which either some or no children were hospitalised before the study for stabilisation (Chi<sup>2</sup> = 0.54; df = 1; P value = 0.46; I<sup>2</sup> = 0%; 3 studies, n = 2090; <a href="./references#CD009000-fig-0054" title="">Analysis 3.16</a>). However, we detected a significant difference (Chi<sup>2</sup> = 4.69; df = 1; P value = 0.03; I<sup>2</sup> = 78.7%; <a href="./references#CD009000-fig-0055" title="">Analysis 3.17</a>) between studies where the control RUTF had less or no milk powder (MD 0.04, 95% CI 0.02 to 0.06; 2 studies, n = 1949; Chi<sup>2</sup> = 0.16; df = 1; P value = 0.69; I<sup>2</sup> = 0%; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>) versus studies where the control RUTF was a standard formulation with specific fatty acids (MD −0.09, 95% CI −0.21 to 0.03; 1 trial, n = 141; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>). </p> </section> <section id="CD009000-sec-0162"> <p><b>Height‐for‐age z score (HAZ) during intervention</b></p> <p>When comparing the end values after eight weeks of intervention between standard RUTF and RUTFs with less (<a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>), or no (<a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>), milk powder, we detected no significant difference in HAZ (MD 0.09, 95% CI −0.04 to 0.22; n = 1949; <a href="./references#CD009000-fig-0056" title="">Analysis 3.18</a>), with no significant heterogeneity (Chi<sup>2</sup> = 0.14; df = 1; P value = 0.71; I<sup>2</sup> = 0%). </p> <p>Another trial, <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>, also measured this outcome and we obtained the change in length/height for age after 12 weeks of intervention from the study authors. The median change in the standard RUTF group (n = 18) was 0.18 cm (interquartile range −0.38 to 0.47) compared to 0.34 cm (interquartile range 0.04 to 0.49) in the control RUTF containing specific fatty acids (n = 12). </p> </section> <section id="CD009000-sec-0163"> <p><b>Mid‐upper arm circumference (MUAC) gain during intervention</b></p> <p>Two studies measured MUAC gain in mm/day after eight weeks of intervention (<a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>), while one study measured the same outcome after four weeks of intervention (<a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>). After pooling the results in a meta‐analysis, we found no significant difference between the groups (MD 0.02, 95% CI −0.02 to 0.07; 3 studies, n = 2089; <a href="./references#CD009000-fig-0057" title="">Analysis 3.19</a>), and there was significant heterogeneity (Chi<sup>2</sup> = 4.67; df = 2; P value = 0.10; I<sup>2</sup> = 57%). </p> <p>For one trial, <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>, we obtained data for the change in mm/day after 12 weeks of intervention from the study authors. The median change in the standard RUTF group (n = 18) was 0.022 mm/day (interquartile range 0.02 to 0.04) compared to 0.029 mm/day (0.02 to 0.02) in the control RUTF with specific fatty acids (n = 12). </p> </section> <section id="CD009000-sec-0164"> <p><b>Subgroup analysis</b></p> <p>In a subgroup analysis, we found no significant difference between subgroups in which either some or no children were hospitalised before the study for stabilisation (Chi<sup>2</sup> = 0.53; df = 1; P value = 0.47; I<sup>2</sup> = 0%; 3 studies, n = 2089; <a href="./references#CD009000-fig-0058" title="">Analysis 3.20</a>). However, we detected a significant difference (Chi<sup>2</sup> = 4.67; df = 1; P value = 0.03; I<sup>2</sup> = 78.6%; <a href="./references#CD009000-fig-0059" title="">Analysis 3.21</a>) between studies where the control RUTF had less or no milk powder (MD 0.04, 95% CI 0.02 to 0.06; 2 studies, n = 1948; Chi<sup>2</sup> = 0.00; df = 1; P value = 1.00; I<sup>2</sup> = 0%; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>) versus studies where the control RUTF was a standard formulation but containing specific fatty acids (MD −0.07, 95% CI −0.17 to 0.03; 1 trial, n = 141; <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>). </p> </section> </section> <section id="CD009000-sec-0165"> <h6 class="title">Cognitive function and development</h6> <p>No study provided data for this outcome.</p> </section> <section id="CD009000-sec-0166"> <h6 class="title">Adverse outcomes</h6> <p>Four studies reported adverse outcomes (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a>). </p> <p><a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a> reported no significant difference in the proportion of children with a history of diarrhoea during the first weekly follow‐up visit (RR 0.80, 95% CI 0.55 to 1.15, n = 549; <a href="./references#CD009000-fig-0060" title="">Analysis 3.22</a>). The overall incidence rate of diarrhoea at the end of the intervention period was similar between groups (P = 0.478): standard RUTF = 11.8 episodes per 100 child visits (range = 142 to 1198); and other RUTF group = 11.5 episodes per 100 child visits (range 146 to 1270). </p> <p><a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a> reported finding no "adverse reactions" to any of the study foods, while <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a> reported that no "adverse events" were considered to be directly related to the RUTFs and found no significant difference in total illness episodes (P = 0.27) or diarrhoea (P = 0.75) between the experimental and control groups. </p> <p><a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a> asked caregivers at every fortnightly visit whether the child had had diarrhoea in the previous two weeks, but did not report the results. </p> <p><b>Acceptability</b> </p> <p>Five studies reported on acceptability (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a>; <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a>). </p> <p><a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a> only measured acceptability as an outcome; it is reported in the same article as <a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a>. They found no significant difference in the proportion of children giving the highest RUTF likeability score between the standard RUTF and the RUTF with omega‐3 fatty acids groups (RR 1.08, 95% CI 0.94 to 1.26, n = 148; <a href="./references#CD009000-fig-0061" title="">Analysis 3.23</a>). However, significantly less food remained after the taste test among the standard RUTF compared to the omega‐3 RUTF groups (MD −2.40 g, 95% CI −4.50 to −0.30; n = 148; <a href="./references#CD009000-fig-0062" title="">Analysis 3.24</a>; <a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a>). </p> <p><a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a> used a five‐point hedonic rating scale to rate how many participants (according to the caregivers) liked or disliked their allocated RUTF. A score of 1 indicated that the child liked the product very much ('very good'); 2 indicated 'good'; 3 indicated 'neutral'; 4 indicated 'bad'; and 5 indicated 'very bad'. Acceptability was seen as having a score of 1, 2 or 3. The median score on this scale was 2.0 (interquartile range 2.00 to 3.00) for the standard RUTF and 2.0 (interquartile range 2.0 to 4.0) for the fish‐based RUTF. At the first two‐weekly visit, the study authors found standard RUTF to be more acceptable than the fish‐based RUTF (RR 1.29, 95% CI 1.04 to 1.60; n = 78; <a href="./references#CD009000-fig-0063" title="">Analysis 3.25</a>). However, for the following three, two‐weekly visits during the eight‐week treatment period, they detected no difference in likeability between the standard and fish‐based RUTF groups. </p> <p><a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a> (n = 20), measured acceptability as compliance by interview of caregivers and counting full and empty sachets of RUTF at each visit. They reported that the median compliance at the end of the intervention period (day 84) was 90% (interquartile range 80 to 101) in the standard RUTF group compared to 96% (interquartile range 67 to 100) in the group where the RUTF had specific fatty acids (P = 0.98). <a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a> also measured compliance based on "counts of returned RUTF packages" and estimated that 51.7% of participants in the standard RUTF group, compared to 48.1% participants in the fish‐based RUTF group, utilised their RUTF. We could not calculate an effect size here because the sample size per group for this outcome was not reported, and the primary study authors adjusted this finding for age and gender. </p> <p>In <a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a> and <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>, caregivers were asked at each visit about the acceptability of the standard RUTF compared to formulations with less or no milk powder; however, the results were not reported. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009000-sec-0167" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009000-sec-0167"></div> <section id="CD009000-sec-0168"> <h3 class="title" id="CD009000-sec-0168">Summary of main results</h3> <p>Our review aimed to assess the effects of home‐based nutritional rehabilitation with RUTF on recovery, relapse, mortality and rate of weight gain in children aged six months to five years with SAM. We found 15 eligible studies, 14 of which contributed to meta‐analyses, and four of which were cluster trials. We addressed three comparisons with a total effective sample size of 6630 children. We judged the overall risk of bias to be high for six studies, unclear for three studies, and low for six studies. </p> <p>Based on the pooled data from seven studies comparing a standard RUTF at a dosage to meet total daily nutritional requirements with an alternative dietary approach, we conclude that RUTF probably improves recovery from SAM and may increase the rate of weight gain slightly. However, the effects on relapse and mortality are uncertain. </p> <p>Evidence from two cluster trials indicate that a standard RUTF meeting total daily nutritional requirements, compared with a similar RUTF used as a supplement only, may improve recovery and reduce relapse but its effects on mortality and rate of weight gain are currently unclear. </p> <p>We found eight studies that compared standard RUTF with RUTFs with alternative formulations (such as using locally available ingredients, containing less or no milk powder, containing specific fatty acids, or with added pre‐ and probiotics), of which only one focused on RUTF acceptability. For recovery from SAM, it appears to make little or no difference what formulation of RUTF is used. In the case of relapse, however, a standard RUTF seems somewhat more effective. For the outcomes of mortality and rate of weight gain, it probably makes little or no difference whether a standard or alternative formulation of RUTF is used. </p> </section> <section id="CD009000-sec-0169"> <h3 class="title" id="CD009000-sec-0169">Overall completeness and applicability of evidence</h3> <p>The studies included in this review have a number of limitations in respect of external validity. We sought to evaluate the best evidence regarding the effects of RUTF as home‐based treatment for children with SAM. A challenge in this was the completeness of reporting, which we feel ranged from poor to moderate reporting. We were able to obtain some supplementary data from the study authors but a number of important information gaps remain. Particularly, it was not always clear whether study participants had been stabilised in hospital prior to home‐based rehabilitation with RUTF (complicated SAM), and whether this was similar across intervention arms. We conducted a subgroup analysis to explore the influence of this factor on the main outcomes across our three comparisons, but this only explained the heterogeneity for the outcome of relapse in Comparison 1. It is plausible that children who first presented with complicated SAM, even though stabilised in hospital, may be more likely to relapse during the rehabilitation phase. However, the current evidence base does not allow for firm conclusions regarding this issue. </p> <p>Among the included studies, there is a lack of consistent (routine) testing for HIV and tuberculosis, and reporting on other comorbidities, with appropriate stratification and analysis according to infection status. These comorbidities may have considerable impact on growth, immunity and risk of death, and affected children with these comorbidities may respond differently to SAM treatment (<a href="./references#CD009000-bbs2-0095" title="HeikensGT , BunnJ , AmadiB , ManaryM , ChhaganM , BerkleyJA , et al. Case management of HIV‐infected severely malnourished children: challenges in the area of highest prevalence. Lancet2008;371(9620):1305‐7. [DOI: 10.1016/S0140‐6736(08)60565‐6; PUBMED: 18406865] ">Heikens 2008</a>; <a href="./references#CD009000-bbs2-0107" title="JonesKD , BerkleyJA . Severe acute malnutrition and infection. Paediatrics and International Child Health2014;34(Suppl 1):1‐29. [DOI: 10.1179/2046904714Z.000000000218; PMC4266374; PUBMED: 25475887] ">Jones 2014</a>; <a href="./references#CD009000-bbs2-0120" title="ModyA , BartzS , HornikCP , KiyimbaT , BainJ , MuehlbauerM , et al. Effects of HIV infection on the metabolic and hormonal status of children with severe acute malnutrition. PLoS One2014;9(7):e102233. [DOI: 10.1371/journal.pone.0102233; PMC4106836; PUBMED: 25050734] ">Mody 2014</a>; <a href="./references#CD009000-bbs2-0136" title="TrehanI , ManaryMJ . Management of severe acute malnutrition in low‐income and middle‐income countries. Archives of Disease in Childhood2015;100(3):283‐7. [DOI: 10.1136/archdischild‐2014‐306026; PUBMED: 25421910] ">Trehan 2015</a>). </p> <p>The included studies assessed a wide age range of children with SAM, but data did not allow for exploration of possible differences in effects across age groups. There is also a lack of information regarding the likelihood of sharing RUTF and control diets with the family, and whether the extent of such sharing differed between comparison groups. In addition, the issue of allergies was not sufficiently addressed. In most studies, children were exposed to peanuts or soy, which are known allergens in children, but few studies reported testing for food allergies. </p> <p>One of the theoretical benefits of RUTF is its low water availability (and therefore lower risk of contamination with microorganisms), which should lead to fewer episodes of diarrhoea. However, not all studies reported on diarrhoea, despite it being one of the biggest causes of mortality in young children. Furthermore, where studies did report on diarrhoea they measured it in different ways, so that we mostly could not pool data across studies. </p> <p>With the introduction of the WHO Child Growth Standards in 2006 (<a href="./references#CD009000-bbs2-0144" title="World Health Organization. The WHO child growth standards. www.who.int/childgrowth/en/ (accessed 30 November 2017). ">WHO 2006</a>), and the change in cut‐off for MUAC from 110 mm to 115 mm (<a href="#CD009000-tbl-0004">Table 1</a>), some children who would have been classified previously as having MAM were classified as SAM (<a href="./references#CD009000-bbs2-0079" title="CollinsS , DentN , BinnsP , BahwereP , SadlerK , HallamA . Management of severe acute malnutrition in children. Lancet2006;368(9551):1992‐2000. [DOI: 10.1016/S0140‐6736(06)69443‐9; PUBMED: 17141707] ">Collins 2006a</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>; <a href="./references#CD009000-bbs2-0128" title="SealA , KeracM . Operational implications of using 2006 World Health Organization growth standards in nutrition programmes: secondary data analysis. BMJ2007;334:733‐8. [DOI: 10.1136/bmj.39101.664109.AE] ">Seal 2007</a>; <a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009</a>). Therefore, studies that were carried out before 2006 (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>), or that used older definitions for SAM (<a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a>; <a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a>; <a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a>), or that deviated from the standard WHO definition for SAM (<a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a> used WHZ of −2.8 or less instead of less than −3), included a somewhat different profile of participants than studies using the latest (formal) criteria. Furthermore, and also in the earlier studies, antiretroviral drugs for HIV were not readily available in LMICs, and the lack thereof could have influenced HIV‐infected children's response to treatment for SAM. </p> <p>We needed to take into account the type of control group against which standard RUTF was compared. Specifically, for Comparison 3 where different RUTF formulations were compared, we found substantial statistical heterogeneity for the rate of weight gain. Exploration of this heterogeneity by subgroup analysis for the type of control RUTF (studies with less or no milk powder; studies with standard formulation but containing omega‐3 fatty acids; studies with standard formulation but with added pre‐ and probiotics) seems to have accounted for the differences in effects. However, this must be viewed with caution given that data for two of the subgroups were derived from only one trial. In Comparison 1, the control groups ‐ being locally available and culturally acceptable foods ‐ differed across studies and could not be subgrouped. However, this resembles 'real life' situations and adds to the generalisability of the findings. </p> <p>Studies varied in the definition of the main outcome of recovery, and in the duration of the intervention, which could have had an impact on almost all of the review's outcomes. Among the 12 included studies that reported on recovery, only five used the anticipated definition of having a WHZ score of −2 or above (or a similar ≥ 80% weight for height of the National Center for Health Statistics (NCHS) reference population (<a href="./references#CD009000-bbs2-0093" title="HamillPV , DrizdTA , JohnsonCL , ReedRB , RocheAF , MooreWM . Physical growth: National Center for Health Statistics percentiles. American Journal of Clinical Nutrition1979;32(3):607‐29. [DOI: 10.1093/ajcn/32.3.607] ">Hamil 1979</a>)); two studies used 100% weight for height (NCHS reference population); and the other studies used either weight gain percentage from baseline (≥ 15%, ≥ 18%) or MUAC (&gt; 11 cm, &gt; 11.5 cm, &gt; 12.4 cm). Even though we did not detect substantial heterogeneity in the meta‐analyses for recovery (<a href="./references#CD009000-fig-0007" title="">Analysis 1.1</a>; <a href="./references#CD009000-fig-0031" title="">Analysis 2.1</a>; <a href="./references#CD009000-fig-0039" title="">Analysis 3.1</a>), it is possible that the different cut‐offs for recovery influenced the findings. </p> <p>The probability of a positive outcome for the review's primary outcomes is likely to be higher with a longer intervention period. On the other hand, for the outcome of rate of weight gain (g/kg/day) where the steepest increase occurs in the first weeks of the rehabilitation phase, studies where weight gain was assessed after four weeks of intervention were more likely to yield better results than those where average weight gain was measured over 16 weeks of intervention. We could not determine the potential long‐term effects of RUTF on growth and development as studies generally did not follow up all participants after the end of the intervention period, and no study assessed cognitive function and development, which is important for future school performance. </p> <p>In summary, the current body of evidence for the three comparisons addressed in this review is insufficient to allow evaluation of applicability of the current findings to children with SAM across different ages and levels of severity of SAM, with and without comorbidity. New research (potentially including the 11 ongoing studies identified in this review) might also influence the findings in future review updates. </p> </section> <section id="CD009000-sec-0170"> <h3 class="title" id="CD009000-sec-0170">Quality of the evidence</h3> <p>We identified selection bias, attrition bias and reporting bias in the included studies as concerns in the majority of the studies. Although we performed sensitivity analyses for the four most important outcomes (Comparisons 1 and 3; data did not allow this for Comparison 2), the interpretation of these are limited due to a relatively small number of studies per comparison and outcome. Using low risk of bias as a marker, the findings of the sensitivity analyses were in line with that of the main analysis for all outcomes, except for relapse in Comparison 3. </p> <p>For the outcomes of recovery and relapse, a comparison of findings from individually randomised trials with that of cluster‐randomised trials showed no difference between the groups for the individually randomised trials, while the cluster trials found a difference in favour of standard RUTF. For mortality, findings from both types of studies showed no difference between groups, while for rate of weight gain in Comparison 1 the findings from both types of studies favoured RUTF. In Comparison 3, the findings from individually randomised trials showed no difference between groups, whereas the findings from the cluster trials favoured RUTF. </p> <p>Another issue, in terms of the outcomes evaluated, is that while we wanted to report on change from baseline for all continuous outcomes, this was not always possible due to a lack of required information (for example, values at baseline and SD of change). In such cases, we assessed the difference in outcomes between comparison groups at the end of the intervention period. This approach, however, was not ideal given that studies were generally small and many were at high or unclear risk of selection bias. </p> <p>In our GRADE assessments (<a href="./full#CD009000-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD009000-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD009000-tbl-0003">summary of findings Table 3</a>), we judged the quality of the evidence for the majority of outcomes (eight) to be very low or low. We judged the quality of the evidence to be moderate for two outcomes and high for two outcomes. Our reasons for downgrading the quality of the evidence varied between comparisons; for Comparisons 1 and 2 we downgraded for risk of bias, indirectness, inconsistency and imprecision; while for Comparison 3 we downgraded for inconsistency and imprecision. </p> <p>The results of our subgroup analyses should be interpreted with caution, as they were based on a smaller number of studies. Also, our main subgroup analysis on pre‐trial hospitalisation was not decided a priori<i>.</i> The results of our sensitivity analyses should also be interpreted with caution, as they are likely underpowered to detect differences between experimental and control interventions. This might also be the reason why the effect of the intervention was not statistically significant in some cases. </p> </section> <section id="CD009000-sec-0171"> <h3 class="title" id="CD009000-sec-0171">Potential biases in the review process</h3> <p>It is unlikely that we have missed any relevant studies since, aside from our electronic searches without any language restriction, we also screened reference lists of included studies and relevant reviews and contacted the corresponding authors of included and ongoing studies (and some of the excluded studies) as well as professionals working in the field. </p> <p>In our 2013 review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>), there were two ongoing studies with the same contact author from whom we could not obtain information on study completion or a (published or unpublished) manuscript. The author of another study did not provide us with the manuscript after having indicated an intention to do so. Furthermore, not all studies measured or reported data on recovery, relapse, mortality or rate of weight gain that could be included in a meta‐analysis. This was especially problematic in Comparison 1 where, although six of seven studies provided data for the meta‐analysis on recovery, we were able to pool data for relapse, mortality and rate of weight gain from only four studies. Regarding Comparison 3, six of eight studies provided data for the meta‐analysis for recovery, relapse and rate of weight gain, and seven for mortality. In Comparison 2, both studies provided data on all four main outcomes for meta‐analysis. </p> <p>We were unable to assess the likelihood of publication bias formally, due to having less than 10 included studies per comparison. </p> <p>None of the review authors have any links to companies that manufacture or sell RUTF; one author is a paediatrician who provides care to patients with SAM. </p> </section> <section id="CD009000-sec-0172"> <h3 class="title" id="CD009000-sec-0172">Agreements and disagreements with other studies or reviews</h3> <p>To our knowledge, the 2013 version of this review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>), which included four studies ‐ all conducted in Malawi, was the first systematic review that specifically investigated home‐based RUTF for the treatment of children with SAM. For Comparison 1, we found that RUTF may improve recovery (RR 1.33, 95% CI 1.16 to 1.54; moderate‐quality evidence) and increase the rate of weight gain slightly (MD 1.12 g/kg/day, 95% CI 0.27 to 1.96; low‐quality evidence), but the effects on relapse and mortality are unclear (both very low‐quality evidence). This is in line with the findings of this update, except that we also found that standard RUTF may increase the rate of weight gain. In this current review, we did not find any additional studies for Comparison 2, and thus the conclusions did not change. For Comparison 3 in the 2013 review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>), there was only one eligible trial, which compared RUTF containing 10% milk powder to a standard formulation containing 25% milk powder. There was probably little or no difference between the groups for recovery (RR 0.97, 95% CI 0.93 to 1.01; moderate‐quality evidence), but RUTF containing less milk powder may have led to slightly more children relapsing (RR 1.33, 95% CI 1.03 to 1.72; low‐quality evidence) and to a lower rate of weight gain (MD −0.5 g/kg/day, 95% CI −0.75 to −0.25; low‐quality evidence) than standard RUTF with 25% milk powder. In terms of recovery, this finding is similar to the finding in this update, which shows that it makes little or no difference whether standard or alternative formulation RUTF is used (high‐quality evidence). However, in line with the findings of the 2013 review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>), standard RUTF decreases relapse (RR 0.84, 95% CI 0.72 to 0.98; high‐quality evidence). For mortality (RR 1.00, 95% CI 0.8 to 1.24; moderate‐quality evidence) and rate of weight gain (MD 0.11 g/kg/day, 95% CI −0.32 to 0.54; low‐quality evidence) it may make little or no difference what formulation for RUTF is used. </p> <p><a href="./references#CD009000-bbs2-0087" title="GeraT . Efficacy and safety of therapeutic nutrition products for home based therapeutic nutrition for severe acute malnutrition: a systematic review. Indian Pediatrics2010;47(8):709‐18. [PUBMED: 20972288] ">Gera 2010</a> assessed the "efficacy and safety of home‐based management of SAM using 'therapeutic nutrition products' or ready to use therapeutic foods and efficacy of these products in comparison with F‐100 and home‐based diet" and included two reviews, seven "controlled trials", seven cohort studies and two consensus statements. The outcomes assessed were recovery rate (as defined by the study authors), weight gain (g/kg/day), relapse, mortality and morbidities (for example, diarrhoea, malaria and respiratory infections). Of the seven "controlled trials", we have included two in our review (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>). We did not include the remaining five studies because one was facility‐based (<a href="./references#CD009000-bbs2-0025" title="DiopEH , DossouNI , NdourMM , BriendA , WadeS . Comparison of the efficacy of a solid ready‐to‐use food and a liquid, milk‐based diet for the rehabilitation of severely malnourished children: a randomized trial. American Journal of Clinical Nutrition2003;78(2):302‐7. [DOI: 10.1093/ajcn/78.2.302; PUBMED: 12885713] ">Diop 2003</a>), three did not have an eligible control group (<a href="./references#CD009000-bbs2-0026" title="DiopEI , DossouNI , BriendA , YayaMM , NdourMM , WadeS . Home‐based rehabilitation for severely malnourished children using locally made ready‐to‐use therapeutic food (RTUF). Second World Congress of Pediatric Gastroenterology, Hepatology and Nutrition; 2004 Jul 3‐7; Paris (FR)2004:101‐5. ">Diop 2004</a>; <a href="./references#CD009000-bbs2-0085" title="GaboulandV , Dan‐BouzouaN , BrasherC , FedidaG , GergonneB , BrownV . Could nutritional rehabilitation at home complement or replace centre‐based therapeutic feeding programmes for severe malnutrition?. Journal of Tropical Paediatrics2007;53(1):49‐51. [DOI: 10.1093/tropej/fml052; PUBMED: 17030533] ">Gabouland 2007</a>; <a href="./references#CD009000-bbs2-0047" title="SandigeH , NdekhaMJ , BriendA , AshornP , ManaryMJ . Home‐based treatment of malnourished Malawian children with locally produced or imported ready‐to‐use food. Journal of Pediatric Gastroenterology and Nutrition2004;39(2):141‐6. [PUBMED: 15269617] ">Sandige 2004</a>), and one study included Spirulina® and not RUTF (<a href="./references#CD009000-bbs2-0132" title="SimporeJ , KaboreF , ZongoF , DansouD , BereA , PignatelliS , et al. Nutrition rehabilitation of undernourished children utilizing Spiruline and Misola. Nutrition Journal2006;5:3. [DOI: 10.1186/1475‐2891‐5‐3; PMC1386687; PUBMED: 16430775] ">Simpore 2006</a>). <a href="./references#CD009000-bbs2-0087" title="GeraT . Efficacy and safety of therapeutic nutrition products for home based therapeutic nutrition for severe acute malnutrition: a systematic review. Indian Pediatrics2010;47(8):709‐18. [PUBMED: 20972288] ">Gera 2010</a> did not perform a meta‐analysis of studies on any of the comparisons that we evaluated in our review, but pooled four cohort studies that assessed the effect of home‐based RUTF on weight gain in SAM children and found a "mean weight gain" of 3.2 g/kg/day (95% CI 3.06 to 3.34; I<sup>2</sup> = 89.8%) (software used and type of effects model not reported). In this update, we too found that children who received standard RUTF, as opposed to alternative dietary approaches, gained more weight; however, the effect was smaller (MD 1.12 g/kg/day, 95% CI 0.27 to 1.96; random‐effects analysis, heterogeneity Chi<sup>2</sup> = 7.40; df = 3; P = 0.06; I<sup>2</sup> = 59%; <a href="./references#CD009000-fig-0017" title="">Analysis 1.11</a>). </p> <p>Guidelines by Ashworth and colleagues categorised weight gain during the rehabilitation phase for children with SAM as poor if less then 5 g/kg/day, moderate if between 5 and 10 g/kg/day and good if more than 10 g/kg/day (<a href="./references#CD009000-bbs2-0069" title="AshworthA , KhanumS , JacksonA , SchofieldC . Guidelines for the inpatient treatment of severely malnourished children. www.who.int/nutrition/publications/guide_inpatient_text.pdf (accessed 2 November 2017). ">Ashworth 2003</a>). The highest average weight gain among our included studies was 5.1 g/kg/day over the first four weeks of the intervention period. This occurred in the study that included only HIV‐uninfected children (<a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>). Rate of weight gain in children with SAM is complex and depends on a number of different factors. These include the protein quality of the nutritional intervention (<a href="./references#CD009000-bbs2-0119" title="ManaryM , CallaghanM , SinghL , BriendA . Protein quality and growth in malnourished children. Food and Nutrition Bulletin2016;37(Suppl 1):S29‐36. [DOI: 10.1177/0379572116629023; PUBMED: 26857118] ">Manary 2016</a>); infections and treatment for conditions such as HIV, tuberculosis (<a href="./references#CD009000-bbs2-0119" title="ManaryM , CallaghanM , SinghL , BriendA . Protein quality and growth in malnourished children. Food and Nutrition Bulletin2016;37(Suppl 1):S29‐36. [DOI: 10.1177/0379572116629023; PUBMED: 26857118] ">Manary 2016</a>), and diarrhoea (<a href="./references#CD009000-bbs2-0102" title="IannottiLL , TrehanI , ClitheroeKL , ManaryMJ . Diagnosis and treatment of severely malnourished children with diarrhoea. Journal of Paediatrics and Child Health2015;51(4):387‐95. [DOI: 10.1111/jpc.12711; PUBMED: 25196813] ">Iannotti 2015</a>); and non‐dietary factors, such as the mother's educational status and her knowledge about feeding practices, socioeconomic status, and previous history of malnutrition (<a href="./references#CD009000-bbs2-0127" title="SanghviJ , MehtaS , KumarR . Predicators for weight gain in children treated for severe acute malnutrition: a prospective study at nutritional rehabilitation center. ISRN Pediatrics2014;2014:808756. [DOI: 10.1155/2014/808756; PMC3972911; PUBMED: 25006491] ">Sanghvi 2014</a>). Although rapid weight gain in the rehabilitation phase of SAM is desired, its long‐term impact ‐ especially if height gain does not also occur ‐ is of concern in the context of the 'double burden' of disease and overnutrition in adulthood (<a href="./references#CD009000-bbs2-0074" title="BlackRE , VictoraCG , WalkerSP , BhuttaZA , ChristianP , deOnisM , et al. Maternal and child undernutrition and overweight in low‐income and middle‐income countries. Lancet2013;382(9890):427‐51. [DOI: 10.1016/S0140‐6736(13)60937‐X] ">Black 2013</a>; <a href="./references#CD009000-bbs2-0136" title="TrehanI , ManaryMJ . Management of severe acute malnutrition in low‐income and middle‐income countries. Archives of Disease in Childhood2015;100(3):283‐7. [DOI: 10.1136/archdischild‐2014‐306026; PUBMED: 25421910] ">Trehan 2015</a>). </p> <p>In the same year that our review was first published, <a href="./references#CD009000-bbs2-0115" title="LentersLM , WaznyK , WebbP , AhmedT , BhuttaZA . Treatment of severe and moderate acute malnutrition in low‐ and middle‐income settings: a systematic review, meta‐analysis and Delphi process. BMC Public Health2013;13(Suppl 3):S23. [DOI: 10.1186/1471‐2458‐13‐S3‐S23; PMC3847503 ; PUBMED: 24564235] ">Lenters 2013</a> evaluated the effectiveness of interventions for inpatient management of SAM, community‐based management of SAM with RUTF, and interventions for MAM in children under five years of age in LMICs. Lenters and colleagues included the same three studies that were conducted in Malawi that we did (<a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a>; <a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>; <a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a>) and, for their comparison 'community‐based management with RUTF versus "standard therapy"', came to similar conclusions as reported in our 2013 review (<a href="./references#CD009000-bbs2-0154" title="SchooneesA , LombardM , MusekiwaA , NelE , VolminkJ . Ready‐to‐use therapeutic food for home‐based treatment of severe acute malnutrition in children from six months to five years of age. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009000.pub2] ">Schoonees 2013</a>). Since then, a number of new studies have been conducted and we have included them in this update. We could not find any other systematic reviews that included the recent studies for home‐based rehabilitation with RUTF for young children with SAM. <a href="./references#CD009000-bbs2-0102" title="IannottiLL , TrehanI , ClitheroeKL , ManaryMJ . Diagnosis and treatment of severely malnourished children with diarrhoea. Journal of Paediatrics and Child Health2015;51(4):387‐95. [DOI: 10.1111/jpc.12711; PUBMED: 25196813] ">Iannotti 2015</a> investigated the most effective diagnostic and therapeutic measures for community‐based management of SAM children with diarrhoea; however, their search was done in 2013 and did not identify any studies that directly addressed this question in outpatients. </p> <p>Although not specifically the focus of our review, it should be noted that RUTF may be used in the context of humanitarian emergencies, where paediatric mortality and morbidity may largely be due to malnutrition (<a href="./references#CD009000-bbs2-0071" title="BalharaKS , SilvestriDM , WindersWT , SelvamA , KivlehanSM , BeckerTK , et al. Impact of nutrition interventions on pediatric mortality and nutrition outcomes in humanitarian emergencies: a systematic review. Tropical Medicine &amp; International Health2017;22(12):1464‐92. [DOI: 10.1111/tmi.12986; PUBMED: 28992388] ">Balhara 2017</a>; <a href="./references#CD009000-bbs2-0109" title="The Global Burden of Disease Child and Adolescent Health Collaboration. Child and adolescent health from 1990 to 2015 findings from the Global Burden of Diseases, Injuries, and Risk factors 2015 study. JAMA Pediatrics2017;171(6):573‐92. [DOI: 10.1001/jamapediatrics.2017.0250; PMC5540012; PUBMED: 28384795] ">Kassebaum 2017</a>; <a href="./references#CD009000-bbs2-0122" title="MossWJ , RamakrishnanM , StormsD , Henderson SiegleA , WeissWM , LejnevI , et al. Child health in complex emergencies. Bulletin of the World Health Organization2006;84:58‐64. [www.who.int/hac/techguidance/pht/Child_health_in_emergencies.pdf] ">Moss 2006</a>). A systematic review by Balhara and colleagues aimed to characterise specific nutritional interventions in these settings and their effects on paediatric (ages 1 to 18 years) mortality, anthropometric measures and serum markers of nutrition (<a href="./references#CD009000-bbs2-0071" title="BalharaKS , SilvestriDM , WindersWT , SelvamA , KivlehanSM , BeckerTK , et al. Impact of nutrition interventions on pediatric mortality and nutrition outcomes in humanitarian emergencies: a systematic review. Tropical Medicine &amp; International Health2017;22(12):1464‐92. [DOI: 10.1111/tmi.12986; PUBMED: 28992388] ">Balhara 2017</a>). Of the 31 included studies, two studies from Niger (<a href="./references#CD009000-bbs2-0103" title="IsanakaS , NombelaN , DjiboA , PoupardM , vanBeckhovenD , GaboulandV , et al. Effect of preventive supplementation with ready‐to‐use therapeutic food on the nutritional status, mortality, and morbidity of children aged 6 to 60 months in Niger: a cluster randomized trial. JAMA2009;301(3):277‐85. [DOI: 10.1001/jama.2008.1018; PMC3144630; NCT00682708; PUBMED: 19155454] ">Isanaka 2009</a>; <a href="./references#CD009000-bbs2-0042" title="NackersF , BroilletF , OumarouD , DjiboA , GaboulaudV , GuerinPJ . Effectiveness of ready‐to‐use therapeutic food compared to a corn/soy‐blend‐based pre‐mix for the treatment of childhood moderate acute malnutrition in Niger. Journal of Tropical Pediatrics2010;56(6):407‐13. [DOI: 10.1093/tropej/fmq019; PUBMED: 20332221] ">Nackers 2010</a>), and three observational studies from Malawi (<a href="./references#CD009000-bbs2-0016" title="AmthorRE , ColeSM , ManaryMJ . The use of home‐based therapy with ready‐to‐use therapeutic food to treat malnutrition in a rural area during a food crisis. Journal of the American Dietetic Association2009;109(3):464‐7. [DOI: 10.1016/j.jada.2008.11.028; PUBMED: 19248863] ">Amthor 2009</a>), Myanmar (<a href="./references#CD009000-bbs2-0105" title="JamesPT , Van denBrielN , RozetA , IsraëlAD , FennB , Navarro‐ColoradoC . Low‐dose RUTF protocol and improved service delivery lead to good programme outcomes in the treatment of uncomplicated SAM: a programme report from Myanmar. Maternal &amp; Child Nutrition2015;11(4):859‐69. [DOI: 10.1111/mcn; PMC4672709; PUBMED: 25850698] ">James 2015</a>), and Sri Lanka (<a href="./references#CD009000-bbs2-0106" title="JayatissaR , BekeleA , KethiswaranA , DeSilvaAH . Community‐based management of severe and moderate acute malnutrition during emergencies in Sri Lanka: challenges of implementation. Food and Nutrition Bulletin2012;33(4):251‐60. [DOI: 10.1177/156482651203300405] ">Jayatissa 2012</a>), included RUTF as intervention. We excluded <a href="./references#CD009000-bbs2-0042" title="NackersF , BroilletF , OumarouD , DjiboA , GaboulaudV , GuerinPJ . Effectiveness of ready‐to‐use therapeutic food compared to a corn/soy‐blend‐based pre‐mix for the treatment of childhood moderate acute malnutrition in Niger. Journal of Tropical Pediatrics2010;56(6):407‐13. [DOI: 10.1093/tropej/fmq019; PUBMED: 20332221] ">Nackers 2010</a> from our review because the participants were children with MAM. We also excluded <a href="./references#CD009000-bbs2-0103" title="IsanakaS , NombelaN , DjiboA , PoupardM , vanBeckhovenD , GaboulandV , et al. Effect of preventive supplementation with ready‐to‐use therapeutic food on the nutritional status, mortality, and morbidity of children aged 6 to 60 months in Niger: a cluster randomized trial. JAMA2009;301(3):277‐85. [DOI: 10.1001/jama.2008.1018; PMC3144630; NCT00682708; PUBMED: 19155454] ">Isanaka 2009</a> as the study was concerned with the prevention, not treatment, of severe wasting. <a href="./references#CD009000-bbs2-0071" title="BalharaKS , SilvestriDM , WindersWT , SelvamA , KivlehanSM , BeckerTK , et al. Impact of nutrition interventions on pediatric mortality and nutrition outcomes in humanitarian emergencies: a systematic review. Tropical Medicine &amp; International Health2017;22(12):1464‐92. [DOI: 10.1111/tmi.12986; PUBMED: 28992388] ">Balhara 2017</a> found that "[h]igh‐ and medium‐quality studies demonstrated positive impact of fortified spreads, ready‐to‐use therapeutic foods, micronutrients supplementation, and food and cash transfers". </p> <p>A Cochrane Review evaluated the safety and effectiveness of different types of foods (which included RUTF as a lipid‐based nutrient supplement) for children aged six months to five years with MAM in LMICs (<a href="./references#CD009000-bbs2-0114" title="LazzeriniM , RubertL , PaniP . Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD009584.pub2; PUBMED: 23794237] ">Lazzerini 2013</a>), and found no significant difference in mortality (moderate‐quality evidence), progression to SAM (high‐quality evidence) or in the number of dropouts from the nutritional programme (moderate‐quality evidence) when comparing lipid‐based nutrient supplements at full dose with any blended foods (without a high lipid content). However, lipid‐based supplements significantly increased the number of children who recovered (RR 1.10, 95% CI 1.04 to 1.16; 5 studies, 6367 children; moderate‐quality evidence) and decreased the number of "non‐recovering children" (quote; RR 0.53, 95% CI 0.40 to 0.69; 3 studies, 4537 children; high‐quality evidence). <a href="./references#CD009000-bbs2-0088" title="GeraT , Pena‐RosasJP , Boy‐MenaE , SachdevHS . Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): a systematic review. PLoS One2017;12(9):e0182096. [DOI: 10.1371/journal.pone.0182096; PMC5608196; PUBMED: 28934235] ">Gera 2017</a> also evaluated the effectiveness and safety of lipid‐based nutrient supplements (which included RUTF) for the treatment of MAM in children aged between six and 59 months. In a subgroup analysis to explore heterogeneity for their primary outcome recovery, they found that the RUTF group had a higher recovery rate than the group consuming RUSF foods (RR 1.23, 95% CI 1.09 to 1.38; 1 trial, 451 children for RUTF and RR 1.06, 95% CI 1.01 to 1.11; 7 studies, 8483 children for RUSF; Chi<sup>2</sup> = 5.17; df = 1; P = 0.02; I<sup>2</sup> = 80.7% for subgroup differences). Gera and colleagues also reported that lipid‐based nutrient supplements containing milk had a higher recovery rate (RR 1.15, 95% CI 1.03 to 1.29; 2 studies, 1140 children) than those without milk (RR 1.06, 95% CI 1.01 to 1.11; 7 studies, 7795 children; heterogeneity indicators not reported). </p> <section id="CD009000-sec-0173"> <h4 class="title">Economic commentary</h4> <p>Historically, SAM was managed within healthcare facilities. However, due to the large number of children requiring treatment and limited resources, alternative treatment strategies were sought. Since 2007, WHO has recommended community‐based management of malnutrition (CMAM) (<a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>). Mortality rates comparable to those in facility‐based care have been reported with this approach (<a href="./references#CD009000-bbs2-0068" title="AkpariboR , HarrisJ , BlankL , CampbellMJ , HoldsworthM . Severe acute malnutrition in children aged under 5 years can be successfully managed in a non‐emergency routine community healthcare setting in Ghana. Maternal &amp; Child Nutrition2017;13(4):e12417. [DOI: 10.1111/mcn.12417; MEDLINE: 28185414] ">Akparibo 2017</a>; <a href="./references#CD009000-bbs2-0076" title="CollinsS , SadlerK . Outpatient care for severely malnourished children in emergency relief programmes: a retrospective cohort study. Lancet2002;360(9348):1824‐30. [DOI: 10.1016/S0140‐6736(02)11770‐3] ">Collins 2002</a>; <a href="./references#CD009000-bbs2-0080" title="CollinsS , SadlerK , DentN , KharaT , GuerreroS , MyattM , et al. Key issues in the success of community‐based management of severe malnutrition. Food and Nutrition Bulletin2006;27(Suppl 3):S49‐82. [DOI: 10.1177/15648265060273S304; PUBMED: 17076213] ">Collins 2006b</a>; <a href="./references#CD009000-bbs2-0108" title="KabaloMY , SeifuCN . Treatment outcomes of severe acute malnutrition in children treated within Outpatient Therapeutic Program (OTP) at Wolaita Zone, Southern Ethiopia: retrospective cross‐sectional study. Journal of Health, Population and Nutrition2017;36(1):7. [DOI: 10.1186/s41043‐017‐0083‐3; PMC5345228; PUBMED: 28279227] ">Kabalo 2017</a>). The success of CMAM largely relies on the provision of an adequate and safe therapeutic feed, and RUTF was developed to address this need. A major concern has been the contribution of RUTF to the total cost of CMAM and the effect that it may have on the cost‐effectiveness of the programmes. A few studies addressing the cost and cost‐effectiveness of community‐based management have identified RUTF as one of the most important cost components. </p> <p>Our searches in 2017 and 2018 yielded 526 records. After screening by two authors independently, we identified seven studies as potentially eligible. All of them evaluated the cost or cost‐effectiveness of CMAM and specified the contribution of RUTF to the total cost (<a href="./references#CD009000-bbs2-0070" title="BachmannMO . Cost effectiveness of community‐based therapeutic care for children with severe acute malnutrition in Zambia: decision tree model. Cost Effectiveness and Resource Allocation2009;7:2. [DOI: 10.1186/1478‐7547‐7‐2; PMC2630929; PUBMED: 19146668] ">Bachmann 2009</a>; <a href="./references#CD009000-bbs2-0086" title="GargCC , MazumderS , TanejaS , ShekharM , MohanSB , BoseA , et al. Costing of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition from a randomised trial in India. BMJ Global Health2018;3:e000702. [DOI: 10.1136/bmjgh‐2017‐000702] ">Garg 2018</a>; <a href="./references#CD009000-bbs2-0104" title="IsanakaS , MenziesNA , SayyadJ , AyoolaM , GraisRF , DoyonS . Cost analysis of the treatment of severe acute malnutrition in West Africa. Maternal &amp; Child Nutrition2017;13(4):e12398. [DOI: 10.1111/mcn.12398; PUBMED: 27921381] ">Isanaka 2017</a>; <a href="./references#CD009000-bbs2-0124" title="PuettC , SadlerK , AldermanH , CoatesJ , FiedlerJL , MyattM . Cost‐effectiveness of the community‐based management of severe acute malnutrition by community health workers in southern Bangladesh. Health Policy and Planning2013;28(4):386‐99. [DOI: 10.1093/heapol/czs070; PUBMED: 22879522] ">Puett 2013</a>; <a href="./references#CD009000-bbs2-0126" title="RogersE , MartínezK , MoránJL , AléFG , CharleP , GuerreroS , et al. Cost‐effectiveness of the treatment of uncomplicated severe acute malnutrition by community health workers compared to treatment provided at an outpatient facility in rural Mali. Human Resources for Health2018;16(1):12. [DOI: 10.1186/s12960‐018‐0273‐0; PMC5819265; PUBMED: 29458382] ">Rogers 2018</a>; <a href="./references#CD009000-bbs2-0135" title="TekesteA , WondafrashM , AzeneG , DeribeK . Cost effectiveness of community‐based and in‐patient therapeutic feeding programs to treat severe acute malnutrition in Ethiopia. Cost Effectiveness and Resource Allocation2012;10:4. [DOI: 10.1186/1478‐7547‐10‐4; PMC3323427; PUBMED: 22429892] ">Tekeste 2012</a>; <a href="./references#CD009000-bbs2-0152" title="WilfordR , GoldenK , WalkerDG . Cost‐effectiveness of community‐based management of acute malnutrition in Malawi. Health Policy and Planning2012;27(2):127‐37. [DOI: 10.1093/heapol/czr017; PUBMED: 21378101] ">Wilford 2012</a>), and thus we included them in the Economic commentary. Although we did not perform a critical appraisal of these studies, we extracted relevant study information to provide the reader with additional information on the use of RUTF (<a href="#CD009000-tbl-0014">Table 11</a>). </p> <div class="table" id="CD009000-tbl-0014"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Summary of cost‐ and cost‐effectiveness studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Author</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0070" title="BachmannMO . Cost effectiveness of community‐based therapeutic care for children with severe acute malnutrition in Zambia: decision tree model. Cost Effectiveness and Resource Allocation2009;7:2. [DOI: 10.1186/1478‐7547‐7‐2; PMC2630929; PUBMED: 19146668] ">Bachmann 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009000-bbs2-0086" title="GargCC , MazumderS , TanejaS , ShekharM , MohanSB , BoseA , et al. Costing of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition from a randomised trial in India. BMJ Global Health2018;3:e000702. [DOI: 10.1136/bmjgh‐2017‐000702] ">Garg 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0104" title="IsanakaS , MenziesNA , SayyadJ , AyoolaM , GraisRF , DoyonS . Cost analysis of the treatment of severe acute malnutrition in West Africa. Maternal &amp; Child Nutrition2017;13(4):e12398. [DOI: 10.1111/mcn.12398; PUBMED: 27921381] ">Isanaka 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009000-bbs2-0126" title="RogersE , MartínezK , MoránJL , AléFG , CharleP , GuerreroS , et al. Cost‐effectiveness of the treatment of uncomplicated severe acute malnutrition by community health workers compared to treatment provided at an outpatient facility in rural Mali. Human Resources for Health2018;16(1):12. [DOI: 10.1186/s12960‐018‐0273‐0; PMC5819265; PUBMED: 29458382] ">Rogers 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0135" title="TekesteA , WondafrashM , AzeneG , DeribeK . Cost effectiveness of community‐based and in‐patient therapeutic feeding programs to treat severe acute malnutrition in Ethiopia. Cost Effectiveness and Resource Allocation2012;10:4. [DOI: 10.1186/1478‐7547‐10‐4; PMC3323427; PUBMED: 22429892] ">Tekeste 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0124" title="PuettC , SadlerK , AldermanH , CoatesJ , FiedlerJL , MyattM . Cost‐effectiveness of the community‐based management of severe acute malnutrition by community health workers in southern Bangladesh. Health Policy and Planning2013;28(4):386‐99. [DOI: 10.1093/heapol/czs070; PUBMED: 22879522] ">Puett 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0152" title="WilfordR , GoldenK , WalkerDG . Cost‐effectiveness of community‐based management of acute malnutrition in Malawi. Health Policy and Planning2012;27(2):127‐37. [DOI: 10.1093/heapol/czr017; PUBMED: 21378101] ">Wilford 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention assessed</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM compared to a hypothetical alternative of providing no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Home‐based management of SAM in a community setting: 2 different RUTF feeding regimens were compared against an energy‐dense, home‐prepared food regimen </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Routine inpatient and outpatient management CMAM of SAM. There was no control group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHW delivered treatment of SAM compared to outpatient facility‐based care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CTC of SAM in comparison to facility‐based TFC care in emergencies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community‐based management of SAM added to a community‐based health and nutrition programme versus inpatient treatment augmented with community surveillance by CHW </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community‐based management of acute malnutrition integrated into health services in comparison to health services with no CMAM </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Location</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zambia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>India</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Niger</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mali</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ethiopia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bangladesh</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Malawi</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children &lt; 5 years with SAM (MUAC &lt; 11 cm, or bilateral pitting oedema)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 6 months‐5 years with uncomplicated SAM (WHZ &lt; ‐3, or oedema, or both)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 6 months‐5 years with uncomplicated or complicated SAM</p> <p>(MUAC &lt; 115 mm, or WHZ &lt; ‐3 and MUAC &gt; 115 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 6‐59 months with uncomplicated SAM</p> <p>(MUAC &lt; 115 mm, WHZ &lt; ‐3, or bilateral oedema)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM (age and diagnostic criteria used for eligible participants not reported) that required treatment during a drought crisis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 6‐36 months with uncomplicated SAM</p> <p>(MUAC &lt; 110 mm, or oedema, or both)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children &lt; 5 years old with SAM (oedema or wasting); defaulters and readmissions were included </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type of analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cost‐effectiveness analysis based on a</p> <p>decision tree model</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Costing analysis where the costs were calculated per week per child for activities under research setting and estimated for the activities that are likely to be done under the government setting </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cost analysis of in‐ and outpatient treatment, including cost of F‐75, F‐100, and RUTF (Plumpy'nut®) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Activity‐based cost analysis was developed. Costs were estimated via document review, interviews and focus groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective comparative cost‐effectiveness evaluation of therapeutic feeding programmes in emergencies. </p> <p>Assessed parental costs by interview. Sourced other costs from existing data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cost‐effectiveness analysis of CMAM delivered by CHW versus inpatient treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cost effectiveness analysis based on a decision tree model.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Perspective taken</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health services</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health services</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health services</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Societal perspective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Societal perspective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Societal perspective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health services</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Major outcome(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recovery during treatment period (WHZ &gt; ‐2), and absence of oedema in the feet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable, as cost analysis and not cost‐effectiveness analysis was done</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recovery rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cure rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death, recovery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death, cure, default or non‐recovery</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Main cost category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF, health centre visit, programme establishment, hospitalisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human resources (per week per child based on salaries and time taken) and consumables (RUTF, medicines) and programmatic and administrative costs. Estimated cost of resources that would be used in the government setting </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient: therapeutic food and personnel</p> <p>Inpatient: personnel, transport and logistical support and therapeutic food</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All costs incurred by institutions, beneficiaries and communities were included. Variable costs per child were costs to households and RUTF costs (that included its purchase, storage, security and transport costs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthcare costs and costs to parents were assessed (the latter by using questionnaires).</p> <p>Personnel, capital depreciation and utilities, medication, RUTF or milk‐based formula, caretakers' food, non‐food items </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total costs to households (transport, time, food) and the health service (personnel, supervision, training, medication, therapeutic feeds including RUTF) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Administration, personnel, transport, RUTF, therapeutic milk, medication, and bed costs </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Currency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>International dollars</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD and INR (USD 1 = 62 rupees)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Euros</p> <p>(EUR 1 = 656 XOF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD</p> <p>(USD 1 = 67.94 BDT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD</p> <p>(USD 1 = 140 MWK)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Price year</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013 and 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TFC: July 2003‐January 2004; CTC: July 2005 to April 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2007 (Janauary‐December)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (one‐ and two‐way analysis)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (one‐way)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (univariate, multivariate probabilistic, and modelled scenario sensitivity analyses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was done, but not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (one‐way)</p> <p>Relative effect of different inputs on the DALYs averted in community and inpatient treatment </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (one‐way)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Result summary</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM cost USD 203 per child</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Average total cost per treated child in the government setting was estimated at USD 56 (&lt; 3500 rupees)<br/> <br/> <br/> <br/> No significant difference in costs was detected across the 3 feeding regimens </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total cost was EUR 148.86 per child</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The average cost per child treated by CHWs was USD 244 compared to USD 442 in the outpatient facility. The cost per child recovered was USD 259 by CHWs and USD 501 in the outpatient facility </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institutional cost:</p> <p>TFC: USD 262.62</p> <p>CMAM: USD 128.58</p> <p>Costs to care‐givers:</p> <p>TFC USD 0.92 + USD 21.01 = USD 21.93</p> <p>CTC USD 0.42 + USD 5.87 = USD 6.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM:</p> <p>USD 165 per child;</p> <p>cost per child recovered USD 180;</p> <p>cost per death averted USD 869;</p> <p>cost per DALY averted USD 26</p> <p>Inpatient treatment:</p> <p>USD 1344;</p> <p>cost per child recovered USD 9149;</p> <p>cost per death averted USD 45688;</p> <p>cost per DALY averted USD 1344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The total cost of providing CMAM was USD 470,703, and for non‐CMAM (USD 23,394) treatment for SAM in Dowa district (scenario 1) was USD 494,097 </p> <p>USD 42 per DALY averted (or USD 1365 per</p> <p>life saved)</p> <p>Average cost per child treated in CMAM: USD 169.3 (140.3 to 211.6)</p> <p>Average cost per child treated in non‐CMAM: USD 16.7 (12.5 to 20.9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RUTF cost</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 72.52 (mean) per child, i.e. 35.8% of the total cost</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 36.4 per child treated in the government setting; that is 65% of total average cost </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM: RUTF cost was 44% (EUR 32.98 per child) of total cost</p> <p>Inpatient care: RUTF cost was 11% (EUR 14.34 per child) of total cost</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF's average cost per treated child was (17795+5648)/(617+212) = USD 28.8;</p> <p>(RUTF costs were 11.8% of total cost in the CHWs group and 6.0% of total cost in the outpatient facility group) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Facility‐based: USD 42.93 (mean) per child, that is 16.35% of total cost</p> <p>CMAM: USD 55.53 (mean) per child, that is 43.19% of total cost</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 36.36 per child enrolled, that is 24% of total cost of CMAM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF was USD 169.3, that is 32% of total cost of CMAM</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cost per death averted</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 1760</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM: USD 869</p> <p>Inpatient treatment: USD 45688</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 1365</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cost per DALY averted</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM: USD 26</p> <p>Inpatient treatment: USD 1344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 42</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Production</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Valid International</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF‐C was produced by Comparct Foods Ltd, India; RUTF‐L was prepared at each participating site in a designated room </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified, but implied that the RUTF came from Nutriset, France as Plumpy'nut® was used </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UNICEF provided the RUTF for the study; unclear who produced it</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified, but implied that imported RUTF was used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Plumpy'nut®, Nutriset France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified, but implied that imported RUTF was used</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Funder</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Valid International and Concern</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bill and Melinda Gates Foundation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study authors reported that there was no funding for the preparation of the manuscript</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Innocent Foundation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Jimma University</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GAIN, the Global Alliance for Improved Nutrition. Additional support was provided by the Feinstein International Center at Tufts University </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Concern Worldwide</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CHW:</b> community health worker; <b>CMAM:</b> community‐based management of acute malnutrition; <b>CTC:</b> community‐based therapeutic care; <b>DALY:</b> disability‐adjusted life year; <b>MUAC:</b> mid‐upper arm circumference; <b>RUTF:</b> ready‐to‐use therapeutic food; <b>RUTF‐C:</b> commercially produced ready‐to‐eat therapeutic food; <b>RUTF‐L:</b> locally produced ready‐to‐eat therapeutic food; <b>SAM:</b> severe acute malnutrition; <b>TFC:</b> therapeutic feeding centre; <b>WHZ:</b> weight for height z score </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> <p>In Niger, Isanaka and colleagues conducted a cost analysis of in‐ and outpatient treatment of SAM (<a href="./references#CD009000-bbs2-0104" title="IsanakaS , MenziesNA , SayyadJ , AyoolaM , GraisRF , DoyonS . Cost analysis of the treatment of severe acute malnutrition in West Africa. Maternal &amp; Child Nutrition2017;13(4):e12398. [DOI: 10.1111/mcn.12398; PUBMED: 27921381] ">Isanaka 2017</a>). RUTF accounted for 44% (EUR 32.98) of the cost of CMAM. </p> <p>Two studies, one from Zambia (comparing CMAM to no treatment) and the other from Malawi (comparing CMAM to no CMAM), used a decision‐tree model to assess cost‐effectiveness of CMAM (<a href="./references#CD009000-bbs2-0070" title="BachmannMO . Cost effectiveness of community‐based therapeutic care for children with severe acute malnutrition in Zambia: decision tree model. Cost Effectiveness and Resource Allocation2009;7:2. [DOI: 10.1186/1478‐7547‐7‐2; PMC2630929; PUBMED: 19146668] ">Bachmann 2009</a>; <a href="./references#CD009000-bbs2-0152" title="WilfordR , GoldenK , WalkerDG . Cost‐effectiveness of community‐based management of acute malnutrition in Malawi. Health Policy and Planning2012;27(2):127‐37. [DOI: 10.1093/heapol/czr017; PUBMED: 21378101] ">Wilford 2012</a>). RUTF contributed 36% and 32% respectively to the cost of CMAM in the studies. The incremental cost per death averted was USD 1760 and USD 1365 respectively, and the incremental cost per DALY (disability‐adjusted‐life year) USD 53 and USD 42. </p> <p>Another two studies, from Ethiopia (<a href="./references#CD009000-bbs2-0135" title="TekesteA , WondafrashM , AzeneG , DeribeK . Cost effectiveness of community‐based and in‐patient therapeutic feeding programs to treat severe acute malnutrition in Ethiopia. Cost Effectiveness and Resource Allocation2012;10:4. [DOI: 10.1186/1478‐7547‐10‐4; PMC3323427; PUBMED: 22429892] ">Tekeste 2012</a>), and Bangladesh (<a href="./references#CD009000-bbs2-0124" title="PuettC , SadlerK , AldermanH , CoatesJ , FiedlerJL , MyattM . Cost‐effectiveness of the community‐based management of severe acute malnutrition by community health workers in southern Bangladesh. Health Policy and Planning2013;28(4):386‐99. [DOI: 10.1093/heapol/czs070; PUBMED: 22879522] ">Puett 2013</a>), took a societal perspective in their cost‐effectiveness analysis, comparing facility‐based treatment to community‐based treatment. In Ethiopia, RUTF contributed 43.2% to the cost of CMAM whereas in Bangladesh, it was 24%. The authors ascribed the relatively low contribution of RUTF to total costs to the high management costs incurred. The incremental cost of death averted with CMAM in Bangladesh was USD 869 and DALY averted was USD 26; this was significantly less than with inpatient care. </p> <p>In India, Garg and colleagues conducted a costing analysis of three feeding regimens (two different types of RUTFs and energy‐dense, home‐prepared food as per <a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a>), for home‐based management of children with uncomplicated SAM (<a href="./references#CD009000-bbs2-0086" title="GargCC , MazumderS , TanejaS , ShekharM , MohanSB , BoseA , et al. Costing of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition from a randomised trial in India. BMJ Global Health2018;3:e000702. [DOI: 10.1136/bmjgh‐2017‐000702] ">Garg 2018</a>). The authors estimated the average cost per treated child in the government setting to be USD 56 (&lt; INR 3500). RUTF contributed about 65% of this total CMAM cost. </p> <p>In rural Mali, <a href="./references#CD009000-bbs2-0126" title="RogersE , MartínezK , MoránJL , AléFG , CharleP , GuerreroS , et al. Cost‐effectiveness of the treatment of uncomplicated severe acute malnutrition by community health workers compared to treatment provided at an outpatient facility in rural Mali. Human Resources for Health2018;16(1):12. [DOI: 10.1186/s12960‐018‐0273‐0; PMC5819265; PUBMED: 29458382] ">Rogers 2018</a> assessed costs and cost‐effectiveness of community health worker (CHW)‐delivered care and found that CHW‐delivered care amounted to approximately half the cost per child treated (USD 244 versus USD 442) and recovered (USD 259 versus USD501) compared to outpatient facility‐based care. </p> <p>The data available indicates that CMAM is more cost‐effective than facility‐based treatment of uncomplicated SAM, despite the relatively high cost of RUTF. </p> </section> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009000-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Diagram depicting our review question and main subgroup analysis" data-id="CD009000-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Diagram depicting our review question and main subgroup analysis</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow diagram of search for effectiveness section of the review" data-id="CD009000-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>PRISMA flow diagram of search for effectiveness section of the review</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies" data-id="CD009000-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD009000-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of Comparison 1. Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, outcome: 1.1 recovery during intervention" data-id="CD009000-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of Comparison 1. Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, outcome: 1.1 recovery during intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of Comparison 3. Standard RUTF versus RUTF using an alternative formulation, outcome: 3.1 recovery during intervention" data-id="CD009000-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of Comparison 3. Standard RUTF versus RUTF using an alternative formulation, outcome: 3.1 recovery during intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 1 Recovery during intervention." data-id="CD009000-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 1 Recovery during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 2 Recovery during intervention: pre‐trial hospitalisation subgroups." data-id="CD009000-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 2 Recovery during intervention: pre‐trial hospitalisation subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 3 Recovery at follow‐up." data-id="CD009000-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 3 Recovery at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 4 Relapse during intervention." data-id="CD009000-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 4 Relapse during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 5 Relapse during intervention: pre‐trial hospitalisation subgroups." data-id="CD009000-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 5 Relapse during intervention: pre‐trial hospitalisation subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 6 Relapse during intervention: factory‐ versus local site‐produced subgroups." data-id="CD009000-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 6 Relapse during intervention: factory‐ versus local site‐produced subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 7 Relapse during intervention: HIV status subgroups." data-id="CD009000-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 7 Relapse during intervention: HIV status subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 8 Relapse at follow‐up." data-id="CD009000-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 8 Relapse at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 9 Mortality during intervention." data-id="CD009000-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 9 Mortality during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 10 Mortality during intervention: pre‐trial hospitalisation subgroups." data-id="CD009000-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 10 Mortality during intervention: pre‐trial hospitalisation subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 11 Rate of weight gain (g/kg/day) during intervention." data-id="CD009000-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 11 Rate of weight gain (g/kg/day) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 12 Rate of weight gain (g/kg/day) during intervention: pre‐trial hospitalisation subgroups." data-id="CD009000-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 12 Rate of weight gain (g/kg/day) during intervention: pre‐trial hospitalisation subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 13 Rate of weight gain (g/kg/day) during intervention: factory‐ versus local site‐produced subgroups." data-id="CD009000-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 13 Rate of weight gain (g/kg/day) during intervention: factory‐ versus local site‐produced subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 14 Rate of weight gain (g/kg/day) during intervention: HIV status subgroups." data-id="CD009000-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 14 Rate of weight gain (g/kg/day) during intervention: HIV status subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 15 Time to recovery (days) during intervention." data-id="CD009000-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 15 Time to recovery (days) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 16 Weight‐for‐height z score (WHZ) during intervention." data-id="CD009000-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 16 Weight‐for‐height z score (WHZ) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 17 WHZ at follow‐up." data-id="CD009000-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 17 WHZ at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 18 Length/height gain (mm/day) during intervention." data-id="CD009000-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 18 Length/height gain (mm/day) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 19 Height‐for‐age z score (HAZ) at follow‐up." data-id="CD009000-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 19 Height‐for‐age z score (HAZ) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 20 Mid‐upper arm circumference (MUAC) gain (mm/day) during intervention." data-id="CD009000-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 20 Mid‐upper arm circumference (MUAC) gain (mm/day) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 21 MUAC gain (cm) at follow‐up." data-id="CD009000-fig-0027" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 21 MUAC gain (cm) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 22 Diarrhoea events during intervention." data-id="CD009000-fig-0028" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 22 Diarrhoea events during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 23 Days of diarrhoea during intervention." data-id="CD009000-fig-0029" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 23 Days of diarrhoea during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 24 Acceptability." data-id="CD009000-fig-0030" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach, Outcome 24 Acceptability. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 1 Recovery during intervention." data-id="CD009000-fig-0031" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 1 Recovery during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 2 Relapse during intervention." data-id="CD009000-fig-0032" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 2 Relapse during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 3 Mortality during intervention." data-id="CD009000-fig-0033" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 3 Mortality during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 4 Rate of weight gain (g/kg/day) during intervention." data-id="CD009000-fig-0034" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 4 Rate of weight gain (g/kg/day) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 5 Time to recovery (days) during intervention." data-id="CD009000-fig-0035" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 5 Time to recovery (days) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 6 WHZ at follow‐up." data-id="CD009000-fig-0036" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 6 WHZ at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 7 Length/height gain (mm/day) during intervention." data-id="CD009000-fig-0037" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 7 Length/height gain (mm/day) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 8 MUAC gain (mm/day) during intervention." data-id="CD009000-fig-0038" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet, Outcome 8 MUAC gain (mm/day) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 1 Recovery during intervention." data-id="CD009000-fig-0039" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 1 Recovery during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 2 Recovery during intervention: pre‐trial hospitalisation subgroups." data-id="CD009000-fig-0040" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 2 Recovery during intervention: pre‐trial hospitalisation subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 3 Relapse during intervention." data-id="CD009000-fig-0041" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 3 Relapse during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 4 Relapse during intervention: pre‐trial hospitalisation subgroups." data-id="CD009000-fig-0042" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 4 Relapse during intervention: pre‐trial hospitalisation subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 5 Mortality during intervention." data-id="CD009000-fig-0043" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 5 Mortality during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 6 Mortality during intervention: pre‐trial hospitalisation subgroups." data-id="CD009000-fig-0044" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 6 Mortality during intervention: pre‐trial hospitalisation subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 7 Rate of weight gain (g/kg/day) during intervention." data-id="CD009000-fig-0045" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 7 Rate of weight gain (g/kg/day) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 8 Rate of weight gain (g/kg/day) during intervention: pre‐trial hospitalisation subgroups." data-id="CD009000-fig-0046" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 8 Rate of weight gain (g/kg/day) during intervention: pre‐trial hospitalisation subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 9 Rate of weight gain (g/kg/day) during intervention: different types of control RUTF subgroups." data-id="CD009000-fig-0047" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 9 Rate of weight gain (g/kg/day) during intervention: different types of control RUTF subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 10 Time to recovery (days) during intervention." data-id="CD009000-fig-0048" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 10 Time to recovery (days) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 11 WHZ during intervention." data-id="CD009000-fig-0049" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 11 WHZ during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 12 WHZ during intervention: pre‐trial hospitalisation subgroups." data-id="CD009000-fig-0050" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 12 WHZ during intervention: pre‐trial hospitalisation subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 13 WHZ during intervention: different types of control RUTF subgroups." data-id="CD009000-fig-0051" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 13 WHZ during intervention: different types of control RUTF subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 14 WHZ during intervention." data-id="CD009000-fig-0052" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 14 WHZ during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 15 Length/height gain (mm/day) during intervention." data-id="CD009000-fig-0053" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 15 Length/height gain (mm/day) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 16 Length/height gain (mm/day) during intervention: pre‐trial hospitalisation subgroups." data-id="CD009000-fig-0054" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 16 Length/height gain (mm/day) during intervention: pre‐trial hospitalisation subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 17 Length/height gain (mm/day) during intervention: different types of control RUTF subgroups." data-id="CD009000-fig-0055" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.17</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 17 Length/height gain (mm/day) during intervention: different types of control RUTF subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 18 HAZ during intervention." data-id="CD009000-fig-0056" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.18</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 18 HAZ during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 19 MUAC gain (mm/day) during intervention." data-id="CD009000-fig-0057" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.19</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 19 MUAC gain (mm/day) during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 20 MUAC gain (mm/day) during intervention: pre‐trial hospitalisation subgroups." data-id="CD009000-fig-0058" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.20</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 20 MUAC gain (mm/day) during intervention: pre‐trial hospitalisation subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 21 MUAC gain (mm/day) during intervention: different types of control RUTF subgroups." data-id="CD009000-fig-0059" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.21</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 21 MUAC gain (mm/day) during intervention: different types of control RUTF subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 22 Diarrhoea events during intervention." data-id="CD009000-fig-0060" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.22</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 22 Diarrhoea events during intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 23 Acceptability on first day of intervention." data-id="CD009000-fig-0061" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.23</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 23 Acceptability on first day of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 24 Acceptability: grams of food remained after taste test." data-id="CD009000-fig-0062" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.24</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 24 Acceptability: grams of food remained after taste test. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009000-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/urn:x-wiley:14651858:media:CD009000:CD009000-CMP-003-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_t/tCD009000-CMP-003-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 25 Acceptability after first 2 weeks of treatment." data-id="CD009000-fig-0063" src="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.25</div> <div class="figure-caption"> <p>Comparison 3 Standard RUTF versus RUTF using an alternative formulation, Outcome 25 Acceptability after first 2 weeks of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/media/CDSR/CD009000/image_n/nCD009000-CMP-003-25.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009000-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children aged 6 months‐5 years with SAM (and mixed HIV comorbidity), some of whom had been stabilised as inpatients pre‐trial<br/> <b>Setting:</b> 3 studies conducted in India and 3 in Malawi; in 2 studies rehabilitation started in hospital, but in most cases, across all studies, the rehabilitation phase occurred at home<br/> <b>Experimental intervention:</b> standard RUTF formulations, produced either in a factory or local site kitchens, and meeting total daily nutritional requirements<br/> <b>Control intervention:</b> alternative dietary approaches: caregiver‐prepared locally available foods, some of which were fortified and energy dense </p> <p><b>Intervention duration:</b> 8‐16 weeks across studies </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with alternative dietary approaches</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard RUTF meeting total daily requirements</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recovery during intervention</b> </p> <p>defined as achieving WHZ ≥ −2 and absence of oedema in 1 study; reaching a WHZ score &gt; −2 and without oedema in 1 study; WHZ &gt; −2 in 1 study; having a WHZ score ≥ 0 in 1 study; reaching 100% weight for height in 1 study; and reaching 115% of baseline weight in 1 study </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.33<br/> (1.16 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1852<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children are probably more likely to recover on standard RUTF</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>391 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>521 per 1000</b><br/> (454 to 603) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Relapse during intervention</b> </p> <p>defined as admission to inpatient therapeutic care or recurrence of oedema or systematic infections during the study period, and dropouts during intervention period </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.55<br/> (0.30 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1505<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>b,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are uncertain whether standard RUTF decreases relapse</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>195 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>107 per 1000</b><br/> (59 to 197) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality during intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/> (0.51 to 2.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1505<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are uncertain whether standard RUTF decreases mortality</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>23 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 1000</b><br/> (12 to 50) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate of weight gain (g/kg/day) during intervention</b> </p> <p>3 studies measured weight gain during the first 4 weeks of the intervention period and 1 study until recovery or 16 weeks after enrolment, whichever was earlier </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the control groups was <b>2.76 g/kg/day</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the intervention groups was, on average,<b>1.12g/kg/day higher</b> (0.27 higher to 1.96 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1450<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standard RUTF may increase the rate of weight gain slightly</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>RUTF:</b> ready‐to‐use therapeutic food; <b>SAM: s</b> evere acute malnutrition; <b>WHZ:</b> weight‐for‐age z score </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for risk of bias: three studies judged to have a high risk of selection bias, and one study judged to have a high risk of attrition and other bias.<br/> <sup>b</sup>Downgraded by one level for indirectness: significant difference between subgroups based on whether all or some children were stabilised in hospital before the trial.<br/> <sup>c</sup>Downgraded by one level for risk of bias: three studies judged to have a high risk of selection bias.<br/> <sup>d</sup>Downgraded by one level for inconsistency: I<sup>2</sup> statistic is more than 50%.<br/> <sup>e</sup>Downgraded by one level for imprecision: 95% CI includes both an important benefit and harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009000-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children aged 6 months‐5 years with SAM (1 study included HIV‐uninfected children; 1 study included HIV‐infected children), all of whom had been stabilised as inpatients pre‐trial.<br/> <b>Setting:</b> both studies conducted in Malawi, with rehabilitation at home<br/> <b>Experimental intervention:</b> standard RUTF formulation, produced in a factory, and meeting total daily nutritional requirements<br/> <b>Control intervention:</b> a similar RUTF to that used as the experimental intervention, but given as a supplement to the usual diet </p> <p><b>Intervention duration:</b> 16 weeks in 1 study; undefined duration in 1 study </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RUTF supplement</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard RUTF formulation meeting total daily requirements</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recovery during intervention</b> </p> <p>defined as WHZ &gt; 0 in 1 study; 100% weight for height in 1 study</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.41<br/> (1.19 to 1.68) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>210<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a,b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Children may be more likely to recover on standard RUTF in amounts meeting total daily nutritional requirements </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>582 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>821 per 1000</b><br/> (693 to 978) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Relapse during intervention</b> </p> <p>defined as admission to inpatient therapeutic care or recurrence of oedema or systematic infections during the study period, and dropouts during intervention period </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.11<br/> (0.01 to 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>210<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a,b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Standard RUTF meeting total daily nutritional requirements may decrease relapse</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>107 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b><br/> (1 to 91) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality during intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.36<br/> (0.46 to 4.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>210<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low<sup>a,b,c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are uncertain whether standard RUTF meeting total daily nutritional requirements decreases mortality </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b><br/> (23 to 199) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate of weight gain (g/kg/day) during intervention</b> </p> <p>defined as change between baseline and week 4 of the intervention period</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the control groups was <b>3.05 g/kg/day</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the intervention groups was, on average, <b>1.21 g/kg/day higher</b> (0.74 lower to 3.16 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low<sup>a,c,d,e</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are uncertain whether standard RUTF meeting total daily nutritional requirements increases the rate of weight gain </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>RUTF:</b> ready‐to‐use therapeutic food; <b>SAM: s</b> evere acute malnutrition; <b>WHZ:</b> weight‐for‐age z score </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for risk of bias: high risk of selection and attrition bias.<br/> <sup>b</sup>Downgraded by one level for indirectness: the two studies were conducted in the same country.<br/> <sup>c</sup>Downgraded by one level for imprecision: 95% CI includes both an important benefit and harm.<br/> <sup>d</sup>Downgraded by one level for imprecision: 95% CI includes both an important benefit and harm, and the total sample size is smaller than the optimal information size.<br/> <sup>e</sup>Downgraded by one level for inconsistency: I<sup>2</sup> statistic more than 50%; subgrouped for HIV‐status as one study included only HIV‐uninfected children (RR 2.1, 95% CI 1.12 to 3.08) and the other study included only HIV‐infected children (RR 0.1, 95% CI −1.53 to 3.16). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Standard ready‐to‐use therapeutic food (RUTF) provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009000-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Standard ready‐to‐use therapeutic food (RUTF) versus RUTF using an alternative formulation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Standard ready‐to‐use therapeutic food (RUTF) versus RUTF using an alternative formulation</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children aged 6 months‐5 years with SAM (and mixed HIV comorbidity), some of whom had been stabilised as inpatients pre‐trial<br/> <b>Setting:</b> 4 studies conducted in Malawi, 1 in Zambia, 1 in Kenya and 1 in Cambodia; although in 2 studies, some or all children started rehabilitation in hospital and much of the rehabilitation phase across all studies occurred at home<br/> <b>Experimental intervention:</b> standard RUTF formulations, produced either in a factory or local site kitchens, and meeting total daily nutritional requirements<br/> <b>Control intervention:</b> RUTF with alternative ingredients, produced in a factory </p> <p><b>Intervention duration:</b> 8‐16 weeks across studies </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RUTF with alternative ingredients</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RUTF with standard ingredients (peanut‐ and milk‐based)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recovery during intervention</b> </p> <p>defined as weight gain ≥ 15% in relation to baseline weight, absence of complications and oedema, and MUAC &gt; 110 mm in 2 studies; MUAC &gt; 12.4 cm without oedema in 1 study; WHZ ≥ 80% for two consecutive visits in 1 study; WHZ &gt; −2 and no oedema in 1 study; and not defined in 1 study </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.99 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4188<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Makes little or no difference whether standard or alternative recipe formulation RUTF is used for recovery </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>717 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>738 per 1000</b><br/> (710 to 774) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Relapse during intervention</b> </p> <p>defined as admission to inpatient therapeutic care, remain wasted, and dropouts during intervention period </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.84<br/> (0.72 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4188<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Standard, factory‐produced RUTF meeting total daily nutritional requirements decreases relapse slightly </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>137 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>115 per 1000</b><br/> (99 to 135) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality during intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.80 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4309<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>It probably makes little or no difference to mortality whether standard or alternative recipe formulation RUTF is used </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b><br/> (68 to 106) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate of weight gain (g/kg/day) during intervention</b> </p> <p>defined as change over first 4, 8, 10, 16 weeks of the intervention period in 4 studies; change until end of intervention period (no maximum number of weeks applied) in 1 study; and regression analysis with adjustment over the entire study in 1 study </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the control groups was <b>2.6 g/kg/day</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean rate of weight gain during intervention in the intervention groups was, on average, <b>0.11 g/kg/day higher</b><br/> (0.32 lower to 0.54 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3807<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a,b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It may make little or no difference in the rate of weight gain whether standard or alternative recipe formulation RUTF is used </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>MUAC:</b> mid‐upper arm circumference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>RUTF:</b> ready‐to‐use therapeutic food; <b>SAM: s</b> evere acute malnutrition; <b>WHZ:</b> weight‐for‐age z score </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for imprecision: the 95% CI includes both an important benefit and harm.<br/> <sup>b</sup>Downgraded by one level for inconsistency: I<sup>2</sup> statistic more than 50%. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Standard ready‐to‐use therapeutic food (RUTF) versus RUTF using an alternative formulation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009000-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Classification of severe acute malnutrition in children under 60 months old by Collins and colleagues in 2006*</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severe acute malnutrition with complications</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severe acute malnutrition without complications</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral pitting oedema grade 3<sup>a</sup> (severe oedema) </p> <p>OR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MUAC &lt; 115<sup>b</sup> mm </p> <p>OR</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MUAC &lt; 115<sup>b</sup> mm and bilateral pitting oedema grades 1<sup>a</sup> or 2<sup>a</sup> (marasmic kwashiorkor) </p> <p>OR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral pitting oedema grades 1<sup>a</sup> or 2<sup>a</sup> with MUAC ≥ 115<sup>b</sup> mm </p> <p>AND</p> <p> <ol id="CD009000-list-0001"> <li> <p>Appetite</p> </li> <li> <p>Clinically well</p> </li> <li> <p>Alert</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MUAC &lt; 110<sup>b</sup> mm or bilateral pitting oedema grades 1<sup>a</sup> or 2<sup>a</sup> </p> <p>AND 1 of the following</p> <p> <ol id="CD009000-list-0002"> <li> <p>Anorexia</p> </li> <li> <p>Lower‐respiratory tract infection<sup>c</sup> </p> </li> <li> <p>Severe palmar pallor</p> </li> <li> <p>High fever</p> </li> <li> <p>Severe dehydration</p> </li> <li> <p>Not alert</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>↓</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>↓</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient care IMCI/WHO protocol</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient therapeutic care protocols</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>IMCI:</b> Integrated Management of Childhood Illness; <b>MUAC:</b> mid‐upper arm circumference; <b>UNICEF:</b> United Nations Children's Fund; <b>WHO:</b> World Health Organization </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p><sup>*</sup><a href="./references#CD009000-bbs2-0079" title="CollinsS , DentN , BinnsP , BahwereP , SadlerK , HallamA . Management of severe acute malnutrition in children. Lancet2006;368(9551):1992‐2000. [DOI: 10.1016/S0140‐6736(06)69443‐9; PUBMED: 17141707] ">Collins 2006a</a> </p> <p><sup>a</sup>Grade 1: mild oedema on both feet or both ankles; Grade 2: moderate oedema on both feet, and on lower legs, hands or lower arms; Grade 3: severe generalised oedema affecting feet, legs, hands, arms and face.<br/> <sup>b</sup>Both the WHO and UNICEF recommend that the cut‐off value for the MUAC for severe acute malnutrition is 115 mm (<a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009</a>). Previously it was 110 mm (<a href="./references#CD009000-bbs2-0079" title="CollinsS , DentN , BinnsP , BahwereP , SadlerK , HallamA . Management of severe acute malnutrition in children. Lancet2006;368(9551):1992‐2000. [DOI: 10.1016/S0140‐6736(06)69443‐9; PUBMED: 17141707] ">Collins 2006a</a>). The adoption of this higher cut‐off value will sharply increase the caseloads, which may influence the cost of nutrition programmes greatly (<a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009</a>). However, detecting more children as severely malnourished earlier will lead to a shorter treatment period, which may bring down the cost per child (<a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009</a>).<br/> <sup>c</sup>IMCI criteria: 60 respirations/min for children aged &lt; 2 months; 50 respirations/min for children aged 2 to 12 months; 40 respirations/min for children aged 1 to 5 years; 30 respirations/min for children aged &gt; 5 years. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Classification of severe acute malnutrition in children under 60 months old by Collins and colleagues in 2006*</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009000-tbl-0005"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Nutritional composition of ready‐to‐use therapeutic food, as recommended by the World Health Organizationa </span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Nutritional element</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Amount</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moisture content</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.5% maximum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Energy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>520‐550 kCal/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10%‐12% total energy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lipids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45%‐60% total energy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sodium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>290 mg/100 g maximum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Potassium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1110‐1400 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Calcium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300‐600 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phosphorus (excluding phytate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>300‐600 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Magnesium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80‐140 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10‐14 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Zinc</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11‐14 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Copper</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4‐1.8 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selenium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20‐40 μg</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70‐140 μg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.8‐1.1 mg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15‐20 μg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin E</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin K</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 to 30 μg/100 g</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin B1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin B2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.6 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin B6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vitamin B12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.6 μg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Folic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200 μg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Niacin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pantothenic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 mg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Biotin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 μg/100 g minimum</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n‐6 fatty acids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3%‐10% of total energy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n‐3 fatty acids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3%‐2.5% of total energy</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD009000-bbs2-0151" title="World Health Organization, World Food Programme, United Nations System Standing Committee on Nutrition (UNSCN), United Nations Children's Fund(UNICEF) . Community‐based management of severe acute malnutrition. www.who.int/nutrition/topics/Statement_community_based_man_sev_acute_mal_eng.pdf (accessed 20 May 2013). ">WHO/WFP/UNSCN/UNICEF 2007</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Nutritional composition of ready‐to‐use therapeutic food, as recommended by the World Health Organizationa </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009000-tbl-0006"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">A typical recipe for a WHO‐recommended ready‐to‐use therapeutic fooda </span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ingredient</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>% weight</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Full‐fat milk</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sugar</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vegetable oil</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peanut butter<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mineral‐vitamin mix</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.6</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD009000-bbs2-0117" title="ManaryMJ . Local production and provision of ready‐to‐use therapeutic food (RUTF) spread for the treatment of severe childhood malnutrition. Food and Nutrition Bulletin2006;27(3 Suppl):S83‐9. [DOI: 10.1177/15648265060273S305; PUBMED: 17076214] ">Manary 2006</a><br/> <sup>b</sup>Strict quality control is essential. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">A typical recipe for a WHO‐recommended ready‐to‐use therapeutic fooda </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009000-tbl-0007"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Nutritional information of Plumpy'nut® by Collins and Henry in 2004*</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nutrient</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unit</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Plumpy'nut® (100 g)</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Energy<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>kCal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>530</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Energy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>kJ</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2218</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Protein</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14.5 (11% of product's energy)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Carbohydrate<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43 (32% of product's energy)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fat</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.5 (57% of product's energy)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ash</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moisture</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>g</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 5</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Water activity</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>a<sub>w</sub> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.241</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Copper</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.7</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zinc</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calcium</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>310</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sodium</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 290</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Magnesium</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mg/kg</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.45</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><sup>*</sup><a href="./references#CD009000-bbs2-0078" title="CollinsS , HenryJ . Alternative RUTF formulations (special supplement 2). Community‐based Therapeutic Care2004;Suppl 2:35. [www.ennonline.net/fex/102/4‐3‐2] ">Collins 2004</a> </p> <p><sup>a</sup>Atwater factors used to calculate energy.<br/> <sup>b</sup>Carbohydrate is by difference assuming protein to be nitrogen multiplied by 6.25. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Nutritional information of Plumpy'nut® by Collins and Henry in 2004*</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009000-tbl-0008"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Severe acute malnutrition management as recommended by the WHO and UNICEFa </span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Independent additional criteria</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0005"> <li> <p>No appetite</p> </li> <li> <p>Medical complications</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0006"> <li> <p>Appetite</p> </li> <li> <p>No medical complications</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>↓</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>↓</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type of therapeutic feeding</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Facility‐based feeding</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community‐based feeding</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0007"> <li> <p>F75 (Phase 1)</p> </li> <li> <p>F100/RUTF (Phase 2)</p> </li> <li> <p>24‐hour medical care</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0008"> <li> <p>RUTF</p> </li> <li> <p>Basic medical care</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Discharge criteria (transition criteria from facility‐ to community‐based care)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0009"> <li> <p>Reduced oedema</p> </li> <li> <p>Good appetite (with acceptable<sup>b</sup> intake of RUTF) </p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD009000-list-0010"> <li> <p>15%‐20% weight gain</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>RUTF:</b> ready‐to‐use therapeutic food; <b>UNICEF:</b> United Nations Children's Fund; <b>WHO:</b> World Health Organization </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD009000-bbs2-0150" title="World Health Organization, United Nations Children'sFund . WHO child growth standards and the identification of severe acute malnutrition in infants and children: a joint statement. www.who.int/nutrition/publications/severemalnutrition/9789241598163/en/index.html (accessed 20 May 2013). ">WHO/UNICEF 2009</a><br/> <sup>b</sup>Children who eat at least 75% of their calculated RUTF ration for the day. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Severe acute malnutrition management as recommended by the WHO and UNICEFa </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009000-tbl-0009"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Classification of attrition from included studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants recruited (n)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pre‐randomisation attrition (n)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Immediate post‐randomisation attrition (n)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dropouts during the intervention period (n)</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] ">Bahwere 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>619</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 = allocated to an arm prior to randomisation</p> <p>1 = re‐admission (had SAM before and return from defaulting)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (all from the control group) = 3 had no baseline data and 2 were older than 59 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 = dropped out; reasons not reported</p> <p>7 = deaths; reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] ">Bhandari 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1190</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>193 = complicated SAM</p> <p>3 = allergic to animal milk</p> <p>29 = family moving away</p> <p>35 = non‐consent</p> <p>22 = siblings already enrolled</p> <p>2 = incorrectly identified as SAM</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48 = withdrew consent</p> <p>3 = moved away</p> <p>3 = deaths; reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1178 (includes children with MAM and SAM)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41 = reasons not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 = reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 = deaths; reasons not reported</p> <p>8 = lost to follow‐up; reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0005" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] ">Hsieh 2015b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unlikely</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2462</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>265 = not meeting eligibility criteria</p> <p>153 = required inpatient care</p> <p>70 = relapsed</p> <p>47 = refused</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>251 = deaths; reasons not reported</p> <p>543 = "defaulters"; 116 could be traced and 427 moved from the location</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] ">Jadhav 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1268</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>947 = reasons not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106 = dropped out over first 2 weeks; reasons not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>183 = dropped out; reasons not reported; deaths not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] ">Jones 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>236</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 = not residing in area</p> <p>33 = age not eligible</p> <p>23 = HIV‐infected</p> <p>19 = not SAM</p> <p>6 = treated for TB</p> <p>5 = already on lipid‐based supplements</p> <p>6 = discharged/screened before screening was finalised</p> <p>2 = previously enrolled in the study</p> <p>18 = refused</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><sup>b</sup>4 = deaths </p> <p><sup>b</sup>1 = ineligible </p> <p><sup>b</sup>5 = voluntarily withdrew; reasons not reported </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><sup>b</sup>4 = deaths; reasons not reported </p> <p><sup>b</sup>6 = voluntarily withdrew; reasons not reported </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] ">Kerac 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1024 (eligible age was 5 to 168 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>124 = deaths</p> <p>21 = absconded from ward</p> <p>13 = not SAM</p> <p>67 = refused</p> <p>4 = "other"</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><sup>b</sup>175 = deaths; reasons not reported </p> <p><sup>b</sup>53 = dropped out; outpatient defaulters or ward absconders; reasons not reported </p> <p><sup>b</sup>8 = "other"; transfers out or final outcome unknown </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a>* </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>452</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77 = refused</p> <p>93 = HIV infected</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 = deaths; reasons not reported</p> <p>47 = dropped out; reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 = deaths; reasons not reported</p> <p>17 = dropped outs; reasons not reported</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] ">Oakley 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1961</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87 = reasons not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64 = deaths; reasons not reported</p> <p>51 = lost to follow‐up; no reasons reported other than "those lost were more likely to be younger and marasmic" (quote) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] ">Shewade 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 = refused</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] ">Sigh 2018</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 = Down Syndrome</p> <p>1 = cerebral palsy</p> <p>1 = had a stoma</p> <p>1 = fever</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 = deaths; 1 related to HIV and 1 related to TB</p> <p>47 = dropped out, "mainly due to long traveling distances" (quote)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] ">Thapa 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 = sick</p> <p>5 = migrants</p> <p>3 = refused</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>MAM:</b> moderate acute malnutrition; <b>SAM:</b> severe acute malnutrition; <b>TB:</b> tuberculosis </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>For cluster‐randomised trials: actual values reported here (not adjusted for design effect).<br/> <sup>b</sup>Only data for relevant study arms/eligible study participants were reported here. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Classification of attrition from included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009000-tbl-0010"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">TIDieR table: Comparison 1</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0002" title="BhandariN , MohanSB , BoseA , IyengarSD , TanejaS , MazumderS , et al. Efficacy of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Global Health2016;1(4):e000144. [DOI: 10.1136/bmjgh‐2016‐000144] "><b>Bhandari 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] "><b>Ciliberto 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0007" title="JadhavA , DiasB , ShahN , FernandesL , FernandesS , SurveA , et al. A randomized controlled facility based trial to assess the impact of indigenously prepared ready to use therapeutic food (RUTF) for children with severe acute malnutrition in Inda. Pediatric Oncall2016;13(4):93‐8. [DOI: 10.7199/ped.oncall.2016.61] "><b>Jadhav 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] "><b>Manary 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] "><b>Ndekha 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0013" title="ShewadeHD , PatroBK , BhartiB , SoundappanK , KaurA , TanejaN . Effectiveness of indigenous ready‐to‐use therapeutic food in community‐based management of uncomplicated severe acute malnutrition: a randomized controlled trial from India. Journal of Tropical Pediatrics2013;59(5):393‐8. [DOI: 10.1093/tropej/fmt039; PUBMED: 23751252] "><b>Shewade 2013</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0015" title="ThapaBR , GoyalP , MenonJ , SharmaA . Acceptability and efficacy of locally produced ready‐to‐use therapeutic food Nutreal in the management of severe acute malnutrition in comparison with defined food. Food and Nutrition Bulletin2017;38(1):18‐26. [DOI: 10.1177/0379572116689743; PUBMED: 28125907] "><b>Thapa 2017</b> </a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study period and brief comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>October 2012 ‐ April 2015 Commercially‐ and non‐commercially produced S‐RUTF compared to energy‐dense, micronutrient‐enriched, locally available, home‐prepared foods. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>December 2002 ‐ June 2003. S‐RUTF, commercially produced, versus maize/soy flour prepared by caregivers as a porridge. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2011‐June 2013. S‐RUTF, non‐commercially produced, versus locally available, home‐prepared foods high in energy and protein. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January‐October 2001. S‐RUTF, factory produced, compared to caregiver‐prepared flour porridge (made from a maize and soy flour blend). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January‐September 2001. S‐RUTF, factory produced, compared to caregiver‐prepared flour porridge (made from a maize and soy flour blend). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2011. S‐RUTF, non‐commercially produced, "supplementary nutrition" (quote) and nutrition counselling versus "supplementary nutrition" (quote) and nutrition counselling. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>August 2013‐March 2014. S‐RUTF, non‐commercially produced, versus locally available foods precooked and packaged non‐commercially and prepared at home by caregivers. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Why?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐commercially produced RUTF may be less expensive and more sustainable in some countries. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>To investigate whether home‐based therapy with RUTF results in higher rates of recovery and lower rates of relapse or death than the (then) standard therapy in Malawi. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There is a need in India for "indigenously" (quote) produced RUTF.</p> <p>To investigate the efficacy of such RUTF in children with SAM when compared to "standard nutritional therapy" (quote). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the time the study started, the WHO recommended inpatient therapy until recovery for the treatment of children with SAM. For many families this was not feasible. </p> <p>To investigate the effects of home‐based RUTF compared to ample amounts of the local staple food (porridge) in HIV‐uninfected children with SAM. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the time the study started, the WHO recommended inpatient therapy until recovery for the treatment of children with SAM. For many families this was not feasible. </p> <p>To investigate the effects of home‐based RUTF compared to ample amounts of the local staple food (porridge) in HIV‐infected children (not on ARV) with SAM. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>To investigate the effectiveness of RUTF in therapeutic doses in community‐based management of uncomplicated SAM. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There is a need in India for "indigenously" (quote) produced RUTF equivalent to the WHO RUTF recommendations. </p> <p>The study authors carried out a preliminary study to investigate the acceptance and efficacy of such a RUTF among SAM children in informal settlements in India. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What educational materials were provided to caregivers? </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Government trained health educators and promoters visited families weekly, and used site‐specific counselling cards (of which the families received copies) in the local language to convey messages regarding frequency, amount and how to feed the study foods; as well as on continuing breastfeeding, good hygiene and advice on family meals. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All caregivers were counselled about nutritional requirements and good feeding practices. However, it is unclear who performed the counselling and whether caregivers received educational material. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children in both groups received weekly feeding counselling at the OTP site. Unclear if caregivers received counselling material. Study staff were 2 medical doctors, 1 social worker and "anganwadi workers" (quote) (community health workers); it is unclear who performed the nutrition counselling. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All study staff (2 nutritionists, 2 anthropometrists, 3 technical assistants, 3 "lady health workers" (quote), and "4 other helpers" (quote)) were trained regarding all aspects of the study. They were also instructed to guide the caregivers (of children in both groups) regarding the schedule, method and hygienic conditions of feeding; and the cooking of the control intervention to the relevant caregivers. It is unclear whether caregivers were provided with educational material. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What procedures?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications, or those with complications but who were stabilised first in hospital, were eligible. </p> <p>Follow‐up of those who dropped out of the study was not reported. However, health workers, peer supporters and community leaders were involved in the study and thus tracing of and motivating those who dropped out of the study was probably done. </p> <p>Health workers referred sick children, those whose WHZ did not improve in 4 weeks, and children who deteriorated for 2 consecutive weeks to physicians. Children with severe illness were admitted to hospital, and the study intervention was restarted after the child returned home. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All children from the maize/soy flour group and less than half of children from the RUTF group were stabilised in hospital pre‐trial. </p> <p>Children who failed to attend their follow‐up visits (3 weeks after their previous visit) were sought through local village health workers, to determine whether the child had died or relapsed. Children who relapsed exited the study and were treated as in‐patients. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All children were hospitalised for 2 weeks or longer based on their complications.</p> <p>Study staff did not carry out regular home visits, and it is not reported whether children who were lost to follow‐up were traced. It is also unclear whether children who deteriorated stayed in the study and were admitted to hospital. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM were eligible, after they were stabilised as inpatients.</p> <p>Study staff did not make home visits; children who were lost to follow‐up were not traced at home. </p> <p>Children who deteriorated were admitted to hospital.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM were eligible, after they were stabilised as inpatients.</p> <p>Study staff did not make home visits; children who got lost to follow‐up were not traced at home. </p> <p>Children who deteriorated were admitted to hospital.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications were eligible. Children who missed their weekly appointment at the OTP were followed up at their homes by Anganwadi workers. Children with complications were referred to inpatient care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications were eligible.</p> <p>It appears as if no children were lost to follow‐up, and that no children were admitted to hospital for complications. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Who provided the intervention?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trained health educators dispensed RUTF, and families of children in the comparison group were given raw ingredients to prepare foods. </p> <p>Caregivers at home fed the children, but neighbourhood peer support workers visited homes (of children across all 3 groups) several times a day to help caregivers feed their children. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is unclear who dispensed the RUTF to caregivers.</p> <p>The maize/soy flour was given in one 50 kg bag to caregivers. The flour intervention was supplemented with micronutrients. </p> <p>Caregivers at home fed their children.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not explicitly reported, but it seems as if RUTF was dispensed at the NRU. It is not clear who dispensed the RUTF or who dispensed the ingredients for the control diet. </p> <p>After hospital discharge, caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is not reported who dispensed the study interventions to the caregivers. Caregivers of children in the maize and soy flour group also received a micronutrient supplement to give to their children daily. </p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is not reported who dispensed the study interventions to the caregivers. Caregivers of children in the maize and soy flour group also received a micronutrient supplement to give to their children daily. </p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The RUTF dose per child was prescribed by a doctor and dispensed by study staff (including Anganwadi workers) at the OTP. </p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily, caregivers fed their children at home under supervision of nutritionists and "lady health visitors" (quote). Mothers were asked to feed their child as much as they could eat over half an hour. </p> <p>In both groups, nutritionists weighed the amount of food children needed to take daily.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>How was the intervention provided?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly, an independent trained team measured children's weight, height, MUAC, skinfold thickness and assessed for oedema on feet. It is not explicitly reported, but it seems that these measurements were done at the children's homes and not at a health facility's outpatient department. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 2 weeks, children were assessed at the NRU. Weight, length and MUAC were measured. It is unclear who did the measurements. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is unclear whether anthropometrical measurements (weight, length/height and MUAC) were done weekly or biweekly, and by whom. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 2 weeks, caregivers and children had to visit the outpatient department for anthropometrical measurements (weight, statural growth and MUAC) and "health assessment" (quote) ‐ it is unclear who performed these assessments. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 2 weeks, caregivers and children had to visit the outpatient department for anthropometrical measurements (weight, statural growth and MUAC) and "health assessment" (quote) ‐ it is unclear who performed these assessments. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly, at the OTP, the social worker measured the children's weight, length/height and MUAC. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weight was measured daily by "anthropometrists" (quote) at the children's homes. It is unclear how often measurements of length/height and MUAC were taken. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 diverse geographical settings in India, with a mix of rural and urban areas. The study populations were low‐income households, and most study activities took place at the families' homes. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The participating NRUs were mission and public facilities in small towns and rural areas of southern Malawi. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study was conducted at an urban health centre associated with a tertiary hospital in Mumbai, India. Most participants were from lower socio‐economic status backgrounds due to the centre's close proximity to a very large informal settlement. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients to NRU at the teaching hospital in Blantyre, Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients to NRU at the teaching hospital in Blantyre, Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OTP site at an urban health and training centre near a densely populated urban resettlement colony in Chandigarh, India. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 informal settlements in North India. Most study activities took place at the families' homes. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>When and how much?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In all groups, 175 kCal/kg/day of the interventions were dispensed weekly until recovery or a maximum of 16 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided as 175 kCal/kg/day and dispensed every 2 weeks until recovery or a maximum of 8 weeks. The control group were told to consume the flour porridge 7 times a day (portion sizes not reported). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once weekly, children across groups received their dietary intervention at 175 kCal/kg/day for 8 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The interventions were dispensed every 2 weeks, with the RUTF at 733 kJ/kg/day and the maize and soy flour blend at 2400 g raw product/day. Caregivers were instructed to feed the RUTF over the course of the day, while those in the control group were instructed to feed their children porridge 7 times/day, with the aim of reaching 1500 g of cooked porridge (about 733 kJ/kg/day) daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The interventions were dispensed every 2 weeks, with the RUTF at 733 kJ/kg/day and the maize and soy flour blend at 2400 g raw product per day. Caregivers were instructed to feed the RUTF over the course of the day, while those in the control group were instructed to feed their children porridge 7 times a day, with the aim of reaching 1500 g of cooked porridge (about 733 kJ/kg/day) daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children in the experimental group received RUTF at 200 kCal/kg/day weekly, in addition to "nutritional supplementation" (quote) of 500 kcal and 12‐15 g protein per day, which all children received. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both diets were dispensed daily.</p> <p>The RUTF provided 2280 kJ/100 g, with protein 15.7% of product, while the control diet provided from 1556 kJ to 1887 kJ/100 g, with protein from 6.8% to 13.6% of product. </p> <p>Children from both groups could consume as much as they wanted, and were offered the foods 6 times/day. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tailoring?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Modifications of intervention throughout the trial?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In the original protocol, the intervention duration was set at 8 weeks. However, after 20 children were enrolled and an independent Data Safety Monitoring Board reviewed their results, they recommended that the intervention period be extended for another 8 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The intervention foods were continued for 6 weeks. Since these were liked by the children, these were extended for 2 weeks more" (quote). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Strategies to improve/maintain intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Consumption data for children in the 2 RUTF groups were collected weekly by trained health educators, as were the amounts of ingredients used for children in the control group. The total amount of calories consumed could only be estimated for the RUTF groups. </p> <p>Study authors reported that, in addition to providing the diets, extra support for feeding seems important in their setting. Enhanced engagement and sharing of skills of local, experienced women (peer supporters) seemed to improve children's food intake. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The intake of RUTF, but not the control diet, was monitored. However, detail regarding this was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No measurements of home dietary intake were conducted.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No measurements of home dietary intake were conducted.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is unclear what the children's adherence to the "nutritional supplementation" (quote) was, which both groups received. </p> <p>"Objective assessment of RUTF compliance was done by noting down the amount of RUTF consumed in previous week" (quote). However, it is unclear who of the study staff collected data on RUTF adherence. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily, after the meals, study staff (presumably nutritionists as they weighed the portions for the meals) weighed the leftover food. The amount of food consumed daily was then estimated and recorded. </p> <p>Intake of energy and protein was calculated from the amount of food eaten daily, throughout the study period. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Extent of intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "The mean (SD) amount of RUTF‐L [con‐commercial] consumed was<br/> 193.27 (94.03) g/day and RUTF‐C [commercial] 172.83 (89.10). The<br/> mean (SD) kcal/kg/day consumed was 140.19 (65.41)<br/> and 129.69 (65.09), respectively. Consumption was not<br/> measured in the A‐HPF [control] group" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study authors reported that children in the RUTF group consumed significantly more food, energy and protein in comparison to the control group (P &lt; 0.001). </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><b>A‐HPF:</b> augmented energy‐dense home‐prepared foods; <b>ARV:</b> antiretroviral therapy; <b>MUAC:</b> mid‐upper arm circumference; <b>NRU:</b> Nutritional Rehabilitation Unit; <b>OTP:</b> outpatient therapeutic programme; <b>RUTF:</b> Ready‐to‐use therapeutic food; <b>RUTF‐C:</b> commercially produced ready‐to‐eat therapeutic food; <b>RUTF‐L:</b> locally produced ready‐to‐eat therapeutic food; <b>S‐RUTF:</b> standard ready‐to‐use therapeutic food; <b>SAM:</b> severe acute malnutrition; <b>SD:</b> standard deviation; <b>WHO:</b> World Health Organization; <b>WHZ:</b> weight‐for‐height z score </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">TIDieR table: Comparison 1</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009000-tbl-0011"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">TIDieR table: Comparison 2</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] "><b>Manary 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] "><b>Ndekha 2005</b> </a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study period and brief comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January‐October 2001.</p> <p>S‐RUTF (factory‐produced), at a dose that met total daily nutritional requirements compared to a similar RUTF given as a supplement to the habitual diet. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January‐September 2001.</p> <p>S‐RUTF (factory‐produced) compared to caregiver‐prepared flour porridge (made from a maize and soy flour blend). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Why?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the time the study started, the WHO recommended inpatient therapy until recovery for the treatment of children with SAM. For many families this was not feasible. </p> <p>The study sought to investigate the effects of home‐based RUTF compared to a similar RUTF but given as a supplement in HIV‐uninfected children with SAM. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the time the study started, the WHO recommended inpatient therapy until recovery for the treatment of children with SAM. For many families this was not feasible. </p> <p>The study sought to investigate the effects of home‐based RUTF compared to a similar RUTF but given as a supplement in HIV‐infected children (who were not on ARV therapy) with SAM. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What educational materials were provided to caregivers? </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What procedures?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM were eligible for intervention after they were stabilised as inpatients.</p> <p>Study staff did not make home visits; children who were lost to follow‐up were not traced at home. </p> <p>Children who deteriorated during the study were admitted to hospital.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM were eligible for intervention after they were stabilised as inpatients.</p> <p>Study staff did not make home visits; children who got lost to follow‐up were not traced at home. </p> <p>Children who deteriorated during the study were admitted to hospital.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Who provided the intervention?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is not reported who dispensed the study interventions to the caregivers.</p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is not reported who dispensed the study interventions to the caregivers.</p> <p>Caregivers fed their children at home.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>How was the intervention provided?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 2 weeks, caregivers and their children had to visit the outpatient department for anthropometrical measurements (weight, statural growth and MUAC) and "health assessment" (quote) ‐ it is unclear who performed these assessments. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Every 2 weeks, caregivers and their children had to visit the outpatient department for anthropometrical measurements (weight, statural growth and MUAC) and "health assessment" (quote) ‐ it is unclear who performed these assessments. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients of the NRU at the teaching hospital in Blantyre, Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatients of the NRU, at the teaching hospital in Blantyre, Malawi.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>When and how much?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The interventions were dispensed every 2 weeks, with the RUTF at 733 kJ/kg/day and the RUTF supplement at 2090 kJ/day (about 92 g per child). Caregivers in the RUTF group were instructed to feed the RUTF over the course of the day, while those in the RUTF supplement group were instructed to give their children the RUTF in addition to their usual diet daily. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The interventions were dispensed every 2 weeks, with the RUTF at 733 kJ/kg/day and the RUTF supplement at 2090 kJ/day (about 92 g per child). Caregivers in the RUTF group were instructed to feed the RUTF over the course of the day, while those in the RUTF supplement group were instructed to give their children the RUTF in addition to their usual diet daily. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tailoring?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Modifications of intervention throughout the trial?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Strategies to improve/maintain intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No measurements of home dietary intake were conducted.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No measurements of home dietary intake were conducted.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Extent of intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured.</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><b>ARV:</b> antiretroviral therapy; <b>MUAC:</b> mid‐upper arm circumference; <b>NRU:</b> Nutritional Rehabilitation Unit; <b>RUTF:</b> Ready‐to‐use therapeutic food; <b>S‐RUTF:</b> standard ready‐to‐use therapeutic food; <b>SAM:</b> severe acute malnutrition; <b>WHO:</b> World Health Organization </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">TIDieR table: Comparison 2</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009000-tbl-0012"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">TIDieR table: Comparison 3</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0001" title="BahwereP , BandaT , SadlerK , NyirendaG , OwinoV , ShabaB , et al. Effectiveness of milk whey protein‐based ready‐to‐use therapeutic food in treatment of severe acute malnutrition in Malawian under‐5 children: a randomised, double‐blind, controlled non‐inferiority clinical trial. Maternal &amp; Child Nutrition2014;10(3):436‐51. [DOI: 10.1111/mcn.12112; PUBMED: 24521353] "><b>Bahwere 2014</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0004" title="HsiehJ‐C , LiuL , ZeilaniM , IckesS , TrehanI , MaletaK , et al. High‐oleic ready‐to‐use therapeutic food maintains docosahexaenoic acid status in severe malnutrition. Journal of Pediatric Gastroenterology and Nutrition2015;61(1):138‐43. [DOI: 10.1097/MPG.0000000000000741; PMC4483140; PUBMED: 25633498] "><b>Hsieh 2015a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] "><b>Irena 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0008" title="JonesKD , AliR , KhasiraMA , OderaD , WestAL , KosterG , et al. Ready‐to‐use therapeutic food with elevated n‐3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial. BMC Medicine2015;13:93. [DOI: 10.1186/s12916‐015‐0315‐6; PMC4407555; PUBMED: 25902844] "><b>Jones 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0009" title="KeracM . Improving the Treatment of Severe Acute Malnutrition in Childhood: A Randomized Controlled Trial of Synbiotic‐enhanced Therapeutic Food with Long Term Follow‐up of Post‐treatment Mortality and Morbidity [Doctoral thesis]. London (UK): University College London, 2011. [discovery.ucl.ac.uk/1306755/] KeracM , BunnJ , SealA , ThindwaM , TomkinsA , SadlerK , et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double‐blind efficacy randomised controlled trial in Malawi. Lancet2009;374(9684):136‐44. [DOI: 10.1016/S0140‐6736(09)60884‐9; PUBMED: 19595348] "><b>Kerac 2009</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0012" title="OakleyE , ReinkingJ , SandigeH , TrehanI , KennedyG , MaletaK , et al. A ready‐to‐use therapeutic food containing 10% milk is less effective than one with 25% milk in the treatment of severely malnourished children. The Journal of Nutrition2010;140(12):2248‐52. [DOI: 10.3945/jn.110.123828; PMC2981006; PUBMED: 20980648] "><b>Oakley 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0014" title="SighS , RoosN , ChamnanC , LaillouA , PrakS , WieringaFT . Effectiveness of a locally produced, fish‐based food product on weight gain among Cambodian children in the treatment of acute malnutrition: a randomized controlled trial. Nutrients2018;10(7):e909. [DOI: 10.3390/nu10070909; PMC6073612; PUBMED: 30012981] SighS , RoosN , SokD , BorgB , ChamnanC , LaillouA , et al. Development and acceptability of locally made fish‐based, ready‐to‐use products for the prevention and treatment of malnutrition in Cambodia. Food and Nutrition Bulletin2018;39(3):420‐34. [DOI: 10.1177/0379572118788266; PUBMED: 30092653 ] "><b>Sigh 2018</b> </a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study period and brief comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>March 2010‐March 2011RUTF prepared from whey protein concentrate versus S‐RUTF (prepared from dried skimmed milk). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>January‐May 2014RUTF with high oleic acid content versus S‐RUTF.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>June 2009‐August 2010Milk‐free soy‐maize‐sorghum based RUTF versus S‐RUTF.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>June 2012‐July 2013RUTF with elevated omega‐3 fatty acids versus S‐RUTF.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>July 2006‐March 2007RUTF with added pre‐ and probiotics versus S‐RUTF.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>July 2008‐April 2009RUTF containing 10% milk with soy versus S‐RUTF (25% milk).</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>September 2015‐January 2017Fish‐based RUTF versus S‐RUTF (BP100).</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Why?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dried skimmed milk is the most expensive component of RUTF. This study assessed the effectiveness of a RUTF using whey protein (a cheaper alternative) instead. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This study assessed the effect of a RUTF with high oleic acid content on plasma DHA and eicosapentaenoic acid status. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The milk content of S‐RUTF increases the cost. The use of alternative sources of protein will reduce the cost of RUTF. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Current RUTF formulations do not provide significant ALA or omega‐3 long chain polyunsaturated fatty acids. Previous studies have found low omega‐3 fatty acids levels in children recovering from SAM. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probiotics and prebiotics may be of benefit in SAM by correcting dysbiosis and improving intestinal function. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Milk is the most expensive component of RUTF. Reducing the milk content will reduce the cost of the RUTF. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There is low acceptability in Cambodia for the S‐RUTF Plumpy'nut® ; therefore, this study assessed the effects of RUTF made with locally‐available fish. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What educational materials were provided to caregivers? </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health and nutrition advice was provided once after enrolment in the study; unclear by whom and if materials were provided. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“…focused nutritional counselling and instructions on therapeutic feeding were provided by the nurses” (quote). Nurses were “experienced pediatric nutrition nurses” (quote). It is unclear if materials were provided to caregivers. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health and nutrition advice was provided as a one‐off after enrolment in the study; unclear by whom and if materials were provided. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers were told that no food should be consumed during the treatment period other than the RUTF or breast milk. It is unclear who conveyed this information to caregivers, and whether materials were provided. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Senior research nurses gave instruction on the administration and importance of RUTF, that no other foods were required and that the RUTF must not be mixed or diluted with porridge. It is unclear if this was done as a one off or regularly, and whether materials were provided. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers received general health and nutrition advice; unclear by whom and if materials were provided. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>What procedures?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications, or those with complications but who were stabilised first in hospital, were eligible. </p> <p>Defaulters (absent for 3 consecutive visits) were followed up by trained volunteers and invited back into the study. Children whose condition deteriorated as outpatients were referred to inpatient care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No children were stabilised in hospital before the study. Nothing reported on whether defaulters were traced or whether children with complications were referred to inpatient care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No children were stabilised in hospital before the study.</p> <p>Defaulters (absent for 3 consecutive visits) were</p> <p>followed up and invited back into the programme by trained volunteers. SAM children with complications were referred to inpatient care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications, or those with complications but who were stabilised first in hospital, were eligible. Participants’ homesteads were mapped </p> <p>and defaulters (definition not provided) were traced in the community. Participants who required </p> <p>ongoing inpatient care were reviewed by a member of</p> <p>the study team daily until discharge to the outpatient programme.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All children were stabilised in hospital with F‐75 for 2‐4 days and started RUTF as rehabilitation in hospital. Upon easily finishing at least 75% of their daily RUTF, they were discharged to continue rehabilitation at home. Defaulters (having missed 2 consecutive outpatient visits) were followed up by a mobile team. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No children were stabilised in hospital before the study. Children who remained wasted after 4 visits, or clinically worsened during outpatient treatment, were referred for inpatient care. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM and without complications, or those with complications but who were stabilised first in hospital, were eligible. Nothing reported on whether defaulters were traced. </p> <p>Participants who refused</p> <p>to eat the RUTF for &gt; 4 days/week over 2 consecutive weeks or who lost weight during 2 consecutive visits were excluded from the trial. </p> <p>Participants received an incentive after finishing the trial.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Who provided the intervention?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear who among the study staff (trained study nurses, nurses, CHW) dispensed the RUTF to caregivers. </p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear who dispensed the RUTF to caregivers.</p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear who among the study staff dispensed the RUTF to caregivers.</p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear who among the study staff dispensed the RUTF to caregivers.</p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear who among the study staff dispensed the RUTF to caregivers.</p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF was distributed by field assistants. Senior research nurses instructed caretakers on amount to feed. </p> <p>Caregivers fed their children at home.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study staff were a combination of trained doctors, nurses, midwives and Masters in nutrition students, but it is unclear who dispensed the RUTF to caregivers. </p> <p>Caregivers fed their children at home.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>How was the intervention provided?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly visits to the outpatient department. MUAC, oedema and weight were recorded and children were screened for medical problems, including appetite and RUTF side effects. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fortnightly visits to the outpatient department. Anthropometrical measurements were taken, and caregivers were asked about their child’s health status. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly visits to the outpatient department. MUAC, oedema and weight were recorded and children were screened for medical problems, including appetite and RUTF side effects. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly visits to the outpatient department during the first month, and monthly visits for the second and third month of the intervention period. MUAC, weight and length/height were probably measured. Monitoring for side effects or </p> <p>adverse events was conducted at all scheduled and unscheduled visits. (No information on unscheduled visits was reported.) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In hospital, trained staff used a pre‐piloted, standardised questionnaire to obtain caregiver‐reported clinical outcome indicators of children. During outpatient rehabilitation, this was collected at each 2‐weekly visit. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fortnightly visits to the outpatient department. Weight, length/height and MUAC were measured, and children were assessed for oedema. Caregivers were asked how many days in the last 2 weeks the child had had fever, cough, and diarrhoea. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fortnightly visits to the outpatient department; “all anthropometrical measures and oedema were assessed” (quote) and children were also screened for medical complications, including possible side effects of the RUTFs. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient treatment programmes in central Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient treatment programme in rural, southern Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient treatment programmes around Lusaka, Zambia.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An outpatient treatment programme at a hospital in coastal Kenya, where the majority of the community is involved in rural subsistence farming. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient and outpatient programmes in a large, urban teaching and referral hospital in Malawi. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient treatment programme in rural, southern Malawi.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At the national paediatric hospital in Cambodia and its outpatient programme.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>When and how much?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided at 175 kCal/kg and dispensed weekly until recovery or maximum 4 months of intervention. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided at 175 kCal/kg/day (735 kJ/kg/day) and dispensed every 2 weeks until recovery or a maximum of 12 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided at 200 kCal/kg/day and dispensed every week until recovery (no maximum intervention period specified). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided as per national Kenyan guidelines and dispensed once a week for the first month and then once a month for the other 2 months until recovery or a maximum of 84 days. Children who recovered before day 84 were given 50% of the therapeutic dose (to be taken alongside family foods) until day 84. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided at 200 kCal/kg/day and dispensed every second week until recovery or a maximum of 5 visits (about 10 weeks). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided as 175 kCal/kg/day and dispensed every 2 weeks until recovery or a maximum of 8 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF provided at 160‐180 kCal/kg/day and dispensed every 2 weeks until recovery or a maximum of 8 weeks. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tailoring?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the child was still hungry, additional RUTF was offered.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adjustment of the RUTF dose reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Modifications of intervention throughout the trial?</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In May 2013, provision of all study RUTF was stopped due to peroxidation of the control group's F‐RUTF. The children who were still on RUTF at that time were switched to S‐RUTF supplied by Kenya's Ministry of Health. All of these participants were followed up for the full study duration and included in the intention‐to‐treat analyses. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If children did not eat the RUTF to which they were assigned, they were offered the alternative RUTF. This happened in both groups, with 2/61 children from the experimental group and 1/60 child from the control group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Strategies to improve/maintain intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers were interviewed at each visit on the acceptability of the RUTF, and whether the child had eaten a RUTF formulation other than the one that they had been allocated. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twins were given a RUTF ration to limit sharing. Also, where there were study participants from the same household, they received the same food to prevent contamination of the allocated RUTF. </p> <p>At every visit, caregivers were asked about their child’s feeding habits (no more detail provided). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers were interviewed at each visit on the acceptability of the RUTF, and whether the child had eaten a RUTF formulation other than the one that they had been allocated. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence was monitored by interviews with caregivers and counting full and empty sachets of RUTF. Adherence was calculated according to “'full ration’ taking account of the participant’s weight and stage of treatment” (quote). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers reported on adherence and non‐sharing to trained staff.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twins were given a RUTF ration to limit sharing. Children with MAM from the same household were given the same food as the SAM child. Also, where there were study participants from the same household, they received the same food to prevent contamination of the allocated RUTF. It is unclear if information on participant adherence was collected. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caregivers were asked to bring the remaining RUTF to each visit, to check for adherence.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Extent of intervention fidelity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43 children switched from the SMS‐RUTF (control) to the P‐RUTF (S‐RUTF, experimental) arm. No children switched from P‐RUTF to SMS‐RUTF. The amount of RUTF consumed (adherence results) was not measured. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The median compliance on day 84 was 90% (range 80‐101) in the experimental arm and 96% (range 67‐100) in the control arm. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adherence results not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean utilisation of RUTF was 51.7% in the experimental arm and 48.1% in the control arm. Upon questioning, 41% of caregivers in the experimental arm versus 27% in the control arm reported they had either sold, given away, thrown away, lost the RUTF, or that it was eaten by animals. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><b>ALA:</b> alpha‐linolenic acid; <b>BP100:</b> solid biscuit made from cooked wheat; <b>CHW:</b> community health workers; <b>DHA:</b> docosahexaenoic acid; <b>F‐RUTF</b> : flax‐seed containing ready‐to‐use therapeutic food; <b>MAM:</b> Moderate acute malnutrition; <b>MUAC:</b> mid‐upper arm circumference; <b>P‐RUTF:</b> standard peanut‐based ready‐to‐eat therapeutic food; <b>RUTF:</b> Ready‐to‐use therapeutic food; <b>S‐RUTF:</b> standard ready‐to‐use therapeutic food; <b>SAM:</b> severe acute malnutrition; <b>SMS‐RUTF:</b> milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">TIDieR table: Comparison 3</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009000-tbl-0013"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Additional assessment of risk of bias in included cluster‐randomised trials</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recruitment bias</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Baseline imbalance</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Loss of clusters</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incorrect analysis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparability with individually‐randomised trials</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0003" title="CilibertoMA , SandigeH , NdekhaMJ , AshornP , BriendA , CilibertoHM , et al. Comparison of home‐based therapy with ready‐to‐use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition2005;81(4):864‐70. [DOI: 10.1093/ajcn/81.4.864; PUBMED: 15817865] ">Ciliberto 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Inadequate</b> </p> <p>Being a stepped‐wedge design, recruitment occurred after sites were assigned a specific treatment. All children eventually ended up with RUTF, although the time point at which conversion from standard care to RUTF took place was unknown. The study authors recognised that recruitment bias was possible: "a source of bias might have been that a mother of a moderately malnourished child might have visited the NRU for screening when she heard that home‐based therapy was being offered" (quote). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>Baseline characteristics per intervention arm were reported, but similarities and differences between clusters were not mentioned. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>All randomised children were included in the analyses.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>The study authors did not adjust their analyses for clustering, but did provide sufficient information to allow us calculate and apply an estimated design effect. However, we are unsure how close to the truth the estimated ICC is. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>For the 4 most important outcomes, the findings of this trial are in line with that of the individually‐randomised trials. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0006" title="IrenaAH , BahwereP , OwinoVO , DiopEI , BachmannMO , Mbwili‐MuleyaC , et al. Comparison of the effectiveness of a milk‐free soy‐maize‐sorghum‐based ready‐to‐use therapeutic food to standard ready‐to‐use therapeutic food with 25% milk in nutrition management of severely acutely malnourished Zambian children: an equivalence non‐blinded cluster randomised controlled trial. Maternal &amp; Child Nutrition2015;11(Suppl 4):105‐19. [DOI: 10.1111/mcn.12054; PUBMED: 23782554] ">Irena 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Inadequate</b> </p> <p>Children were recruited after randomisation of clusters (healthcare clinics). The study authors indicate that recruitment bias may have resulted in greater numbers of children attending the S‐RUTF sites: “....preferential referral to or attendance at the sites of the P‐RUTF arm” (quote). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>The study authors reported "...that many important baseline characteristics, such [as] prevalence of oedema, average MUAC, the presence of diarrhoea and presence of dehydration, differed<br/> between the two arms" (quote). However, they performed multivariable analyses to assess the effect of these differences on the outcomes and found that these variables did not appear to interact with the outcomes. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>All randomised children were included in the analyses.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>The study authors adjusted for clustering in their multivariate analyses and provided the ICC that they used. We used this ICC to adjust the raw counts provided in the paper. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>For the 4 most important outcomes, the findings of this trial are in line with that of the individually‐randomised trials. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0010" title="ManaryMJ , NdekhaMJ , AshornP , MaletaK , BriendA . Home based therapy for severe malnutrition with ready‐to‐use food. Archives of Disease in Childhood2004;89(6):557‐61. [PMC1719944; PUBMED: 15155403] ">Manary 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>The unit of systematic allocation was clusters, according to the day of discharge in the month. Children were recruited after discharge days and were allocated to a specific treatment. However, an independent doctor discharged the children without knowing which discharge days matched which treatment. Therefore, the risk of recruitment bias was minimised. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>Baseline characteristics per intervention arm were reported, but similarities and differences between children discharged on different days (i.e. clusters) were not mentioned. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>All randomised children were included in the analyses.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>The study authors did not adjust their analyses for clustering, but did provide sufficient information to calculate and apply an estimated design effect. However, we are unsure how close to the truth the estimated ICC is. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>The findings of this trial are in line with that of the individually randomised trial for the outcomes of 'recovery' and 'mortality', but not for the outcomes of 'relapse' and 'weight gain'. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0011" title="NdekhaMJ , ManaryMJ , AshornP , BriendA . Home‐based therapy with ready‐to‐use therapeutic food is of benefit to malnourished, HIV‐infected Malawian children. Acta Paediatrica2005;94(2):222‐5. [PUBMED: 15981758] ">Ndekha 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>The unit of systematic allocation was clusters, according to the week of discharge. Children were recruited after the weeks of discharge were allocated to a specific treatment. However, an independent doctor discharged the children without knowing which discharge weeks matched which treatment. Therefore, the risk of recruitment bias was minimised. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>Baseline characteristics per intervention arm were reported, but similarities and differences between children discharged during different weeks (i.e. clusters) were not mentioned. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adequate</b> </p> <p>All randomised children were included in the analyses.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>The study authors did not adjust their analyses for clustering, but did provide us with the number of clusters, which allowed us to calculate and apply an estimated design effect. However, we are unsure how close to the truth the estimated ICC is. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> <p>For 3 of the 4 most important outcomes, the findings of this trial are in line with that of the individually randomised trial. However, the findings for the outcome of 'relapse' were different, but this could be due to factors other than the study design as all children in this trial were HIV‐infected. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>ICC:</b> intracluster correlation coefficient; <b>MUAC:</b> mid‐upper arm circumference; <b>NRU:</b> nutrition rehabilitation unit; <b>RUTF:</b> ready‐to‐use therapeutic food; <b>S‐RUTF:</b> standard ready‐to‐use therapeutic food </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Additional assessment of risk of bias in included cluster‐randomised trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009000-tbl-0014"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Summary of cost‐ and cost‐effectiveness studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Author</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0070" title="BachmannMO . Cost effectiveness of community‐based therapeutic care for children with severe acute malnutrition in Zambia: decision tree model. Cost Effectiveness and Resource Allocation2009;7:2. [DOI: 10.1186/1478‐7547‐7‐2; PMC2630929; PUBMED: 19146668] ">Bachmann 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009000-bbs2-0086" title="GargCC , MazumderS , TanejaS , ShekharM , MohanSB , BoseA , et al. Costing of three feeding regimens for home‐based management of children with uncomplicated severe acute malnutrition from a randomised trial in India. BMJ Global Health2018;3:e000702. [DOI: 10.1136/bmjgh‐2017‐000702] ">Garg 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0104" title="IsanakaS , MenziesNA , SayyadJ , AyoolaM , GraisRF , DoyonS . Cost analysis of the treatment of severe acute malnutrition in West Africa. Maternal &amp; Child Nutrition2017;13(4):e12398. [DOI: 10.1111/mcn.12398; PUBMED: 27921381] ">Isanaka 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009000-bbs2-0126" title="RogersE , MartínezK , MoránJL , AléFG , CharleP , GuerreroS , et al. Cost‐effectiveness of the treatment of uncomplicated severe acute malnutrition by community health workers compared to treatment provided at an outpatient facility in rural Mali. Human Resources for Health2018;16(1):12. [DOI: 10.1186/s12960‐018‐0273‐0; PMC5819265; PUBMED: 29458382] ">Rogers 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0135" title="TekesteA , WondafrashM , AzeneG , DeribeK . Cost effectiveness of community‐based and in‐patient therapeutic feeding programs to treat severe acute malnutrition in Ethiopia. Cost Effectiveness and Resource Allocation2012;10:4. [DOI: 10.1186/1478‐7547‐10‐4; PMC3323427; PUBMED: 22429892] ">Tekeste 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0124" title="PuettC , SadlerK , AldermanH , CoatesJ , FiedlerJL , MyattM . Cost‐effectiveness of the community‐based management of severe acute malnutrition by community health workers in southern Bangladesh. Health Policy and Planning2013;28(4):386‐99. [DOI: 10.1093/heapol/czs070; PUBMED: 22879522] ">Puett 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009000-bbs2-0152" title="WilfordR , GoldenK , WalkerDG . Cost‐effectiveness of community‐based management of acute malnutrition in Malawi. Health Policy and Planning2012;27(2):127‐37. [DOI: 10.1093/heapol/czr017; PUBMED: 21378101] ">Wilford 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention assessed</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM compared to a hypothetical alternative of providing no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Home‐based management of SAM in a community setting: 2 different RUTF feeding regimens were compared against an energy‐dense, home‐prepared food regimen </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Routine inpatient and outpatient management CMAM of SAM. There was no control group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHW delivered treatment of SAM compared to outpatient facility‐based care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CTC of SAM in comparison to facility‐based TFC care in emergencies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community‐based management of SAM added to a community‐based health and nutrition programme versus inpatient treatment augmented with community surveillance by CHW </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community‐based management of acute malnutrition integrated into health services in comparison to health services with no CMAM </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Location</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zambia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>India</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Niger</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mali</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ethiopia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bangladesh</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Malawi</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children &lt; 5 years with SAM (MUAC &lt; 11 cm, or bilateral pitting oedema)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 6 months‐5 years with uncomplicated SAM (WHZ &lt; ‐3, or oedema, or both)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 6 months‐5 years with uncomplicated or complicated SAM</p> <p>(MUAC &lt; 115 mm, or WHZ &lt; ‐3 and MUAC &gt; 115 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 6‐59 months with uncomplicated SAM</p> <p>(MUAC &lt; 115 mm, WHZ &lt; ‐3, or bilateral oedema)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children with SAM (age and diagnostic criteria used for eligible participants not reported) that required treatment during a drought crisis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children aged 6‐36 months with uncomplicated SAM</p> <p>(MUAC &lt; 110 mm, or oedema, or both)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children &lt; 5 years old with SAM (oedema or wasting); defaulters and readmissions were included </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type of analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cost‐effectiveness analysis based on a</p> <p>decision tree model</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Costing analysis where the costs were calculated per week per child for activities under research setting and estimated for the activities that are likely to be done under the government setting </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cost analysis of in‐ and outpatient treatment, including cost of F‐75, F‐100, and RUTF (Plumpy'nut®) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Activity‐based cost analysis was developed. Costs were estimated via document review, interviews and focus groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective comparative cost‐effectiveness evaluation of therapeutic feeding programmes in emergencies. </p> <p>Assessed parental costs by interview. Sourced other costs from existing data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cost‐effectiveness analysis of CMAM delivered by CHW versus inpatient treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cost effectiveness analysis based on a decision tree model.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Perspective taken</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health services</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health services</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health services</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Societal perspective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Societal perspective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Societal perspective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health services</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Major outcome(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recovery during treatment period (WHZ &gt; ‐2), and absence of oedema in the feet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not applicable, as cost analysis and not cost‐effectiveness analysis was done</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recovery rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cure rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death, recovery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death, cure, default or non‐recovery</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Main cost category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF, health centre visit, programme establishment, hospitalisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human resources (per week per child based on salaries and time taken) and consumables (RUTF, medicines) and programmatic and administrative costs. Estimated cost of resources that would be used in the government setting </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient: therapeutic food and personnel</p> <p>Inpatient: personnel, transport and logistical support and therapeutic food</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All costs incurred by institutions, beneficiaries and communities were included. Variable costs per child were costs to households and RUTF costs (that included its purchase, storage, security and transport costs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Healthcare costs and costs to parents were assessed (the latter by using questionnaires).</p> <p>Personnel, capital depreciation and utilities, medication, RUTF or milk‐based formula, caretakers' food, non‐food items </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total costs to households (transport, time, food) and the health service (personnel, supervision, training, medication, therapeutic feeds including RUTF) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Administration, personnel, transport, RUTF, therapeutic milk, medication, and bed costs </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Currency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>International dollars</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD and INR (USD 1 = 62 rupees)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Euros</p> <p>(EUR 1 = 656 XOF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD</p> <p>(USD 1 = 67.94 BDT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD</p> <p>(USD 1 = 140 MWK)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Price year</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013 and 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TFC: July 2003‐January 2004; CTC: July 2005 to April 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2007 (Janauary‐December)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (one‐ and two‐way analysis)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (one‐way)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (univariate, multivariate probabilistic, and modelled scenario sensitivity analyses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was done, but not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (one‐way)</p> <p>Relative effect of different inputs on the DALYs averted in community and inpatient treatment </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes (one‐way)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Result summary</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM cost USD 203 per child</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Average total cost per treated child in the government setting was estimated at USD 56 (&lt; 3500 rupees)<br/> <br/> <br/> <br/> No significant difference in costs was detected across the 3 feeding regimens </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total cost was EUR 148.86 per child</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The average cost per child treated by CHWs was USD 244 compared to USD 442 in the outpatient facility. The cost per child recovered was USD 259 by CHWs and USD 501 in the outpatient facility </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institutional cost:</p> <p>TFC: USD 262.62</p> <p>CMAM: USD 128.58</p> <p>Costs to care‐givers:</p> <p>TFC USD 0.92 + USD 21.01 = USD 21.93</p> <p>CTC USD 0.42 + USD 5.87 = USD 6.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM:</p> <p>USD 165 per child;</p> <p>cost per child recovered USD 180;</p> <p>cost per death averted USD 869;</p> <p>cost per DALY averted USD 26</p> <p>Inpatient treatment:</p> <p>USD 1344;</p> <p>cost per child recovered USD 9149;</p> <p>cost per death averted USD 45688;</p> <p>cost per DALY averted USD 1344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The total cost of providing CMAM was USD 470,703, and for non‐CMAM (USD 23,394) treatment for SAM in Dowa district (scenario 1) was USD 494,097 </p> <p>USD 42 per DALY averted (or USD 1365 per</p> <p>life saved)</p> <p>Average cost per child treated in CMAM: USD 169.3 (140.3 to 211.6)</p> <p>Average cost per child treated in non‐CMAM: USD 16.7 (12.5 to 20.9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RUTF cost</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 72.52 (mean) per child, i.e. 35.8% of the total cost</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 36.4 per child treated in the government setting; that is 65% of total average cost </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM: RUTF cost was 44% (EUR 32.98 per child) of total cost</p> <p>Inpatient care: RUTF cost was 11% (EUR 14.34 per child) of total cost</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF's average cost per treated child was (17795+5648)/(617+212) = USD 28.8;</p> <p>(RUTF costs were 11.8% of total cost in the CHWs group and 6.0% of total cost in the outpatient facility group) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Facility‐based: USD 42.93 (mean) per child, that is 16.35% of total cost</p> <p>CMAM: USD 55.53 (mean) per child, that is 43.19% of total cost</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 36.36 per child enrolled, that is 24% of total cost of CMAM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF was USD 169.3, that is 32% of total cost of CMAM</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cost per death averted</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 1760</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM: USD 869</p> <p>Inpatient treatment: USD 45688</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 1365</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cost per DALY averted</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CMAM: USD 26</p> <p>Inpatient treatment: USD 1344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USD 42</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Production</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Valid International</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RUTF‐C was produced by Comparct Foods Ltd, India; RUTF‐L was prepared at each participating site in a designated room </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified, but implied that the RUTF came from Nutriset, France as Plumpy'nut® was used </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UNICEF provided the RUTF for the study; unclear who produced it</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified, but implied that imported RUTF was used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Plumpy'nut®, Nutriset France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified, but implied that imported RUTF was used</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Funder</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Valid International and Concern</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bill and Melinda Gates Foundation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study authors reported that there was no funding for the preparation of the manuscript</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Innocent Foundation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Jimma University</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GAIN, the Global Alliance for Improved Nutrition. Additional support was provided by the Feinstein International Center at Tufts University </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Concern Worldwide</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CHW:</b> community health worker; <b>CMAM:</b> community‐based management of acute malnutrition; <b>CTC:</b> community‐based therapeutic care; <b>DALY:</b> disability‐adjusted life year; <b>MUAC:</b> mid‐upper arm circumference; <b>RUTF:</b> ready‐to‐use therapeutic food; <b>RUTF‐C:</b> commercially produced ready‐to‐eat therapeutic food; <b>RUTF‐L:</b> locally produced ready‐to‐eat therapeutic food; <b>SAM:</b> severe acute malnutrition; <b>TFC:</b> therapeutic feeding centre; <b>WHZ:</b> weight for height z score </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Summary of cost‐ and cost‐effectiveness studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/full#CD009000-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009000-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recovery during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1852</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [1.16, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recovery during intervention: pre‐trial hospitalisation subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1852</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [1.16, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 All children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>568</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [1.04, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Some children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [1.08, 1.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 No children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.0 [0.83, 43.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Recovery at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>907</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.83, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Relapse during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.30, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Relapse during intervention: pre‐trial hospitalisation subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.30, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 All children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.17, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Some children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.53, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Relapse during intervention: factory‐ versus local site‐produced subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.41, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Factory‐produced</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1048</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.29, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Local site‐produced</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.51, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Relapse during intervention: HIV status subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.30, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 HIV‐uninfected or untested</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.34, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 HIV‐infected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.07, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Relapse at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mortality during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.51, 2.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mortality during intervention: pre‐trial hospitalisation subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.51, 2.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 All children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.53, 4.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Some children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.20, 3.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Rate of weight gain (g/kg/day) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.27, 1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Rate of weight gain (g/kg/day) during intervention: pre‐trial hospitalisation subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.27, 1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 All children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>243</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.32, 2.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Some children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.16, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Rate of weight gain (g/kg/day) during intervention: factory‐ versus local site‐produced subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.34, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Factory‐produced</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.08, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Local site‐produced</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.15, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Rate of weight gain (g/kg/day) during intervention: HIV status subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.27, 1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 HIV‐uninfected or untested</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.08, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 HIV‐infected</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [‐0.64, 2.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Time to recovery (days) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>556</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.61 [‐12.84, ‐2.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Weight‐for‐height z score (WHZ) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 WHZ at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>937</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.04, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Length/height gain (mm/day) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>417</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.00, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Height‐for‐age z score (HAZ) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Mid‐upper arm circumference (MUAC) gain (mm/day) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>570</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.04, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 MUAC gain (cm) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Diarrhoea events during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Days of diarrhoea during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Acceptability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Standard RUTF provided at a dose that meets total daily nutritional requirements versus an alternative dietary approach</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009000-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recovery during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [1.19, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 HIV‐uninfected children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [1.15, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 HIV‐infected children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [1.01, 2.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Relapse during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 HIV‐uninfected children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.00, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 HIV‐infected children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 3.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mortality during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.46, 4.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 HIV‐uninfected children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.07 [0.36, 12.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 HIV‐infected children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.26, 4.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rate of weight gain (g/kg/day) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [‐0.74, 3.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 HIV‐uninfected children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [1.12, 3.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 HIV‐infected children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐1.53, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Time to recovery (days) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 WHZ at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Length/height gain (mm/day) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 MUAC gain (mm/day) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.01, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 HIV‐uninfected children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.03, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 HIV‐infected children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.14, 0.20]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Standard RUTF provided at a dose that meets total daily nutritional requirements versus as a supplement to the usual diet</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009000-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Standard RUTF versus RUTF using an alternative formulation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recovery during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.99, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recovery during intervention: pre‐trial hospitalisation subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.99, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 All children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.83, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Some children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.85, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 No children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.99, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Relapse during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.72, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Relapse during intervention: pre‐trial hospitalisation subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.72, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 All children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.66, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Some children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.44, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 No children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.68, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mortality during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.80, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mortality during intervention: pre‐trial hospitalisation subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.80, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 All children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.86, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Some children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>762</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.16, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 No children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.67, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Rate of weight gain (g/kg/day) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3807</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.32, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Rate of weight gain (g/kg/day) during intervention: pre‐trial hospitalisation subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3807</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.32, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 All children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.87, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Some children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>650</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.47, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 No children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2506</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [‐0.40, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Rate of weight gain (g/kg/day) during intervention: different types of control RUTF subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3807</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.32, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Less or no milk powder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [‐0.10, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Standard plus fatty acids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.74, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Standard plus pre‐ and probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.87, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Time to recovery (days) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 WHZ during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.36, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 WHZ during intervention: pre‐trial hospitalisation subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.36, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Some children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.40, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 No children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.62, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 WHZ during intervention: different types of control RUTF subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.36, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Less or no milk powder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1949</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.11, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Standard plus fatty acids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.45 [‐0.83, ‐0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 WHZ during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1949</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.06, 0.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Length/height gain (mm/day) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.09, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Length/height gain (mm/day) during intervention: pre‐trial hospitalisation subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.09, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Some children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.15, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 No children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.14, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Length/height gain (mm/day) during intervention: different types of control RUTF subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.09, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Less or no milk powder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1949</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.02, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 Standard plus fatty acids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.21, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 HAZ during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1949</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.04, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 MUAC gain (mm/day) during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2089</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.02, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 MUAC gain (mm/day) during intervention: pre‐trial hospitalisation subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2089</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.02, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Some children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.01, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 No children hospitalised pre‐trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.11, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 MUAC gain (mm/day) during intervention: different types of control RUTF subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2089</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.02, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Less or no milk powder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1948</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.02, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 Standard plus fatty acids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.17, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Diarrhoea events during intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Acceptability on first day of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Acceptability: grams of food remained after taste test <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Acceptability after first 2 weeks of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Standard RUTF versus RUTF using an alternative formulation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009000.pub3/references#CD009000-tbl-0017">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009000.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009000-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009000-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009000-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD009000-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD009000-note-0001">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009000-note-0022">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009000\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009000\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009000\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009000\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009000\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009000.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009000.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009000.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009000.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009000.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714065156"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009000.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714065160"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009000.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d659219b6937d',t:'MTc0MDcxNDA2NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 